CONSOLIDATED SCHEDULE OF INVESTMENTS

v3.23.2

CONSOLIDATED SCHEDULE OF INVESTMENTS £ in Thousands, $ in Thousands		Jun. 30, 2023 USD ($) shares		Jun. 30, 2023 GBP (£) shares		Dec. 31, 2022 USD ($) shares		Dec. 31, 2022 GBP (£) shares
Investment Holding [Line Items]
Investment, Basis Spread, Variable Rate		8.25%		8.25%		7.50%		7.50%
Investment cost		$ 3,114,097				$ 3,005,696
Investments at Fair Value		3,112,789				$ 2,963,955
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Class A Units
Investment Holding [Line Items]
Investment cost	[1],[2]	238
Investments at Fair Value	[1]	$ 222
Shares | shares	[1]	69,239		69,239
Investments Owned Acquisition Date	[1],[3]	Dec. 27, 2022		Dec. 27, 2022
Investment, Identifier [Axis]: Debt Investments (185.30%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	185.30%		185.30%
Investment cost	[2]	$ 2,936,952
Investments at Fair Value		$ 2,937,942
Investment, Identifier [Axis]: Debt Investments (199.47%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					199.47%		199.47%
Investment cost	[6]					$ 2,818,060
Investments at Fair Value						$ 2,795,444
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (2.08%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	2.08%		2.08%
Investment cost	[2]	$ 32,724
Investments at Fair Value		$ 33,024
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (2.31%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					2.31%		2.31%
Investment cost	[6]					$ 32,339
Investments at Fair Value						$ 32,339
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and Alamar Biosciences, Inc. Senior Secured, Maturity Date June 2026, Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee
Investment Holding [Line Items]
Maturity Date		2026-06	[7],[8],[9]	2026-06	[7],[8],[9]	2026-06	[10]	2026-06	[10]
Investments Maturity Month and Year		2026-06	[7],[8],[9]	2026-06	[7],[8],[9]	2026-06	[10]	2026-06	[10]
Investment, Basis Spread, Variable Rate		3.00%	[7],[8],[9],[11]	3.00%	[7],[8],[9],[11]	3.00%	[10],[12]	3.00%	[10],[12]
Investment, Interest Rate, Floor		6.50%	[7],[8],[9],[11]	6.50%	[7],[8],[9],[11]	6.50%	[10],[12]	6.50%	[10],[12]
Investment, Interest Rate, Paid in Kind		1.00%	[7],[8],[9],[11]	1.00%	[7],[8],[9],[11]	1.00%	[10],[12]	1.00%	[10],[12]
Principal Amount		$ 5,023	[7],[8],[9]			$ 5,000	[10]
Investment cost		5,028	[2],[7],[8],[9]			4,951	[6],[10]
Investments at Fair Value		$ 5,055	[7],[8],[9]			$ 4,951	[10]
Investment Exit Fee		5.95%	[7],[8],[9],[11]	5.95%	[7],[8],[9],[11]	5.95%	[10],[12]	5.95%	[10],[12]
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and PathAI, Inc., Senior Secured, Maturity Date January 2027, Prime + 2.15%, Floor rate 9.15%, 11.21% Exit Fee
Investment Holding [Line Items]
Maturity Date		2027-01	[9]	2027-01	[9]	2027-01	[10]	2027-01	[10]
Investments Maturity Month and Year		2027-01	[9]	2027-01	[9]	2027-01	[10]	2027-01	[10]
Investment, Basis Spread, Variable Rate		2.15%	[9],[11]	2.15%	[9],[11]	2.15%	[10],[12]	2.15%	[10],[12]
Investment, Interest Rate, Floor		9.15%	[9],[11]	9.15%	[9],[11]	9.15%	[10],[12]	9.15%	[10],[12]
Principal Amount		$ 28,000	[9]			$ 28,000	[10]
Investment cost		27,696	[2],[9]			27,388	[6],[10]
Investments at Fair Value		$ 27,969	[9]			$ 27,388	[10]
Investment Exit Fee		11.21%	[9],[11]	11.21%	[9],[11]	11.21%	[10],[12]	11.21%	[10],[12]
Investment, Identifier [Axis]: Debt Investments Communications & Networking (6.64%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	6.64%		6.64%
Investment cost	[2]	$ 104,713
Investments at Fair Value		$ 105,219
Investment, Identifier [Axis]: Debt Investments Communications & Networking (7.26%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					7.26%		7.26%
Investment cost	[6]					$ 99,167
Investments at Fair Value						$ 101,734
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Aryaka Networks, Inc. Senior Secured, Maturity Date July 2026, Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee
Investment Holding [Line Items]
Maturity Date		2026-07	[7],[9],[13]	2026-07	[7],[9],[13]	2026-07	[10],[14],[15]	2026-07	[10],[14],[15]
Investments Maturity Month and Year		2026-07	[7],[9],[13]	2026-07	[7],[9],[13]	2026-07	[10],[14],[15]	2026-07	[10],[14],[15]
Investment, Basis Spread, Variable Rate		3.25%	[7],[9],[11],[13]	3.25%	[7],[9],[11],[13]	3.25%	[10],[12],[14],[15]	3.25%	[10],[12],[14],[15]
Investment, Interest Rate, Floor		6.75%	[7],[9],[11],[13]	6.75%	[7],[9],[11],[13]	6.75%	[10],[12],[14],[15]	6.75%	[10],[12],[14],[15]
Investment, Interest Rate, Paid in Kind		1.05%	[7],[9],[11],[13]	1.05%	[7],[9],[11],[13]	1.05%	[10],[12],[14],[15]	1.05%	[10],[12],[14],[15]
Principal Amount		$ 15,073	[7],[9],[13]			$ 5,023	[10],[14],[15]
Investment cost		14,922	[2],[7],[9],[13]			4,969	[6],[10],[14],[15]
Investments at Fair Value		$ 15,407	[7],[9],[13]			$ 5,053	[10],[14],[15]
Investment Exit Fee		3.55%	[7],[9],[11],[13]	3.55%	[7],[9],[11],[13]	3.55%	[10],[12],[14],[15]	3.55%	[10],[12],[14],[15]
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Cytracom Holdings LLC Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.31%, Floor rate 10.31%
Investment Holding [Line Items]
Maturity Date	[10],[16],[17]					2025-02		2025-02
Investments Maturity Month and Year	[10],[16],[17]					2025-02		2025-02
Investment, Basis Spread, Variable Rate	[10],[12],[16],[17]					9.31%		9.31%
Investment, Interest Rate, Floor	[10],[12],[16],[17]					10.31%		10.31%
Principal Amount	[10],[16],[17]					$ 8,910
Investment cost	[6],[10],[16],[17]					8,768
Investments at Fair Value	[10],[16],[17]					$ 8,748
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Cytracom Holdings LLC Senior Secured, Maturity Date February 2025, 3-month SOFR + 9.62%, Floor rate 10.62%
Investment Holding [Line Items]
Maturity Date	[9],[18],[19]	2025-02		2025-02
Investments Maturity Month and Year	[9],[18],[19]	2025-02		2025-02
Investment, Basis Spread, Variable Rate	[9],[11],[18],[19]	9.62%		9.62%
Investment, Interest Rate, Floor	[9],[11],[18],[19]	10.62%		10.62%
Principal Amount	[9],[18],[19]	$ 3,284
Investment cost	[2],[9],[18],[19]	3,245
Investments at Fair Value	[9],[18],[19]	$ 3,266
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Rocket Lab Global Services, LLC Senior Secured, Maturity Date June 2024, Prime + 4.90%, Floor rate 8.15%, PIK Interest 1.25%, 3.25% Exit Fee
Investment Holding [Line Items]
Maturity Date		2024-06	[7],[8],[18],[20],[21]	2024-06	[7],[8],[18],[20],[21]	2024-06	[15],[16],[22],[23],[24]	2024-06	[15],[16],[22],[23],[24]
Investments Maturity Month and Year		2024-06	[7],[8],[18],[20],[21]	2024-06	[7],[8],[18],[20],[21]	2024-06	[15],[16],[22],[23],[24]	2024-06	[15],[16],[22],[23],[24]
Investment, Basis Spread, Variable Rate		4.90%	[7],[8],[11],[18],[20],[21]	4.90%	[7],[8],[11],[18],[20],[21]	4.90%	[12],[15],[16],[22],[23],[24]	4.90%	[12],[15],[16],[22],[23],[24]
Investment, Interest Rate, Floor		8.15%	[7],[8],[11],[18],[20],[21]	8.15%	[7],[8],[11],[18],[20],[21]	8.15%	[12],[15],[16],[22],[23],[24]	8.15%	[12],[15],[16],[22],[23],[24]
Investment, Interest Rate, Paid in Kind		1.25%	[7],[8],[11],[18],[20],[21]	1.25%	[7],[8],[11],[18],[20],[21]	1.25%	[12],[15],[16],[22],[23],[24]	1.25%	[12],[15],[16],[22],[23],[24]
Principal Amount		$ 85,103	[7],[8],[18],[20],[21]			$ 84,581	[15],[16],[22],[23],[24]
Investment cost		86,546	[2],[7],[8],[18],[20],[21]			85,430	[6],[15],[16],[22],[23],[24]
Investments at Fair Value		$ 86,546	[7],[8],[18],[20],[21]			$ 87,933	[15],[16],[22],[23],[24]
Investment Exit Fee		3.25%	[7],[8],[11],[18],[20],[21]	3.25%	[7],[8],[11],[18],[20],[21]	3.25%	[12],[15],[16],[22],[23],[24]	3.25%	[12],[15],[16],[22],[23],[24]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services (28.15%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	28.15%		28.15%
Investment cost	[2]	$ 461,172
Investments at Fair Value		$ 446,342
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services (30.59%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					30.59%		30.59%
Investment cost	[6]					$ 444,703
Investments at Fair Value						$ 428,750
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and AppDirect, Inc. Senior Secured, Maturity Date April 2026, Prime + 5.50%, Floor rate 8.75%, 7.12% Exit Fee
Investment Holding [Line Items]
Maturity Date	[9],[20]	2026-04		2026-04
Investments Maturity Month and Year	[9],[20]	2026-04		2026-04
Investment, Basis Spread, Variable Rate	[11],[20]	5.50%		5.50%
Investment, Interest Rate, Floor	[9],[11],[20]	8.75%		8.75%
Principal Amount	[20]	$ 55,790
Investment cost	[2],[20]	57,154
Investments at Fair Value	[20]	$ 58,178
Investment Exit Fee	[9],[11],[20]	7.12%		7.12%
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and AppDirect, Inc. Senior Secured, Maturity Date April 2026, Prime + 5.50%, Floor rate 8.75%, 8.29% Exit Fee
Investment Holding [Line Items]
Maturity Date	[10],[23]					2026-04		2026-04
Investments Maturity Month and Year	[10],[23]					2026-04		2026-04
Investment, Basis Spread, Variable Rate	[10],[12],[23]					5.50%		5.50%
Investment, Interest Rate, Floor	[10],[12],[23]					8.70%		8.70%
Principal Amount	[10],[23]					$ 40,790
Investment cost	[6],[10],[23]					41,856
Investments at Fair Value	[10],[23]					$ 42,426
Investment Exit Fee	[10],[12],[23]					8.29%		8.29%
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Carwow LTD Senior Secured, Maturity Date December 2024, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 4.95% Exit Fee
Investment Holding [Line Items]
Maturity Date		2024-12	[7],[9],[25],[26]	2024-12	[7],[9],[25],[26]	2024-12	[15],[27],[28]	2024-12	[15],[27],[28]
Investments Maturity Month and Year		2024-12	[7],[9],[25],[26]	2024-12	[7],[9],[25],[26]	2024-12	[15],[27],[28]	2024-12	[15],[27],[28]
Investment, Basis Spread, Variable Rate		4.70%	[7],[9],[11],[25],[26]	4.70%	[7],[9],[11],[25],[26]	4.70%	[12],[15],[27],[28]	4.70%	[12],[15],[27],[28]
Investment, Interest Rate, Floor		7.95%	[7],[9],[11],[25],[26]	7.95%	[7],[9],[11],[25],[26]	7.95%	[12],[15],[27],[28]	7.95%	[12],[15],[27],[28]
Investment, Interest Rate, Paid in Kind		1.45%	[7],[9],[11],[25],[26]	1.45%	[7],[9],[11],[25],[26]	1.45%	[12],[15],[27],[28]	1.45%	[12],[15],[27],[28]
Principal Amount | £				£ 19,327	[7],[9],[25],[26]			£ 18,890	[15],[27],[28]
Investment cost				26,412	[2],[7],[9],[25],[26]	$ 26,024	[6],[15],[27],[28]
Investments at Fair Value				£ 24,845	[7],[9],[25],[26]	$ 22,971	[15],[27],[28]
Investment Exit Fee		4.95%	[7],[9],[11],[25],[26]	4.95%	[7],[9],[11],[25],[26]	4.95%	[12],[15],[27],[28]	4.95%	[12],[15],[27],[28]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Collective Health, Inc. Senior Secured, Maturity Date September 2023, Prime + 4.75%, Floor rate 12.50%
Investment Holding [Line Items]
Maturity Date		2023-09		2023-09
Investments Maturity Month and Year		2023-09		2023-09
Investment, Basis Spread, Variable Rate	[11]	4.75%		4.75%
Investment, Interest Rate, Floor	[11]	12.50%		12.50%
Principal Amount		$ 4,000
Investment cost	[2]	3,985
Investments at Fair Value		$ 3,985
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Houzz, Inc. Convertible Debt, Maturity Date May 2028, PIK Interest 5.50%
Investment Holding [Line Items]
Maturity Date	[15],[29]					2028-05		2028-05
Investments Maturity Month and Year	[15],[29]					2028-05		2028-05
Investment, Interest Rate, Paid in Kind	[12],[15],[29]					5.50%		5.50%
Principal Amount	[15],[29]					$ 21,853
Investment cost	[6],[15],[29]					21,853
Investments at Fair Value	[15],[29]					$ 20,356
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Houzz, Inc. Convertible Debt, Maturity Date May 2028, PIK Interest 7.00%
Investment Holding [Line Items]
Maturity Date	[7],[30]	2028-05		2028-05
Investments Maturity Month and Year	[7],[30]	2028-05		2028-05
Investment, Interest Rate, Paid in Kind	[7],[11],[30]	7.00%		7.00%
Principal Amount	[7],[30]	$ 22,494
Investment cost	[2],[7],[30]	22,494
Investments at Fair Value	[7],[30]	$ 22,407
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Jobandtalent USA, Inc. Senior Secured, Maturity Date February 2025, 1-month SOFR + 8.75%, Floor rate 9.75%, 3.00% Exit Fee
Investment Holding [Line Items]
Maturity Date	[25],[26]	2025-02		2025-02
Investments Maturity Month and Year	[25],[26]	2025-02		2025-02
Investment, Basis Spread, Variable Rate	[11],[25],[26]	8.75%		8.75%
Investment, Interest Rate, Floor	[11],[25],[26]	9.75%		9.75%
Principal Amount	[25],[26]	$ 14,000
Investment cost	[2],[25],[26]	13,969
Investments at Fair Value	[25],[26]	$ 14,056
Investment Exit Fee	[11],[25],[26]	3.00%		3.00%
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Jobandtalent USA, Inc. Senior Secured, Maturity Date February 2025, 1-month SOFR + 8.86%, Floor rate 9.75%, 3.00% Exit Fee
Investment Holding [Line Items]
Maturity Date	[27],[28]					2025-02		2025-02
Investments Maturity Month and Year	[27],[28]					2025-02		2025-02
Investment, Basis Spread, Variable Rate	[12],[27],[28]					8.86%		8.86%
Investment, Interest Rate, Floor	[12],[27],[28]					9.75%		9.75%
Principal Amount	[27],[28]					$ 14,000
Investment cost	[6],[27],[28]					13,853
Investments at Fair Value	[27],[28]					$ 13,904
Investment Exit Fee	[12],[27],[28]					3.00%		3.00%
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Provi, Senior Secured, Maturity Date December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee
Investment Holding [Line Items]
Maturity Date		2026-12	[1]	2026-12	[1]	2026-12	[31]	2026-12	[31]
Investments Maturity Month and Year		2026-12	[1]	2026-12	[1]	2026-12	[31]	2026-12	[31]
Investment, Basis Spread, Variable Rate		4.40%	[1],[11]	4.40%	[1],[11]	4.40%	[12],[31]	4.40%	[12],[31]
Investment, Interest Rate, Floor		10.65%	[1],[11]	10.65%	[1],[11]	10.65%	[12],[31]	10.65%	[12],[31]
Principal Amount		$ 15,000	[1]			$ 15,000	[31]
Investment cost		14,819	[1],[2]			14,739	[6],[31]
Investments at Fair Value		$ 14,745	[1]			$ 14,739	[31]
Investment Exit Fee		2.95%	[1],[11]	2.95%	[1],[11]	2.95%	[12],[31]	2.95%	[12],[31]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, Maturity Date December 2026, 3-month LIBOR + 5.50%, Floor rate 6.50%, PIK Interest 4.00%
Investment Holding [Line Items]
Maturity Date		2026-12	[1],[7],[8],[9]	2026-12	[1],[7],[8],[9]	2026-12	[10],[15],[22],[31]	2026-12	[10],[15],[22],[31]
Investments Maturity Month and Year		2026-12	[1],[7],[8],[9]	2026-12	[1],[7],[8],[9]	2026-12	[10],[15],[22],[31]	2026-12	[10],[15],[22],[31]
Investment, Basis Spread, Variable Rate		5.50%	[1],[7],[8],[9],[11]	5.50%	[1],[7],[8],[9],[11]	5.50%	[10],[12],[15],[22],[31]	5.50%	[10],[12],[15],[22],[31]
Investment, Interest Rate, Floor		6.50%	[1],[7],[8],[9],[11]	6.50%	[1],[7],[8],[9],[11]	6.50%	[10],[12],[15],[22],[31]	6.50%	[10],[12],[15],[22],[31]
Investment, Interest Rate, Paid in Kind		4.00%	[1],[7],[8],[9],[11]	4.00%	[1],[7],[8],[9],[11]	4.00%	[10],[12],[15],[22],[31]	4.00%	[10],[12],[15],[22],[31]
Principal Amount		$ 28,296	[1],[7],[8],[9]			$ 27,730	[10],[15],[22],[31]
Investment cost		27,892	[1],[2],[7],[8],[9]			27,265	[6],[10],[15],[22],[31]
Investments at Fair Value		$ 28,114	[1],[7],[8],[9]			$ 27,256	[10],[15],[22],[31]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Rhino Labs, Inc. Senior Secured, Maturity Date March 2024, Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25%
Investment Holding [Line Items]
Maturity Date		2024-03	[1],[7]	2024-03	[1],[7]	2024-03	[15],[31]	2024-03	[15],[31]
Investments Maturity Month and Year		2024-03	[1],[7]	2024-03	[1],[7]	2024-03	[15],[31]	2024-03	[15],[31]
Investment, Basis Spread, Variable Rate		5.50%	[1],[7],[11]	5.50%	[1],[7],[11]	5.50%	[12],[15],[31]	5.50%	[12],[15],[31]
Investment, Interest Rate, Floor		8.75%	[1],[7],[11]	8.75%	[1],[7],[11]	8.75%	[12],[15],[31]	8.75%	[12],[15],[31]
Investment, Interest Rate, Paid in Kind		2.25%	[1],[7],[11]	2.25%	[1],[7],[11]	2.25%	[12],[15],[31]	2.25%	[12],[15],[31]
Principal Amount		$ 12,908	[1],[7]			$ 16,500	[15],[31]
Investment cost		12,841	[1],[2],[7]			16,328	[6],[15],[31]
Investments at Fair Value		12,841	[1],[7]			$ 16,496	[15],[31]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc.
Investment Holding [Line Items]
Principal Amount		83,260
Investment cost	[2]	82,697
Investments at Fair Value		$ 83,525
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date July 2025, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%
Investment Holding [Line Items]
Maturity Date	[9],[21]	2025-07		2025-07
Investments Maturity Month and Year	[9],[21]	2025-07		2025-07
Investment, Basis Spread, Variable Rate	[9],[11],[21]	2.50%		2.50%
Investment, Interest Rate, Floor	[9],[11],[21]	10.75%		10.75%
Investment, Interest Rate, Paid in Kind	[9],[11],[21]	0.50%		0.50%
Principal Amount	[9],[21]	$ 58,125
Investment cost	[2],[9],[21]	57,689
Investments at Fair Value	[9],[21]	$ 57,689
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date June 2023, Prime + 5.00%, Floor rate 10.50%, PIK Interest 0.50%
Investment Holding [Line Items]
Maturity Date	[15],[22],[23],[24]					2023-06		2023-06
Investments Maturity Month and Year	[15],[22],[23],[24]					2023-06		2023-06
Investment, Basis Spread, Variable Rate	[12],[15],[22],[23],[24]					5.00%		5.00%
Investment, Interest Rate, Floor	[12],[15],[22],[23],[24]					10.50%		10.50%
Investment, Interest Rate, Paid in Kind	[12],[15],[22],[23],[24]					0.50%		0.50%
Principal Amount	[15],[22],[23],[24]					$ 60,915
Investment cost	[6],[15],[22],[23],[24]					60,721
Investments at Fair Value	[15],[22],[23],[24]					$ 60,721
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%
Investment Holding [Line Items]
Maturity Date	[15],[16],[24]					2026-05		2026-05
Investments Maturity Month and Year	[15],[16],[24]					2026-05		2026-05
Investment, Basis Spread, Variable Rate	[12],[15],[16],[24]					7.00%		7.00%
Investment, Interest Rate, Floor	[12],[15],[16],[24]					10.50%		10.50%
Investment, Interest Rate, Paid in Kind	[12],[15],[16],[24]					0.50%		0.50%
Principal Amount	[15],[16],[24]					$ 25,071
Investment cost	[6],[15],[16],[24]					24,912
Investments at Fair Value	[15],[16],[24]					$ 25,823
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc., Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.05%, 1.00% Exit Fee
Investment Holding [Line Items]
Maturity Date	[7],[9],[18],[21]	2026-05		2026-05
Investments Maturity Month and Year	[7],[9],[18],[21]	2026-05		2026-05
Investment, Basis Spread, Variable Rate	[7],[9],[11],[18],[21]	7.00%		7.00%
Investment, Interest Rate, Floor	[7],[9],[11],[18],[21]	10.50%		10.50%
Investment, Interest Rate, Cap	[7],[9],[11],[18],[21]	0.50%		0.50%
Principal Amount	[7],[9],[18],[21]	$ 25,135
Investment cost	[2],[7],[9],[18],[21]	25,008
Investments at Fair Value	[7],[9],[18],[21]	$ 25,836
Investment Exit Fee	[7],[9],[11],[18],[21]	1.00%		1.00%
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Skyword, Inc. Senior Secured, Maturity Date November 2026, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee
Investment Holding [Line Items]
Maturity Date		2026-11	[7],[8]	2026-11	[7],[8]	2026-11	[15],[22]	2026-11	[15],[22]
Investments Maturity Month and Year		2026-11	[7],[8]	2026-11	[7],[8]	2026-11	[15],[22]	2026-11	[15],[22]
Investment, Basis Spread, Variable Rate		2.75%	[7],[8],[11]	2.75%	[7],[8],[11]	2.75%	[12],[15],[22]	2.75%	[12],[15],[22]
Investment, Interest Rate, Floor		9.25%	[7],[8],[11]	9.25%	[7],[8],[11]	9.25%	[12],[15],[22]	9.25%	[12],[15],[22]
Investment, Interest Rate, Paid in Kind		1.75%	[7],[8],[11]	1.75%	[7],[8],[11]	1.75%	[12],[15],[22]	1.75%	[12],[15],[22]
Principal Amount		$ 9,087	[7],[8]			$ 9,007	[15],[22]
Investment cost		9,051	[2],[7],[8]			8,918	[6],[15],[22]
Investments at Fair Value		$ 9,093	[7],[8]			$ 8,870	[15],[22]
Investment Exit Fee		3.00%	[7],[8],[11]	3.00%	[7],[8],[11]	3.00%	[12],[15],[22]	3.00%	[12],[15],[22]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024 One, PIK Interest 5.00%
Investment Holding [Line Items]
Maturity Date		2024-07	[7],[32],[33]	2024-07	[7],[32],[33]	2024-07	[15],[34],[35]	2024-07	[15],[34],[35]
Investments Maturity Month and Year		2024-07	[7],[32],[33]	2024-07	[7],[32],[33]	2024-07	[15],[34],[35]	2024-07	[15],[34],[35]
Investment, Interest Rate, Paid in Kind		5.00%	[7],[11],[32],[33]	5.00%	[7],[11],[32],[33]	5.00%	[12],[15],[34],[35]	5.00%	[12],[15],[34],[35]
Principal Amount		$ 23,703	[7],[32],[33]			$ 10,680	[15],[34],[35]
Investment cost		$ 13,263	[2],[7],[32],[33]			240	[6],[15],[34],[35]
Investments at Fair Value	[15],[34],[35]					$ 0
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024 Two, PIK Interest 5.00%
Investment Holding [Line Items]
Maturity Date	[15],[34],[35]					2024-07		2024-07
Investments Maturity Month and Year	[15],[34],[35]					2024-07		2024-07
Investment, Interest Rate, Paid in Kind	[12],[15],[34],[35]					5.00%		5.00%
Principal Amount	[15],[34],[35]					$ 13,023
Investment cost	[6],[15],[34],[35]					13,023
Investments at Fair Value	[15],[34],[35]					$ 0
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024, FIXED 8.25%
Investment Holding [Line Items]
Maturity Date		2024-07	[32]	2024-07	[32]	2024-07	[15],[34],[35]	2024-07	[15],[34],[35]
Investments Maturity Month and Year		2024-07	[32]	2024-07	[32]	2024-07	[15],[34],[35]	2024-07	[15],[34],[35]
Investment, Interest Rate, Paid in Cash		8.25%	[11],[32]	8.25%	[11],[32]	8.25%	[12],[15],[34],[35]	8.25%	[12],[15],[34],[35]
Principal Amount		$ 8,250	[32]			$ 8,250	[15],[34],[35]
Investment cost		8,250	[2],[32]			8,250	[6],[15],[34],[35]
Investments at Fair Value		$ 7,073	[32]			$ 8,042	[15],[34],[35]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Thumbtack, Inc. Senior Secured, Maturity Date April 2026, Prime + 4.95%, Floor rate 8.20%, PIK Interest 1.50%, 3.95% Exit Fee
Investment Holding [Line Items]
Maturity Date		2026-04	[7],[9],[20]	2026-04	[7],[9],[20]	2026-04	[10],[15],[23]	2026-04	[10],[15],[23]
Investments Maturity Month and Year		2026-04	[7],[9],[20]	2026-04	[7],[9],[20]	2026-04	[10],[15],[23]	2026-04	[10],[15],[23]
Investment, Basis Spread, Variable Rate		4.95%	[7],[9],[11],[20]	4.95%	[7],[9],[11],[20]	4.95%	[10],[12],[15],[23]	4.95%	[10],[12],[15],[23]
Investment, Interest Rate, Floor		8.20%	[7],[9],[11],[20]	8.20%	[7],[9],[11],[20]	8.20%	[10],[12],[15],[23]	8.20%	[10],[12],[15],[23]
Investment, Interest Rate, Paid in Kind		1.50%	[7],[9],[11],[20]	1.50%	[7],[9],[11],[20]	1.50%	[10],[12],[15],[23]	1.50%	[10],[12],[15],[23]
Principal Amount		$ 10,180	[7],[9],[20]			$ 10,103	[10],[15],[23]
Investment cost		10,180	[2],[7],[9],[20]			10,050	[6],[10],[15],[23]
Investments at Fair Value		$ 10,399	[7],[9],[20]			$ 10,167	[10],[15],[23]
Investment Exit Fee		3.95%	[7],[9],[11],[20]	3.95%	[7],[9],[11],[20]	3.95%	[10],[12],[15],[23]	3.95%	[10],[12],[15],[23]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Udacity, Inc. Senior Secured, Maturity Date September 2024, Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee
Investment Holding [Line Items]
Maturity Date		2024-09	[7],[20]	2024-09	[7],[20]	2024-09	[15],[23]	2024-09	[15],[23]
Investments Maturity Month and Year		2024-09	[7],[20]	2024-09	[7],[20]	2024-09	[15],[23]	2024-09	[15],[23]
Investment, Basis Spread, Variable Rate		4.50%	[7],[11],[20]	4.50%	[7],[11],[20]	4.50%	[12],[15],[23]	4.50%	[12],[15],[23]
Investment, Interest Rate, Floor		7.75%	[7],[11],[20]	7.75%	[7],[11],[20]	7.75%	[12],[15],[23]	7.75%	[12],[15],[23]
Investment, Interest Rate, Paid in Kind		2.00%	[7],[11],[20]	2.00%	[7],[11],[20]	2.00%	[12],[15],[23]	2.00%	[12],[15],[23]
Principal Amount		$ 52,464	[7],[20]			$ 51,937	[15],[23]
Investment cost		53,106	[2],[7],[20]			52,265	[6],[15],[23]
Investments at Fair Value		$ 51,752	[7],[20]			$ 52,976	[15],[23]
Investment Exit Fee		3.00%	[7],[11],[20]	3.00%	[7],[11],[20]	3.00%	[12],[15],[23]	3.00%	[12],[15],[23]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee
Investment Holding [Line Items]
Maturity Date		2025-03	[7],[8]	2025-03	[7],[8]	2025-03	[15],[22]	2025-03	[15],[22]
Investments Maturity Month and Year		2025-03	[7],[8]	2025-03	[7],[8]	2025-03	[15],[22]	2025-03	[15],[22]
Investment, Basis Spread, Variable Rate		4.00%	[7],[8],[11]	4.00%	[7],[8],[11]	4.00%	[12],[15],[22]	4.00%	[12],[15],[22]
Investment, Interest Rate, Floor		7.25%	[7],[8],[11]	7.25%	[7],[8],[11]	7.25%	[12],[15],[22]	7.25%	[12],[15],[22]
Investment, Interest Rate, Paid in Kind		1.25%	[7],[8],[11]	1.25%	[7],[8],[11]	1.25%	[12],[15],[22]	1.25%	[12],[15],[22]
Principal Amount		$ 5,075	[7],[8]			$ 5,043	[15],[22]
Investment cost		5,085	[2],[7],[8]			5,000	[6],[15],[22]
Investments at Fair Value		$ 5,124	[7],[8]			$ 5,042	[15],[22]
Investment Exit Fee		4.50%	[7],[8],[11]	4.50%	[7],[8],[11]	4.50%	[12],[15],[22]	4.50%	[12],[15],[22]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee
Investment Holding [Line Items]
Maturity Date		2025-03	[7]	2025-03	[7]	2025-03	[15]	2025-03	[15]
Investments Maturity Month and Year		2025-03	[7]	2025-03	[7]	2025-03	[15]	2025-03	[15]
Investment, Basis Spread, Variable Rate		4.70%	[7],[11]	4.70%	[7],[11]	4.70%	[12],[15]	4.70%	[12],[15]
Investment, Interest Rate, Floor		7.95%	[7],[11]	7.95%	[7],[11]	7.95%	[12],[15]	7.95%	[12],[15]
Investment, Interest Rate, Paid in Kind		1.50%	[7],[11]	1.50%	[7],[11]	1.50%	[12],[15]	1.50%	[12],[15]
Principal Amount		$ 5,071	[7]			$ 5,033	[15]
Investment cost		5,096	[2],[7]			4,988	[6],[15]
Investments at Fair Value		$ 5,194	[7]			$ 5,124	[15]
Investment Exit Fee		4.50%	[7],[11]	4.50%	[7],[11]	4.50%	[12],[15]	4.50%	[12],[15]
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited
Investment Holding [Line Items]
Principal Amount		$ 94,500
Investment cost	[2]	94,878
Investments at Fair Value		$ 95,011
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2025, 1-month SOFR + 9.25%, Floor rate 10.25%, 3.20% Exit Fee
Investment Holding [Line Items]
Maturity Date	[13],[21],[25],[26]	2025-02		2025-02
Investments Maturity Month and Year	[13],[21],[25],[26]	2025-02		2025-02
Investment, Basis Spread, Variable Rate	[11],[13],[21],[25],[26]	9.25%		9.25%
Investment, Interest Rate, Floor	[11],[13],[21],[25],[26]	10.25%		10.25%
Principal Amount	[13],[21],[25],[26]	$ 6,250
Investment cost	[2],[13],[21],[25],[26]	6,252
Investments at Fair Value	[13],[21],[25],[26]	$ 6,270
Investment Exit Fee	[11],[13],[21],[25],[26]	3.20%		3.20%
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.25%, Floor rate 10.25%, 3.00% Exit Fee
Investment Holding [Line Items]
Maturity Date	[14],[16],[23],[24],[27],[28]					2025-02		2025-02
Investments Maturity Month and Year	[14],[16],[23],[24],[27],[28]					2025-02		2025-02
Investment, Basis Spread, Variable Rate	[12],[14],[16],[23],[24],[27],[28]					9.25%		9.25%
Investment, Interest Rate, Floor	[12],[14],[16],[23],[24],[27],[28]					10.25%		10.25%
Principal Amount	[14],[16],[23],[24],[27],[28]					$ 94,500
Investment cost	[6],[14],[16],[23],[24],[27],[28]					94,418
Investments at Fair Value	[14],[16],[23],[24],[27],[28]					$ 93,837
Investment Exit Fee	[12],[14],[16],[23],[24],[27],[28]					3.00%		3.00%
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2025, 3-month SOFR + 9.25%, Floor rate 10.25%, 3.20% Exit Fee
Investment Holding [Line Items]
Maturity Date	[13],[18],[20],[21],[25],[26]	2025-02		2025-02
Investments Maturity Month and Year	[13],[18],[20],[21],[25],[26]	2025-02		2025-02
Investment, Basis Spread, Variable Rate	[11],[13],[18],[20],[21],[25],[26]	9.25%		9.25%
Investment, Interest Rate, Floor	[11],[13],[18],[20],[21],[25],[26]	10.25%		10.25%
Principal Amount	[13],[18],[20],[21],[25],[26]	$ 88,250
Investment cost	[2],[13],[18],[20],[21],[25],[26]	88,626
Investments at Fair Value	[13],[18],[20],[21],[25],[26]	$ 88,741
Investment Exit Fee	[11],[13],[18],[20],[21],[25],[26]	3.20%		3.20%
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, SeatGeek, Inc.
Investment Holding [Line Items]
Principal Amount						$ 85,986
Investment cost	[6]					85,633
Investments at Fair Value						86,544
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, Tectura Corporation
Investment Holding [Line Items]
Principal Amount		$ 31,953				31,953
Investment cost		21,513	[2]			21,513	[6]
Investments at Fair Value		7,073				8,042
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, Veem, Inc.
Investment Holding [Line Items]
Principal Amount		10,146				10,076
Investment cost		10,181	[2]			9,988	[6]
Investments at Fair Value		$ 10,318				$ 10,166
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services (2.40%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					2.40%		2.40%
Investment cost	[6]					$ 36,567
Investments at Fair Value						$ 33,700
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services (2.94%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	2.94%		2.94%
Investment cost	[2]	$ 46,597
Investments at Fair Value		$ 46,597
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), LLC, Unsecured, Maturity Date September 2026, FIXED 11.50%
Investment Holding [Line Items]
Maturity Date	[32],[36]	2026-09		2026-09
Investments Maturity Month and Year	[32],[36]	2026-09		2026-09
Investment, Interest Rate, Paid in Cash	[11],[32],[36]	11.50%		11.50%
Principal Amount	[32],[36]	$ 25,000
Investment cost	[2],[32],[36]	24,613
Investments at Fair Value	[32],[36]	$ 24,613
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Unsecured, Maturity Date September 2026, FIXED 11.50%
Investment Holding [Line Items]
Maturity Date	[34]					2026-09		2026-09
Investments Maturity Month and Year	[34]					2026-09		2026-09
Investment, Interest Rate, Paid in Cash	[12],[34]					11.50%		11.50%
Principal Amount	[34]					$ 10,000
Investment cost	[6],[34]					9,852
Investments at Fair Value	[34]					$ 8,898
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Unsecured, Maturity Date September 2026, FIXED 14.50%
Investment Holding [Line Items]
Maturity Date	[34]					2026-09		2026-09
Investments Maturity Month and Year	[34]					2026-09		2026-09
Investment, Interest Rate, Paid in Cash	[12],[34]					14.50%		14.50%
Principal Amount	[34]					$ 15,000
Investment cost	[6],[34]					14,715
Investments at Fair Value	[34]					$ 12,802
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Hercules Adviser LLC, Unsecured, Maturity Date June 2025, FIXED 5.00%
Investment Holding [Line Items]
Maturity Date		2025-06	[32]	2025-06	[32]	2025-06	[34]	2025-06	[34]
Investments Maturity Month and Year		2025-06	[32]	2025-06	[32]	2025-06	[34]	2025-06	[34]
Investment, Interest Rate, Paid in Cash		5.00%	[11],[32]	5.00%	[11],[32]	5.00%	[12],[34]	5.00%	[12],[34]
Principal Amount		$ 12,000	[32]			$ 12,000	[34]
Investment cost		12,000	[2],[32]			12,000	[6],[34]
Investments at Fair Value		$ 12,000	[32]			12,000	[34]
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Next Insurance, Inc, Senior Secured, Maturity Date February 2028, Prime + -1.50%, Floor rate 4.75%, PIK Interest 5.50%
Investment Holding [Line Items]
Maturity Date	[7],[9],[13]	2028-02		2028-02
Investments Maturity Month and Year	[7],[9],[13]	2028-02		2028-02
Investment, Basis Spread, Variable Rate	[7],[9],[11],[13]	(1.50%)		(1.50%)
Investment, Interest Rate, Floor	[7],[9],[11],[13]	4.75%		4.75%
Investment, Interest Rate, Paid in Kind	[7],[9],[11],[13]	5.50%		5.50%
Principal Amount	[7],[9],[13]	$ 10,181
Investment cost	[2],[7],[9],[13]	9,984
Investments at Fair Value	[7],[9],[13]	$ 9,984
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services, Gibraltar Business Capital, LLC, Unsecured
Investment Holding [Line Items]
Principal Amount						25,000
Investment cost	[6]					24,567
Investments at Fair Value						$ 21,700
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development (68.62%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	68.62%		68.62%
Investment cost	[2]	$ 1,083,845
Investments at Fair Value		$ 1,087,991
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development (78.59%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					78.59%		78.59%
Investment cost	[6]					$ 1,107,352
Investments at Fair Value						$ 1,101,430
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and ATAI Life Sciences N.V. Senior Secured, Maturity Date August 2026, Prime + 4.55%, Floor rate 8.55%, 6.95% Exit Fee
Investment Holding [Line Items]
Maturity Date		2026-08	[9],[25],[26]	2026-08	[9],[25],[26]	2026-08	[27],[28]	2026-08	[27],[28]
Investments Maturity Month and Year		2026-08	[9],[25],[26]	2026-08	[9],[25],[26]	2026-08	[27],[28]	2026-08	[27],[28]
Investment, Basis Spread, Variable Rate		4.55%	[11],[25],[26]	4.55%	[11],[25],[26]	4.55%	[12],[27],[28]	4.55%	[12],[27],[28]
Investment, Interest Rate, Floor		8.55%	[11],[25],[26]	8.55%	[11],[25],[26]	8.55%	[12],[27],[28]	8.55%	[12],[27],[28]
Principal Amount		$ 10,500	[25],[26]			$ 10,500	[27],[28]
Investment cost		10,592	[2],[25],[26]			10,513	[6],[27],[28]
Investments at Fair Value		$ 10,633	[25],[26]			$ 10,513	[27],[28]
Investment Exit Fee		6.95%	[11],[25],[26]	6.95%	[11],[25],[26]	6.95%	[12],[27],[28]	6.95%	[12],[27],[28]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Akero Therapeutics, Inc. Senior Secured, Maturity Date January 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee
Investment Holding [Line Items]
Maturity Date		2027-01	[8],[9],[25]	2027-01	[8],[9],[25]	2027-01	[10],[22],[27]	2027-01	[10],[22],[27]
Investments Maturity Month and Year		2027-01	[8],[9],[25]	2027-01	[8],[9],[25]	2027-01	[10],[22],[27]	2027-01	[10],[22],[27]
Investment, Basis Spread, Variable Rate		3.65%	[8],[9],[11],[25]	3.65%	[8],[9],[11],[25]	3.65%	[10],[12],[22],[27]	3.65%	[10],[12],[22],[27]
Investment, Interest Rate, Floor		7.65%	[8],[9],[11],[25]	7.65%	[8],[9],[11],[25]	7.65%	[10],[12],[22],[27]	7.65%	[10],[12],[22],[27]
Principal Amount		$ 12,500	[8],[9],[25]			$ 5,000	[10],[22],[27]
Investment cost		12,385	[2],[8],[9],[25]			4,986	[6],[10],[22],[27]
Investments at Fair Value		$ 12,794	[8],[9],[25]			$ 5,039	[10],[22],[27]
Investment Exit Fee		5.85%	[8],[9],[11],[25]	5.85%	[8],[9],[11],[25]	5.85%	[10],[12],[22],[27]	5.85%	[10],[12],[22],[27]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 3.10%, Floor rate 8.60%, 8.90% Exit Fee
Investment Holding [Line Items]
Maturity Date		2024-10	[18]	2024-10	[18]	2024-10	[16]	2024-10	[16]
Investments Maturity Month and Year		2024-10	[18]	2024-10	[18]	2024-10	[16]	2024-10	[16]
Investment, Basis Spread, Variable Rate		3.10%	[11],[18]	3.10%	[11],[18]	3.10%	[12],[16]	3.10%	[12],[16]
Investment, Interest Rate, Floor		8.60%	[11],[18]	8.60%	[11],[18]	8.60%	[12],[16]	8.60%	[12],[16]
Principal Amount		$ 15,000	[18]			$ 15,000	[16]
Investment cost		16,047	[2],[18]			15,879	[6],[16]
Investments at Fair Value		$ 16,179	[18]			$ 15,974	[16]
Investment Exit Fee		8.90%	[11],[18]	8.90%	[11],[18]	8.90%	[12],[16]	8.90%	[12],[16]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Alladapt Immunotherapeutics Inc. Senior Secured, Maturity Date September 2026, Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 10.60% Exit Fee
Investment Holding [Line Items]
Maturity Date	[10],[22]					2026-09		2026-09
Investments Maturity Month and Year	[10],[22]					2026-09		2026-09
Investment, Basis Spread, Variable Rate	[10],[12],[22]					3.65%		3.65%
Investment, Interest Rate, Floor	[10],[12],[22]					8.40%		8.40%
Investment, Interest Rate, Cap	[10],[12],[22]					10.90%		10.90%
Principal Amount	[10],[22]					$ 15,000
Investment cost	[6],[10],[22]					14,920
Investments at Fair Value	[10],[22]					$ 14,920
Investment Exit Fee	[10],[12],[22]					10.60%		10.60%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Alladapt Immunotherapeutics Inc. Senior Secured, Maturity Date September 2026, Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 5.30% Exit Fee
Investment Holding [Line Items]
Maturity Date	[8],[9]	2026-09		2026-09
Investments Maturity Month and Year	[8],[9]	2026-09		2026-09
Investment, Basis Spread, Variable Rate	[8],[11]	3.65%		3.65%
Investment, Interest Rate, Floor	[8],[11]	8.40%		8.40%
Investment, Interest Rate, Cap	[8],[11]	10.90%		10.90%
Principal Amount	[8]	$ 30,000
Investment cost	[2],[8]	29,904
Investments at Fair Value	[8]	$ 29,747
Investment Exit Fee	[8],[11]	5.30%		5.30%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, Maturity Date January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee
Investment Holding [Line Items]
Maturity Date		2027-01	[1]	2027-01	[1]	2027-01	[31]	2027-01	[31]
Investments Maturity Month and Year		2027-01	[1]	2027-01	[1]	2027-01	[31]	2027-01	[31]
Investment, Basis Spread, Variable Rate		2.50%	[1],[11]	2.50%	[1],[11]	2.50%	[12],[31]	2.50%	[12],[31]
Investment, Interest Rate, Floor		9.50%	[1],[11]	9.50%	[1],[11]	9.50%	[12],[31]	9.50%	[12],[31]
Investment, Interest Rate, Cap		10.75%	[1],[11]	10.75%	[1],[11]	10.75%	[12],[31]	10.75%	[12],[31]
Principal Amount		$ 24,000	[1]			$ 24,000	[31]
Investment cost		23,883	[1],[2]			23,663	[6],[31]
Investments at Fair Value		$ 23,728	[1]			$ 23,663	[31]
Investment Exit Fee		5.85%	[1],[11]	5.85%	[1],[11]	5.85%	[12],[31]	5.85%	[12],[31]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aveo Pharmaceuticals, Inc. Senior Secured, Maturity Date September 2024, Prime + 6.40%, Floor rate 9.65%, Cap rate 15.00%, 6.95% Exit Fee
Investment Holding [Line Items]
Maturity Date	[16],[31]					2024-09		2024-09
Investments Maturity Month and Year	[16],[31]					2024-09		2024-09
Investment, Basis Spread, Variable Rate	[12],[16],[31]					6.40%		6.40%
Investment, Interest Rate, Floor	[12],[16],[31]					9.65%		9.65%
Investment, Interest Rate, Cap	[12],[16],[31]					15.00%		15.00%
Principal Amount	[16],[31]					$ 40,000
Investment cost	[6],[16],[31]					41,644
Investments at Fair Value	[16],[31]					$ 43,183
Investment Exit Fee	[12],[16],[31]					6.95%		6.95%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date January 2028 Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee
Investment Holding [Line Items]
Maturity Date	[9],[18],[20],[21],[25]	2028-01		2028-01
Investments Maturity Month and Year	[9],[18],[20],[21],[25]	2028-01		2028-01
Investment, Basis Spread, Variable Rate	[9],[11],[18],[20],[21],[25]	2.20%		2.20%
Investment, Interest Rate, Floor	[9],[11],[18],[20],[21],[25]	9.95%		9.95%
Investment, Interest Rate, Cap	[9],[11],[18],[20],[21],[25]	10.70%		10.70%
Principal Amount	[9],[18],[20],[21],[25]	$ 143,350
Investment cost	[2],[9],[18],[20],[21],[25]	142,818
Investments at Fair Value	[9],[18],[20],[21],[25]	$ 143,739
Investment Exit Fee	[9],[11],[18],[20],[21],[25]	5.78%		5.78%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 5.70%, Floor rate 8.95%, Cap rate 10.70%, 5.31% Exit Fee
Investment Holding [Line Items]
Maturity Date	[10],[16],[23],[24],[27]					2026-10		2026-10
Investments Maturity Month and Year	[10],[16],[23],[24],[27]					2026-10		2026-10
Investment, Basis Spread, Variable Rate	[10],[12],[16],[23],[24],[27]					5.70%		5.70%
Investment, Interest Rate, Floor	[10],[12],[16],[23],[24],[27]					8.95%		8.95%
Investment, Interest Rate, Cap	[10],[12],[16],[23],[24],[27]					10.70%		10.70%
Principal Amount	[10],[16],[23],[24],[27]					$ 81,725
Investment cost	[6],[10],[16],[23],[24],[27]					81,631
Investments at Fair Value	[10],[16],[23],[24],[27]					$ 78,074
Investment Exit Fee	[10],[12],[16],[23],[24],[27]					5.31%		5.31%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Senior Secured, Maturity Date July 2025, Prime + 4.55%, Floor rate 8.05%, Cap rate 9.05%, 5.00% Exit Fee
Investment Holding [Line Items]
Maturity Date		2025-07	[18],[20],[25],[26]	2025-07	[18],[20],[25],[26]	2025-07	[16],[23],[27],[28]	2025-07	[16],[23],[27],[28]
Investments Maturity Month and Year		2025-07	[18],[20],[25],[26]	2025-07	[18],[20],[25],[26]	2025-07	[16],[23],[27],[28]	2025-07	[16],[23],[27],[28]
Investment, Basis Spread, Variable Rate		4.55%	[11],[18],[20],[25],[26]	4.55%	[11],[18],[20],[25],[26]	4.55%	[12],[16],[23],[27],[28]	4.55%	[12],[16],[23],[27],[28]
Investment, Interest Rate, Floor		8.05%	[11],[18],[20],[25],[26]	8.05%	[11],[18],[20],[25],[26]	8.05%	[12],[16],[23],[27],[28]	8.05%	[12],[16],[23],[27],[28]
Investment, Interest Rate, Cap		9.05%	[11],[18],[20],[25],[26]	9.05%	[11],[18],[20],[25],[26]	9.05%	[12],[16],[23],[27],[28]	9.05%	[12],[16],[23],[27],[28]
Principal Amount		$ 11,500	[18],[20],[25],[26]			$ 11,500	[16],[23],[27],[28]
Investment cost		11,818	[2],[18],[20],[25],[26]			11,757	[6],[16],[23],[27],[28]
Investments at Fair Value		$ 11,542	[18],[20],[25],[26]			$ 11,435	[16],[23],[27],[28]
Investment Exit Fee		5.00%	[11],[18],[20],[25],[26]	5.00%	[11],[18],[20],[25],[26]	5.00%	[12],[16],[23],[27],[28]	5.00%	[12],[16],[23],[27],[28]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and BiomX, INC, Senior Secured, Maturity Date September 2025, Prime + 5.70%, Floor rate 8.95%, 6.55% Exit Fee
Investment Holding [Line Items]
Maturity Date		2025-09	[18],[25],[26]	2025-09	[18],[25],[26]	2025-09	[16],[27],[28]	2025-09	[16],[27],[28]
Investments Maturity Month and Year		2025-09	[18],[25],[26]	2025-09	[18],[25],[26]	2025-09	[16],[27],[28]	2025-09	[16],[27],[28]
Investment, Basis Spread, Variable Rate		5.70%	[11],[18],[25],[26]	5.70%	[11],[18],[25],[26]	5.70%	[12],[16],[27],[28]	5.70%	[12],[16],[27],[28]
Investment, Interest Rate, Floor		8.95%	[11],[18],[25],[26]	8.95%	[11],[18],[25],[26]	8.95%	[12],[16],[27],[28]	8.95%	[12],[16],[27],[28]
Principal Amount		$ 8,008	[18],[25],[26]			$ 9,000	[16],[27],[28]
Investment cost		8,277	[2],[18],[25],[26]			9,174	[6],[16],[27],[28]
Investments at Fair Value		$ 8,246	[18],[25],[26]			$ 9,052	[16],[27],[28]
Investment Exit Fee		6.55%	[11],[18],[25],[26]	6.55%	[11],[18],[25],[26]	6.55%	[12],[16],[27],[28]	6.55%	[12],[16],[27],[28]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and BridgeBio Pharma, Inc. Senior Secured, Maturity Date November 2026, FIXED 9.00%, 2.00% Exit Fee
Investment Holding [Line Items]
Maturity Date		2026-11	[7],[8],[20]	2026-11	[7],[8],[20]	2026-11	[15],[22],[23]	2026-11	[15],[22],[23]
Investments Maturity Month and Year		2026-11	[7],[8],[20]	2026-11	[7],[8],[20]	2026-11	[15],[22],[23]	2026-11	[15],[22],[23]
Investment, Interest Rate, Paid in Cash		9.00%	[7],[8],[11],[20]	9.00%	[7],[8],[11],[20]	9.00%	[12],[15],[22],[23]	9.00%	[12],[15],[22],[23]
Interest rate	[12],[15],[22],[23]					2.00%		2.00%
Principal Amount		$ 37,880	[7],[8],[20]			$ 37,312	[15],[22],[23]
Investment cost		37,718	[2],[7],[8],[20]			37,039	[6],[15],[22],[23]
Investments at Fair Value		$ 34,033	[7],[8],[20]			$ 33,344	[15],[22],[23]
Investment Exit Fee	[7],[8],[11],[20]	2.00%		2.00%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Cellarity, Inc. Senior Secured, Maturity Date June 2026, Prime + 5.70%, Floor rate 8.95%, 3.75% Exit Fee
Investment Holding [Line Items]
Maturity Date		2026-06	[1],[8]	2026-06	[1],[8]	2026-06	[22],[31]	2026-06	[22],[31]
Investments Maturity Month and Year		2026-06	[1],[8]	2026-06	[1],[8]	2026-06	[22],[31]	2026-06	[22],[31]
Investment, Basis Spread, Variable Rate		5.70%	[1],[8],[11]	5.70%	[1],[8],[11]	5.70%	[12],[22],[31]	5.70%	[12],[22],[31]
Investment, Interest Rate, Floor		8.95%	[1],[8],[11]	8.95%	[1],[8],[11]	8.95%	[12],[22],[31]	8.95%	[12],[22],[31]
Principal Amount		$ 30,000	[1],[8]			$ 30,000	[22],[31]
Investment cost		30,056	[1],[2],[8]			29,841	[6],[22],[31]
Investments at Fair Value		$ 30,478	[1],[8]			$ 30,097	[22],[31]
Investment Exit Fee		3.75%	[1],[8],[11]	3.75%	[1],[8],[11]	3.75%	[12],[22],[31]	3.75%	[12],[22],[31]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Century Therapeutics, Inc. Senior Secured, Maturity Date April 2024, Prime + 6.30%, Floor rate 9.55%, 3.95% Exit Fee
Investment Holding [Line Items]
Maturity Date	[16]					2024-04		2024-04
Investments Maturity Month and Year	[16]					2024-04		2024-04
Investment, Basis Spread, Variable Rate	[12],[16]					6.30%		6.30%
Investment, Interest Rate, Floor	[12],[16]					9.55%		9.55%
Principal Amount	[16]					$ 10,000
Investment cost	[6],[16]					10,235
Investments at Fair Value	[16]					$ 10,292
Investment Exit Fee	[12],[16]					3.95%		3.95%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Codiak Biosciences, Inc. Senior Secured, Maturity Date October 2025, Prime + 5.00%, Floor rate 8.25%, 5.50% Exit Fee
Investment Holding [Line Items]
Maturity Date	[16]					2025-10		2025-10
Investments Maturity Month and Year	[16]					2025-10		2025-10
Investment, Basis Spread, Variable Rate	[12],[16]					5.00%		5.00%
Investment, Interest Rate, Floor	[12],[16]					8.25%		8.25%
Principal Amount	[16]					$ 25,000
Investment cost	[6],[16]					25,759
Investments at Fair Value	[16]					$ 25,177
Investment Exit Fee	[12],[16]					5.50%		5.50%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Compass Pathways plc Senior Secured, Maturity Date June 2026, Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee
Investment Holding [Line Items]
Maturity Date	[25],[26]	2027-07		2027-07
Investments Maturity Month and Year	[25],[26]	2027-07		2027-07
Investment, Basis Spread, Variable Rate	[11],[25],[26]	1.50%		1.50%
Investment, Interest Rate, Floor	[11],[25],[26]	9.75%		9.75%
Investment, Interest Rate, Paid in Kind	[11],[25],[26]	1.40%		1.40%
Principal Amount	[25],[26]	$ 24,000
Investment cost	[2],[25],[26]	23,443
Investments at Fair Value	[25],[26]	$ 23,443
Investment Exit Fee	[11],[25],[26]	4.75%		4.75%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Corium, Inc. Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee
Investment Holding [Line Items]
Maturity Date		2026-09	[8],[21]	2026-09	[8],[21]	2026-09	[22],[24]	2026-09	[22],[24]
Investments Maturity Month and Year		2026-09	[8],[21]	2026-09	[8],[21]	2026-09	[22],[24]	2026-09	[22],[24]
Investment, Basis Spread, Variable Rate		5.70%	[8],[11],[21]	5.70%	[8],[11],[21]	5.70%	[12],[22],[24]	5.70%	[12],[22],[24]
Investment, Interest Rate, Floor		8.95%	[8],[11],[21]	8.95%	[8],[11],[21]	8.95%	[12],[22],[24]	8.95%	[12],[22],[24]
Principal Amount		$ 132,675	[8],[21]			$ 132,675	[22],[24]
Investment cost		134,545	[2],[8],[21]			133,557	[6],[22],[24]
Investments at Fair Value		$ 136,450	[8],[21]			$ 135,619	[22],[24]
Investment Exit Fee		7.75%	[8],[11],[21]	7.75%	[8],[11],[21]	7.75%	[12],[22],[24]	7.75%	[12],[22],[24]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Curevo, Inc. Senior Secured, Maturity Date June 2027 Prime + 1.70%, Floor rate 9.70%, 6.95% Exit Fee
Investment Holding [Line Items]
Maturity Date	[1]	2027-06		2027-06
Investments Maturity Month and Year	[1]	2027-06		2027-06
Investment, Basis Spread, Variable Rate	[1],[11]	1.70%		1.70%
Investment, Interest Rate, Floor	[1],[11]	9.70%		9.70%
Principal Amount	[1]	$ 10,000
Investment cost	[1],[2]	9,674
Investments at Fair Value	[1]	$ 9,674
Investment Exit Fee	[1],[11]	6.95%		6.95%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Eloxx Pharmaceuticals, Inc. Senior Secured, Maturity Date April 2025, Prime + 6.25%, Floor rate 9.50%, 6.55% Exit Fee
Investment Holding [Line Items]
Maturity Date		2025-04	[1]	2025-04	[1]	2025-04	[31]	2025-04	[31]
Investments Maturity Month and Year		2025-04	[1]	2025-04	[1]	2025-04	[31]	2025-04	[31]
Investment, Basis Spread, Variable Rate		6.25%	[1],[11]	6.25%	[1],[11]	6.25%	[12],[31]	6.25%	[12],[31]
Investment, Interest Rate, Floor		9.50%	[1],[11]	9.50%	[1],[11]	9.50%	[12],[31]	9.50%	[12],[31]
Principal Amount		$ 5,000	[1]			$ 12,500	[31]
Investment cost		5,642	[1],[2]			12,753	[6],[31]
Investments at Fair Value		$ 5,552	[1]			$ 12,535	[31]
Investment Exit Fee		6.55%	[1],[11]	6.55%	[1],[11]	6.55%	[12],[31]	6.55%	[12],[31]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Finch Therapeutics Group, Inc. Senior Secured, Maturity Date November 2026, Prime + 4.05%, Floor rate 7.55%, Cap rate 8.80%, 5.50% Exit Fee
Investment Holding [Line Items]
Maturity Date						2026-11		2026-11
Investments Maturity Month and Year						2026-11		2026-11
Investment, Basis Spread, Variable Rate	[12]					4.05%		4.05%
Investment, Interest Rate, Floor	[12]					7.55%		7.55%
Investment, Interest Rate, Cap	[12]					8.80%		8.80%
Principal Amount						$ 15,000
Investment cost	[6]					15,012
Investments at Fair Value						$ 13,940
Investment Exit Fee	[12]					5.50%		5.50%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and G1 Therapeutics, Inc. Senior Secured, Maturity Date November 2026, Prime + 5.65%, Floor rate 9.15%, 11.41% Exit Fee
Investment Holding [Line Items]
Maturity Date	[1],[18],[20]	2026-11		2026-11
Investments Maturity Month and Year	[1],[18],[20]	2026-11		2026-11
Investment, Basis Spread, Variable Rate	[1],[11],[18],[20]	5.65%		5.65%
Investment, Interest Rate, Floor	[1],[11],[18],[20]	9.15%		9.15%
Principal Amount	[1],[18],[20]	$ 38,750
Investment cost	[1],[2],[18],[20]	39,386
Investments at Fair Value	[1],[18],[20]	$ 39,500
Investment Exit Fee	[1],[11],[18],[20]	11.41%		11.41%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and G1 Therapeutics, Inc. Senior Secured, Maturity Date November 2026, Prime + 5.90%, Floor rate 9.15%, 9.86% Exit Fee
Investment Holding [Line Items]
Maturity Date	[10],[16],[23],[31]					2026-11		2026-11
Investments Maturity Month and Year	[10],[16],[23],[31]					2026-11		2026-11
Investment, Basis Spread, Variable Rate	[10],[12],[16],[23],[31]					5.90%		5.90%
Investment, Interest Rate, Floor	[10],[12],[16],[23],[31]					9.15%		9.15%
Principal Amount	[10],[16],[23],[31]					$ 58,125
Investment cost	[6],[10],[16],[23],[31]					58,674
Investments at Fair Value	[10],[16],[23],[31]					$ 58,407
Investment Exit Fee	[10],[12],[16],[23],[31]					9.86%		9.86%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Geron Corporation, Senior Secured, Maturity Date April 2025, Prime + 5.75%, Floor rate 9.00%, 6.55% Exit Fee
Investment Holding [Line Items]
Maturity Date	[8],[20],[25]	2025-04		2025-04
Investments Maturity Month and Year	[8],[20],[25]	2025-04		2025-04
Investment, Basis Spread, Variable Rate	[8],[11],[20],[25]	5.75%		5.75%
Investment, Interest Rate, Floor	[8],[11],[20],[25]	9.00%		9.00%
Principal Amount	[8],[20],[25]	$ 18,500
Investment cost	[2],[8],[20],[25]	19,243
Investments at Fair Value	[8],[20],[25]	$ 19,482
Investment Exit Fee	[8],[11],[20],[25]	6.55%		6.55%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Geron Corporation, Senior Secured, Maturity Date October 2024, Prime + 5.75%, Floor rate 9.00%, 6.55% Exit Fee
Investment Holding [Line Items]
Maturity Date	[22],[23],[27]					2024-10		2024-10
Investments Maturity Month and Year	[22],[23],[27]					2024-10		2024-10
Investment, Basis Spread, Variable Rate	[12],[22],[23],[27]					5.75%		5.75%
Investment, Interest Rate, Floor	[12],[22],[23],[27]					9.00%		9.00%
Principal Amount	[22],[23],[27]					$ 18,500
Investment cost	[6],[22],[23],[27]					19,109
Investments at Fair Value	[22],[23],[27]					$ 19,174
Investment Exit Fee	[12],[22],[23],[27]					6.55%		6.55%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Gritstone Bio, Inc. Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee
Investment Holding [Line Items]
Maturity Date		2027-07	[7],[8],[9]	2027-07	[7],[8],[9]	2027-07	[10],[15]	2027-07	[10],[15]
Investments Maturity Month and Year		2027-07	[7],[8],[9]	2027-07	[7],[8],[9]	2027-07	[10],[15]	2027-07	[10],[15]
Investment, Basis Spread, Variable Rate		3.15%	[7],[8],[9],[11]	3.15%	[7],[8],[9],[11]	3.15%	[10],[12],[15]	3.15%	[10],[12],[15]
Investment, Interest Rate, Floor		7.15%	[7],[8],[9],[11]	7.15%	[7],[8],[9],[11]	7.15%	[10],[12],[15]	7.15%	[10],[12],[15]
Investment, Interest Rate, Cap		8.65%	[7],[8],[9],[11]	8.65%	[7],[8],[9],[11]	8.65%	[10],[12],[15]	8.65%	[10],[12],[15]
Investment, Interest Rate, Paid in Kind		2.00%	[7],[8],[9],[11]	2.00%	[7],[8],[9],[11]	2.00%	[10],[12],[15]	2.00%	[10],[12],[15]
Principal Amount		$ 22,799	[7],[8],[9]			$ 15,113	[10],[15]
Investment cost		22,874	[2],[7],[8],[9]			15,109	[6],[10],[15]
Investments at Fair Value		$ 22,766	[7],[8],[9]			$ 15,109	[10],[15]
Investment Exit Fee		5.75%	[7],[8],[9],[11]	5.75%	[7],[8],[9],[11]	5.75%	[10],[12],[15]	5.75%	[10],[12],[15]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Hibercell, Inc. Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee
Investment Holding [Line Items]
Maturity Date		2025-05	[1],[8]	2025-05	[1],[8]	2025-05	[22],[31]	2025-05	[22],[31]
Investments Maturity Month and Year		2025-05	[1],[8]	2025-05	[1],[8]	2025-05	[22],[31]	2025-05	[22],[31]
Investment, Basis Spread, Variable Rate		5.40%	[1],[8],[11]	5.40%	[1],[8],[11]	5.40%	[12],[22],[31]	5.40%	[12],[22],[31]
Investment, Interest Rate, Floor		8.65%	[1],[8],[11]	8.65%	[1],[8],[11]	8.65%	[12],[22],[31]	8.65%	[12],[22],[31]
Principal Amount		$ 16,386	[1],[8]			$ 17,000	[22],[31]
Investment cost		16,837	[1],[2],[8]			17,313	[6],[22],[31]
Investments at Fair Value		$ 16,770	[1],[8]			$ 17,265	[22],[31]
Investment Exit Fee		4.95%	[1],[8],[11]	4.95%	[1],[8],[11]	4.95%	[12],[22],[31]	4.95%	[12],[22],[31]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and HilleVax, Inc. Senior Secured, Maturity Date May 2027, Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee
Investment Holding [Line Items]
Maturity Date		2027-05	[1],[7],[9]	2027-05	[1],[7],[9]	2027-05	[10],[15],[31]	2027-05	[10],[15],[31]
Investments Maturity Month and Year		2027-05	[1],[7],[9]	2027-05	[1],[7],[9]	2027-05	[10],[15],[31]	2027-05	[10],[15],[31]
Investment, Basis Spread, Variable Rate		1.05%	[1],[7],[11]	1.05%	[1],[7],[11]	1.05%	[10],[12],[15],[31]	1.05%	[10],[12],[15],[31]
Investment, Interest Rate, Floor		4.55%	[1],[7],[11]	4.55%	[1],[7],[11]	4.55%	[10],[12],[15],[31]	4.55%	[10],[12],[15],[31]
Investment, Interest Rate, Cap		6.05%	[1],[7],[11]	6.05%	[1],[7],[11]	6.05%	[10],[12],[15],[31]	6.05%	[10],[12],[15],[31]
Investment, Interest Rate, Paid in Kind		2.85%	[1],[7],[11]	2.85%	[1],[7],[11]	2.85%	[10],[12],[15],[31]	2.85%	[10],[12],[15],[31]
Principal Amount		$ 20,238	[1],[7]			$ 12,072	[10],[15],[31]
Investment cost		20,209	[1],[2],[7]			12,043	[6],[10],[15],[31]
Investments at Fair Value		$ 19,163	[1],[7]			$ 11,333	[10],[15],[31]
Investment Exit Fee		7.15%	[1],[7],[11]	7.15%	[1],[7],[11]	7.15%	[10],[12],[15],[31]	7.15%	[10],[12],[15],[31]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Iveric Bio, Inc. Senior Secured, Maturity Date August 2027, Prime + 4.00%, Floor rate 8.75%, Cap rate 10.25%, 4.25% Exit Fee
Investment Holding [Line Items]
Maturity Date		2027-08	[9],[20],[25]	2027-08	[9],[20],[25]	2027-08	[23],[27]	2027-08	[23],[27]
Investments Maturity Month and Year		2027-08	[9],[20],[25]	2027-08	[9],[20],[25]	2027-08	[23],[27]	2027-08	[23],[27]
Investment, Basis Spread, Variable Rate		4.00%	[9],[11],[20],[25]	4.00%	[9],[11],[20],[25]	4.00%	[12],[23],[27]	4.00%	[12],[23],[27]
Investment, Interest Rate, Floor		8.75%	[9],[11],[20],[25]	8.75%	[9],[11],[20],[25]	8.75%	[12],[23],[27]	8.75%	[12],[23],[27]
Investment, Interest Rate, Cap		10.25%	[9],[11],[20],[25]	10.25%	[9],[11],[20],[25]	10.25%	[12],[23],[27]	10.25%	[12],[23],[27]
Principal Amount		$ 49,500	[9],[20],[25]			$ 49,500	[23],[27]
Investment cost		49,336	[2],[9],[20],[25]			49,090	[6],[23],[27]
Investments at Fair Value		$ 52,631	[9],[20],[25]			$ 49,090	[23],[27]
Investment Exit Fee		4.25%	[9],[11],[20],[25]	4.25%	[9],[11],[20],[25]	4.25%	[12],[23],[27]	4.25%	[12],[23],[27]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Kura Oncology, Inc. Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee
Investment Holding [Line Items]
Maturity Date		2027-11	[1],[9],[25]	2027-11	[1],[9],[25]	2027-11	[10],[27],[31]	2027-11	[10],[27],[31]
Investments Maturity Month and Year		2027-11	[1],[9],[25]	2027-11	[1],[9],[25]	2027-11	[10],[27],[31]	2027-11	[10],[27],[31]
Investment, Basis Spread, Variable Rate		2.40%	[1],[9],[11],[25]	2.40%	[1],[9],[11],[25]	2.40%	[10],[12],[27],[31]	2.40%	[10],[12],[27],[31]
Investment, Interest Rate, Floor		8.65%	[1],[9],[11],[25]	8.65%	[1],[9],[11],[25]	8.65%	[10],[12],[27],[31]	8.65%	[10],[12],[27],[31]
Principal Amount		$ 5,500	[1],[9],[25]			$ 5,500	[10],[27],[31]
Investment cost		5,489	[1],[2],[9],[25]			5,448	[6],[10],[27],[31]
Investments at Fair Value		$ 5,606	[1],[9],[25]			$ 5,448	[10],[27],[31]
Investment Exit Fee		15.13%	[1],[9],[11],[25]	15.13%	[1],[9],[11],[25]	15.13%	[10],[12],[27],[31]	15.13%	[10],[12],[27],[31]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Locus Biosciences, Inc. Senior Secured, Maturity Date July 2025, Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee
Investment Holding [Line Items]
Maturity Date		2025-07	[1]	2025-07	[1]	2025-07	[31]	2025-07	[31]
Investments Maturity Month and Year		2025-07	[1]	2025-07	[1]	2025-07	[31]	2025-07	[31]
Investment, Basis Spread, Variable Rate		6.10%	[1],[11]	6.10%	[1],[11]	6.10%	[12],[31]	6.10%	[12],[31]
Investment, Interest Rate, Floor		9.35%	[1],[11]	9.35%	[1],[11]	9.35%	[12],[31]	9.35%	[12],[31]
Principal Amount		$ 6,854	[1]			$ 8,000	[31]
Investment cost		7,042	[1],[2]			8,120	[6],[31]
Investments at Fair Value		$ 7,049	[1]			$ 8,085	[31]
Investment Exit Fee		4.95%	[1],[11]	4.95%	[1],[11]	4.95%	[12],[31]	4.95%	[12],[31]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc. Senior Secured, Maturity Date May 2026, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee
Investment Holding [Line Items]
Maturity Date	[25]	2026-05		2026-05
Investments Maturity Month and Year	[25]	2026-05		2026-05
Investment, Basis Spread, Variable Rate	[11],[25]	2.45%		2.45%
Investment, Interest Rate, Floor	[11],[25]	8.25%		8.25%
Principal Amount	[25]	$ 68,000
Investment cost	[2],[25]	67,896
Investments at Fair Value	[25]	$ 68,481
Investment Exit Fee	[11],[25]	5.35%		5.35%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc. Senior Secured, Maturity Date May 2026, Prime + 3.95%, Floor rate 7.45%, 5.35% Exit Fee
Investment Holding [Line Items]
Maturity Date	[10],[27]					2026-05		2026-05
Investments Maturity Month and Year	[10],[27]					2026-05		2026-05
Investment, Basis Spread, Variable Rate	[10],[12],[27]					3.95%		3.95%
Investment, Interest Rate, Floor	[10],[12],[27]					7.45%		7.45%
Principal Amount	[10],[27]					$ 34,000
Investment cost	[6],[10],[27]					33,945
Investments at Fair Value	[10],[27]					$ 33,987
Investment Exit Fee	[10],[12],[27]					5.35%		5.35%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Nabriva Therapeutics, Senior Secured, Maturity Date June 2023, Prime + 4.30%, Floor rate 9.80%, 9.95% Exit Fee
Investment Holding [Line Items]
Maturity Date	[22],[27],[28]					2023-06		2023-06
Investments Maturity Month and Year	[22],[27],[28]					2023-06		2023-06
Investment, Basis Spread, Variable Rate	[12],[22],[27],[28]					4.30%		4.30%
Investment, Interest Rate, Floor	[12],[22],[27],[28]					9.80%		9.80%
Principal Amount	[22],[27],[28]					$ 2,079
Investment cost	[6],[22],[27],[28]					2,734
Investments at Fair Value	[22],[27],[28]					$ 2,804
Investment Exit Fee	[12],[22],[27],[28]					9.95%		9.95%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc. Senior Secured, Maturity Date October 2026, Prime + 2.25%, Floor rate 5.50%, PIK Interest 3.35%, 7.50% Exit Fee
Investment Holding [Line Items]
Maturity Date		2026-10	[1],[7],[9],[20],[21],[25],[37]	2026-10	[1],[7],[9],[20],[21],[25],[37]	2026-10	[10],[15],[23],[24],[27],[31],[38]	2026-10	[10],[15],[23],[24],[27],[31],[38]
Investments Maturity Month and Year		2026-10	[1],[7],[9],[20],[21],[25],[37]	2026-10	[1],[7],[9],[20],[21],[25],[37]	2026-10	[10],[15],[23],[24],[27],[31],[38]	2026-10	[10],[15],[23],[24],[27],[31],[38]
Investment, Basis Spread, Variable Rate		2.25%	[1],[7],[9],[11],[20],[21],[25],[37]	2.25%	[1],[7],[9],[11],[20],[21],[25],[37]	2.25%	[10],[12],[15],[23],[24],[27],[31],[38]	2.25%	[10],[12],[15],[23],[24],[27],[31],[38]
Investment, Interest Rate, Floor		5.50%	[1],[7],[9],[11],[20],[21],[25],[37]	5.50%	[1],[7],[9],[11],[20],[21],[25],[37]	5.50%	[10],[12],[15],[23],[24],[27],[31],[38]	5.50%	[10],[12],[15],[23],[24],[27],[31],[38]
Investment, Interest Rate, Paid in Kind		3.35%	[1],[7],[9],[11],[20],[21],[25],[37]	3.35%	[1],[7],[9],[11],[20],[21],[25],[37]	3.35%	[10],[12],[15],[23],[24],[27],[31],[38]	3.35%	[10],[12],[15],[23],[24],[27],[31],[38]
Principal Amount		$ 96,262	[1],[7],[9],[20],[21],[25],[37]			$ 94,737	[10],[15],[23],[24],[27],[31],[38]
Investment cost		97,177	[1],[2],[7],[9],[20],[21],[25],[37]			95,032	[6],[10],[15],[23],[24],[27],[31],[38]
Investments at Fair Value		$ 96,827	[1],[7],[9],[20],[21],[25],[37]			$ 93,916	[10],[15],[23],[24],[27],[31],[38]
Investment Exit Fee		7.50%	[1],[7],[9],[11],[20],[21],[25],[37]	7.50%	[1],[7],[9],[11],[20],[21],[25],[37]	7.50%	[10],[12],[15],[23],[24],[27],[31],[38]	7.50%	[10],[12],[15],[23],[24],[27],[31],[38]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Provention Bio, Inc. Senior Secured, Maturity Date September 2027, Prime + 2.70%, Floor rate 8.20%, 6.60% Exit Fee
Investment Holding [Line Items]
Maturity Date	[10]					2027-09		2027-09
Investments Maturity Month and Year	[10]					2027-09		2027-09
Investment, Basis Spread, Variable Rate	[10],[12]					2.70%		2.70%
Investment, Interest Rate, Floor	[10],[12]					8.20%		8.20%
Principal Amount	[10]					$ 25,000
Investment cost	[6],[10]					24,670
Investments at Fair Value	[10]					$ 24,670
Investment Exit Fee	[10],[12]					6.60%		6.60%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Redshift Bioanalytics, Inc. Senior Secured, Maturity Date January 2026, Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee
Investment Holding [Line Items]
Maturity Date		2026-01	[1]	2026-01	[1]	2026-01	[31]	2026-01	[31]
Investments Maturity Month and Year		2026-01	[1]	2026-01	[1]	2026-01	[31]	2026-01	[31]
Investment, Basis Spread, Variable Rate		4.25%	[1],[11]	4.25%	[1],[11]	4.25%	[12],[31]	4.25%	[12],[31]
Investment, Interest Rate, Floor		7.50%	[1],[11]	7.50%	[1],[11]	7.50%	[12],[31]	7.50%	[12],[31]
Principal Amount		$ 5,000	[1]			$ 5,000	[31]
Investment cost		5,001	[1],[2]			4,957	[6],[31]
Investments at Fair Value		$ 5,027	[1]			$ 4,946	[31]
Investment Exit Fee		3.80%	[1],[11]	3.80%	[1],[11]	3.80%	[12],[31]	3.80%	[12],[31]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Replimune Group, Inc. Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee
Investment Holding [Line Items]
Maturity Date		2027-10	[7],[25]	2027-10	[7],[25]	2027-10	[10],[15],[27]	2027-10	[10],[15],[27]
Investments Maturity Month and Year		2027-10	[7],[25]	2027-10	[7],[25]	2027-10	[10],[15],[27]	2027-10	[10],[15],[27]
Investment, Basis Spread, Variable Rate		1.75%	[7],[11],[25]	1.75%	[7],[11],[25]	1.75%	[10],[12],[15],[27]	1.75%	[10],[12],[15],[27]
Investment, Interest Rate, Floor		7.25%	[7],[11],[25]	7.25%	[7],[11],[25]	7.25%	[10],[12],[15],[27]	7.25%	[10],[12],[15],[27]
Investment, Interest Rate, Cap		9.00%	[7],[11],[25]	9.00%	[7],[11],[25]	9.00%	[10],[12],[15],[27]	9.00%	[10],[12],[15],[27]
Investment, Interest Rate, Paid in Kind		1.50%	[7],[11],[25]	1.50%	[7],[11],[25]	1.50%	[10],[12],[15],[27]	1.50%	[10],[12],[15],[27]
Principal Amount		$ 20,906	[7],[25]			$ 20,754	[10],[15],[27]
Investment cost		20,904	[2],[7],[25]			20,656	[6],[10],[15],[27]
Investments at Fair Value		$ 21,240	[7],[25]			$ 20,656	[10],[15],[27]
Investment Exit Fee		4.95%	[7],[11],[25]	4.95%	[7],[11],[25]	4.95%	[10],[12],[15],[27]	4.95%	[10],[12],[15],[27]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Scynexis, Inc. Senior Secured, Maturity Date March 2025, Prime + 5.80%, Floor rate 9.05%, 3.95% Exit Fee
Investment Holding [Line Items]
Maturity Date	[22],[23]					2025-03		2025-03
Investments Maturity Month and Year	[22],[23]					2025-03		2025-03
Investment, Basis Spread, Variable Rate	[12],[22],[23]					5.80%		5.80%
Investment, Interest Rate, Floor	[12],[22],[23]					9.05%		9.05%
Principal Amount	[22],[23]					$ 18,667
Investment cost	[6],[22],[23]					18,675
Investments at Fair Value	[22],[23]					$ 18,698
Investment Exit Fee	[12],[22],[23]					3.95%		3.95%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Seres Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 6.40%, Floor rate 9.65%, 4.98% Exit Fee
Investment Holding [Line Items]
Maturity Date	[22],[23]					2024-10		2024-10
Investments Maturity Month and Year	[22],[23]					2024-10		2024-10
Investment, Basis Spread, Variable Rate	[12],[22],[23]					6.40%		6.40%
Investment, Interest Rate, Floor	[12],[22],[23]					9.65%		9.65%
Principal Amount	[22],[23]					$ 37,500
Investment cost	[6],[22],[23]					38,638
Investments at Fair Value	[22],[23]					$ 38,816
Investment Exit Fee	[12],[22],[23]					4.98%		4.98%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and TG Therapeutics, Inc. Senior Secured, Maturity Date January 2026, Prime + 1.20%, Floor rate 8.95%, PIK Interest 2.25%, 5.69% Exit Fee
Investment Holding [Line Items]
Maturity Date	[7],[9],[18],[20],[25]	2026-01		2026-01
Investments Maturity Month and Year	[7],[9],[18],[20],[25]	2026-01		2026-01
Investment, Basis Spread, Variable Rate	[7],[9],[11],[18],[20],[25]	1.20%		1.20%
Investment, Interest Rate, Floor	[7],[9],[11],[18],[20],[25]	8.95%		8.95%
Investment, Interest Rate, Paid in Kind	[7],[9],[11],[18],[20],[25]	2.25%		2.25%
Principal Amount	[7],[9],[18],[20],[25]	$ 65,023
Investment cost	[2],[7],[9],[18],[20],[25]	65,045
Investments at Fair Value	[7],[9],[18],[20],[25]	$ 65,130
Investment Exit Fee	[7],[9],[11],[18],[20],[25]	5.69%		5.69%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and TG Therapeutics, Inc. Senior Secured, Maturity Date January 2026, Prime + 2.15%, Floor rate 5.40%, PIK Interest 3.45%, 5.95% Exit Fee
Investment Holding [Line Items]
Maturity Date	[15],[16],[23],[27]					2026-01		2026-01
Investments Maturity Month and Year	[15],[16],[23],[27]					2026-01		2026-01
Investment, Basis Spread, Variable Rate	[12],[15],[16],[23],[27]					2.15%		2.15%
Investment, Interest Rate, Floor	[12],[15],[16],[23],[27]					5.40%		5.40%
Investment, Interest Rate, Paid in Kind	[12],[15],[16],[23],[27]					3.45%		3.45%
Principal Amount	[15],[16],[23],[27]					$ 47,983
Investment cost	[6],[15],[16],[23],[27]					47,889
Investments at Fair Value	[15],[16],[23],[27]					$ 48,649
Investment Exit Fee	[12],[15],[16],[23],[27]					5.95%		5.95%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc. Senior Secured, Maturity Date February 2027, Prime + 4.45%, Floor rate 8.45%, Cap rate 11.45%, 4.75% Exit Fee
Investment Holding [Line Items]
Maturity Date	[8],[9],[25]	2027-02		2027-02
Investments Maturity Month and Year	[8],[9],[25]	2027-02		2027-02
Investment, Basis Spread, Variable Rate	[8],[9],[11],[25]	4.45%		4.45%
Investment, Interest Rate, Floor	[8],[9],[11],[25]	8.45%		8.45%
Investment, Interest Rate, Cap	[8],[9],[11],[25]	11.45%		11.45%
Principal Amount	[8],[9],[25]	$ 10,313
Investment cost	[2],[8],[9],[25]	10,372
Investments at Fair Value	[8],[9],[25]	$ 10,434
Investment Exit Fee	[8],[9],[11],[25]	4.75%		4.75%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc. Senior Secured, Maturity Date February 2027, Prime + 5.20%, Floor rate 8.45%, 4.75% Exit Fee
Investment Holding [Line Items]
Maturity Date	[10],[22],[27]					2027-02		2027-02
Investments Maturity Month and Year	[10],[22],[27]					2027-02		2027-02
Investment, Basis Spread, Variable Rate	[10],[12],[22],[27]					5.20%		5.20%
Investment, Interest Rate, Floor	[10],[12],[22],[27]					8.45%		8.45%
Principal Amount	[10],[22],[27]					$ 8,250
Investment cost	[6],[10],[22],[27]					8,274
Investments at Fair Value	[10],[22],[27]					$ 8,423
Investment Exit Fee	[10],[12],[22],[27]					4.75%		4.75%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Unity Biotechnology, Inc. Senior Secured, Maturity Date August 2024, Prime + 6.10%, Floor rate 9.35%, 6.25% Exit Fee
Investment Holding [Line Items]
Maturity Date		2024-08	[8]	2024-08	[8]	2024-08	[22]	2024-08	[22]
Investments Maturity Month and Year		2024-08	[8]	2024-08	[8]	2024-08	[22]	2024-08	[22]
Investment, Basis Spread, Variable Rate		6.10%	[8],[11]	6.10%	[8],[11]	6.10%	[12],[22]	6.10%	[12],[22]
Investment, Interest Rate, Floor		9.35%	[8],[11]	9.35%	[8],[11]	9.35%	[12],[22]	9.35%	[12],[22]
Principal Amount		$ 16,766	[8]			$ 20,000	[22]
Investment cost		18,014	[2],[8]			21,079	[6],[22]
Investments at Fair Value		$ 17,999	[8]			$ 20,967	[22]
Investment Exit Fee		6.25%	[8],[11]	6.25%	[8],[11]	6.25%	[12],[22]	6.25%	[12],[22]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Valo Health, LLC, Senior Secured, Maturity Date May 2024, Prime + 6.45%, Floor rate 9.70%, 3.85% Exit Fee
Investment Holding [Line Items]
Maturity Date		2024-05	[8],[18]	2024-05	[8],[18]	2024-05	[16],[22]	2024-05	[16],[22]
Investments Maturity Month and Year		2024-05	[8],[18]	2024-05	[8],[18]	2024-05	[16],[22]	2024-05	[16],[22]
Investment, Basis Spread, Variable Rate		6.45%	[8],[11],[18]	6.45%	[8],[11],[18]	6.45%	[12],[16],[22]	6.45%	[12],[16],[22]
Investment, Interest Rate, Floor		9.70%	[8],[11],[18]	9.70%	[8],[11],[18]	9.70%	[12],[16],[22]	9.70%	[12],[16],[22]
Principal Amount		$ 5,271	[8],[18]			$ 8,146	[16],[22]
Investment cost		5,621	[2],[8],[18]			8,416	[6],[16],[22]
Investments at Fair Value		$ 5,621	[8],[18]			$ 8,410	[16],[22]
Investment Exit Fee		3.85%	[8],[11],[18]	3.85%	[8],[11],[18]	3.85%	[12],[16],[22]	3.85%	[12],[16],[22]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 4.76% Exit Fee
Investment Holding [Line Items]
Maturity Date	[10],[22],[27]					2026-10		2026-10
Investments Maturity Month and Year	[10],[22],[27]					2026-10		2026-10
Investment, Basis Spread, Variable Rate	[10],[12],[22],[27]					4.20%		4.20%
Investment, Interest Rate, Floor	[10],[12],[22],[27]					7.45%		7.45%
Investment, Interest Rate, Cap	[10],[12],[22],[27]					8.95%		8.95%
Principal Amount	[10],[22],[27]					$ 2,000
Investment cost	[6],[10],[22],[27]					2,012
Investments at Fair Value	[10],[22],[27]					$ 1,934
Investment Exit Fee	[10],[12],[22],[27]					4.76%		4.76%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 6.00% Exit Fee
Investment Holding [Line Items]
Maturity Date	[8],[25]	2026-10		2026-10
Investments Maturity Month and Year	[8],[25]	2026-10		2026-10
Investment, Basis Spread, Variable Rate	[8],[11],[25]	4.20%		4.20%
Investment, Interest Rate, Floor	[8],[11],[25]	7.45%		7.45%
Investment, Interest Rate, Cap	[8],[11],[25]	8.95%		8.95%
Principal Amount	[8],[25]	$ 2,000
Investment cost	[2],[8],[25]	2,027
Investments at Fair Value	[8],[25]	$ 1,950
Investment Exit Fee	[8],[11],[25]	6.00%		6.00%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc. Senior Secured, Maturity Date April 2026, Prime + 3.15%, Floor rate 10.15%, 6.35% Exit Fee
Investment Holding [Line Items]
Maturity Date	[8],[18],[20]	2026-04		2026-04
Investments Maturity Month and Year	[8],[18],[20]	2026-04		2026-04
Investment, Basis Spread, Variable Rate	[8],[11],[18],[20]	3.15%		3.15%
Investment, Interest Rate, Floor	[8],[11],[18],[20]	10.15%		10.15%
Principal Amount	[8],[18],[20]	$ 32,500
Investment cost	[2],[8],[18],[20]	32,658
Investments at Fair Value	[8],[18],[20]	$ 32,747
Investment Exit Fee	[8],[11],[18],[20]	6.35%		6.35%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc. Senior Secured, Maturity Date July 2024, Prime + 3.75%, Floor rate 8.75%, 8.80% Exit Fee
Investment Holding [Line Items]
Maturity Date	[16],[22],[23]					2024-07		2024-07
Investments Maturity Month and Year	[16],[22],[23]					2024-07		2024-07
Investment, Basis Spread, Variable Rate	[12],[16],[22],[23]					3.75%		3.75%
Investment, Interest Rate, Floor	[12],[16],[22],[23]					8.75%		8.75%
Principal Amount	[16],[22],[23]					$ 32,500
Investment cost	[6],[16],[22],[23]					33,705
Investments at Fair Value	[16],[22],[23]					$ 33,700
Investment Exit Fee	[12],[16],[22],[23]					8.80%		8.80%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and enGene, Inc. Senior Secured, Maturity Date July 2025, Prime + 5.00%, Floor rate 8.25%, 6.35% Exit Fee
Investment Holding [Line Items]
Maturity Date		2025-07	[8],[20],[25],[26]	2025-07	[8],[20],[25],[26]	2025-07	[22],[23],[27],[28]	2025-07	[22],[23],[27],[28]
Investments Maturity Month and Year		2025-07	[8],[20],[25],[26]	2025-07	[8],[20],[25],[26]	2025-07	[22],[23],[27],[28]	2025-07	[22],[23],[27],[28]
Investment, Basis Spread, Variable Rate		5.00%	[8],[11],[20],[25],[26]	5.00%	[8],[11],[20],[25],[26]	5.00%	[12],[22],[23],[27],[28]	5.00%	[12],[22],[23],[27],[28]
Investment, Interest Rate, Floor		8.25%	[8],[11],[20],[25],[26]	8.25%	[8],[11],[20],[25],[26]	8.25%	[12],[22],[23],[27],[28]	8.25%	[12],[22],[23],[27],[28]
Principal Amount		$ 11,000	[8],[20],[25],[26]			$ 11,000	[22],[23],[27],[28]
Investment cost		11,230	[2],[8],[20],[25],[26]			11,072	[6],[22],[23],[27],[28]
Investments at Fair Value		$ 11,264	[8],[20],[25],[26]			$ 11,067	[22],[23],[27],[28]
Investment Exit Fee		6.35%	[8],[11],[20],[25],[26]	6.35%	[8],[11],[20],[25],[26]	6.35%	[12],[22],[23],[27],[28]	6.35%	[12],[22],[23],[27],[28]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and uniQure B.V. Senior Secured, Maturity Date December 2025, Prime + 4.70%, Floor rate 7.95%, 6.10% Exit Fee
Investment Holding [Line Items]
Maturity Date	[18],[20],[25],[26]	2027-01		2027-01
Investments Maturity Month and Year	[18],[20],[25],[26]	2027-01		2027-01
Investment, Basis Spread, Variable Rate	[11],[18],[20],[25],[26]	4.70%		4.70%
Investment, Interest Rate, Floor	[11],[18],[20],[25],[26]	7.95%		7.95%
Principal Amount	[18],[20],[25],[26]	$ 70,000
Investment cost	[2],[18],[20],[25],[26]	70,682
Investments at Fair Value	[18],[20],[25],[26]	$ 72,066
Investment Exit Fee	[11],[18],[20],[25],[26]	6.10%		6.10%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and uniQure B.V. Senior Secured, Maturity Date December 2025, Prime + 4.70%, Floor rate 7.95%, 7.28% Exit Fee
Investment Holding [Line Items]
Maturity Date	[16],[23],[24],[27],[28]					2025-12		2025-12
Investments Maturity Month and Year	[16],[23],[24],[27],[28]					2025-12		2025-12
Investment, Basis Spread, Variable Rate	[12],[16],[23],[24],[27],[28]					4.70%		4.70%
Investment, Interest Rate, Floor	[12],[16],[23],[24],[27],[28]					7.95%		7.95%
Principal Amount	[16],[23],[24],[27],[28]					$ 70,000
Investment cost	[6],[16],[23],[24],[27],[28]					72,329
Investments at Fair Value	[16],[23],[24],[27],[28]					$ 73,019
Investment Exit Fee	[12],[16],[23],[24],[27],[28]					7.28%		7.28%
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware (1.19%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	1.19%		1.19%
Investment cost	[2]	$ 18,256
Investments at Fair Value		$ 18,942
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware (1.34%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					1.34%		1.34%
Investment cost	[6]					$ 18,171
Investments at Fair Value						$ 18,723
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware and Locus Robotics Corp. Senior Secured, Maturity Date June 2026, Prime + 4.50%, Floor rate 8.00%, 1.00% Exit Fee
Investment Holding [Line Items]
Maturity Date		2026-06	[9],[13]	2026-06	[9],[13]	2026-06	[14]	2026-06	[14]
Investments Maturity Month and Year		2026-06	[9],[13]	2026-06	[9],[13]	2026-06	[14]	2026-06	[14]
Investment, Basis Spread, Variable Rate		4.50%	[9],[11],[13]	4.50%	[9],[11],[13]	4.50%	[12],[14]	4.50%	[12],[14]
Investment, Interest Rate, Floor		8.00%	[9],[11],[13]	8.00%	[9],[11],[13]	8.00%	[12],[14]	8.00%	[12],[14]
Principal Amount		$ 18,281	[9],[13]			$ 18,281	[14]
Investment cost		18,256	[2],[9],[13]			18,171	[6],[14]
Investments at Fair Value		$ 18,942	[9],[13]			$ 18,723	[14]
Investment Exit Fee		1.00%	[9],[11],[13]	1.00%	[9],[11],[13]	1.00%	[12],[14]	1.00%	[12],[14]
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other (13.76%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	13.76%		13.76%
Investment cost	[2]	$ 218,993
Investments at Fair Value		$ 218,185
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other (13.98%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					13.98%		13.98%
Investment cost	[6]					$ 196,342
Investments at Fair Value						$ 195,855
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Better Therapeutics, Inc. Senior Secured, Maturity Date August 2025, Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee
Investment Holding [Line Items]
Maturity Date		2025-08	[1]	2025-08	[1]	2025-08	[31]	2025-08	[31]
Investments Maturity Month and Year		2025-08	[1]	2025-08	[1]	2025-08	[31]	2025-08	[31]
Investment, Basis Spread, Variable Rate		5.70%	[1],[11]	5.70%	[1],[11]	5.70%	[12],[31]	5.70%	[12],[31]
Investment, Interest Rate, Floor		8.95%	[1],[11]	8.95%	[1],[11]	8.95%	[12],[31]	8.95%	[12],[31]
Principal Amount		$ 11,314	[1]			$ 12,000	[31]
Investment cost		11,608	[1],[2]			12,162	[6],[31]
Investments at Fair Value		$ 11,500	[1]			$ 12,053	[31]
Investment Exit Fee		5.95%	[1],[11]	5.95%	[1],[11]	5.95%	[12],[31]	5.95%	[12],[31]
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc. Senior Secured, Maturity Date November 2026, 1-month LIBOR + 5.00%, Floor rate 6.00%, PIK Interest 4.45%
Investment Holding [Line Items]
Maturity Date	[15],[16],[22]					2026-11		2026-11
Investments Maturity Month and Year	[15],[16],[22]					2026-11		2026-11
Investment, Basis Spread, Variable Rate	[12],[15],[16],[22]					5.00%		5.00%
Investment, Interest Rate, Floor	[12],[15],[16],[22]					6.00%		6.00%
Investment, Interest Rate, Paid in Kind	[12],[15],[16],[22]					4.45%		4.45%
Principal Amount	[15],[16],[22]					$ 51,480
Investment cost	[6],[15],[16],[22]					50,813
Investments at Fair Value	[15],[16],[22]					$ 49,732
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc. Senior Secured, Maturity Date November 2026, 1-month SOFR + 5.00%, Floor rate 6.00%, PIK Interest 4.45%
Investment Holding [Line Items]
Maturity Date	[7],[8],[18]	2026-11		2026-11
Investments Maturity Month and Year	[7],[8],[18]	2026-11		2026-11
Investment, Basis Spread, Variable Rate	[7],[8],[11],[18]	5.00%		5.00%
Investment, Interest Rate, Floor	[7],[8],[11],[18]	6.00%		6.00%
Investment, Interest Rate, Paid in Kind	[7],[8],[11],[18]	4.45%		4.45%
Principal Amount	[7],[8],[18]	$ 57,658
Investment cost	[2],[7],[8],[18]	56,974
Investments at Fair Value	[7],[8],[18]	$ 55,819
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc. Senior Secured, Maturity Date March 2025, Prime + 5.60%, Floor rate 8.85%, 4.61% Exit Fee
Investment Holding [Line Items]
Maturity Date		2025-03	[8],[18]	2025-03	[8],[18]	2025-03	[14],[16],[22]	2025-03	[14],[16],[22]
Investments Maturity Month and Year		2025-03	[8],[18]	2025-03	[8],[18]	2025-03	[14],[16],[22]	2025-03	[14],[16],[22]
Investment, Basis Spread, Variable Rate		5.60%	[8],[11],[18]	5.60%	[8],[11],[18]	5.60%	[12],[14],[16],[22]	5.60%	[12],[14],[16],[22]
Investment, Interest Rate, Floor		8.85%	[8],[11],[18]	8.85%	[8],[11],[18]	8.85%	[12],[14],[16],[22]	8.85%	[12],[14],[16],[22]
Principal Amount		$ 46,125	[8],[18]			$ 46,125	[14],[16],[22]
Investment cost		46,859	[2],[8],[18]			46,552	[6],[14],[16],[22]
Investments at Fair Value		$ 47,142	[8],[18]			$ 46,548	[14],[16],[22]
Investment Exit Fee		4.61%	[8],[11],[18]	4.61%	[8],[11],[18]	4.61%	[12],[14],[16],[22]	4.61%	[12],[14],[16],[22]
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2026, Prime + 6.25%, Floor rate 9.50%, PIK Interest 1.55%
Investment Holding [Line Items]
Maturity Date		2026-02	[7],[18],[20]	2026-02	[7],[18],[20]	2026-02	[15],[23]	2026-02	[15],[23]
Investments Maturity Month and Year		2026-02	[7],[18],[20]	2026-02	[7],[18],[20]	2026-02	[15],[23]	2026-02	[15],[23]
Investment, Basis Spread, Variable Rate		6.25%	[7],[11],[18],[20]	6.25%	[7],[11],[18],[20]	6.25%	[12],[15],[23]	6.25%	[12],[15],[23]
Investment, Interest Rate, Floor		9.50%	[7],[11],[18],[20]	9.50%	[7],[11],[18],[20]	9.50%	[12],[15],[23]	9.50%	[12],[15],[23]
Investment, Interest Rate, Paid in Kind		1.55%	[7],[11],[18],[20]	1.55%	[7],[11],[18],[20]	1.55%	[12],[15],[23]	1.55%	[12],[15],[23]
Principal Amount		$ 53,999	[7],[18],[20]			$ 53,587	[15],[23]
Investment cost		53,646	[2],[7],[18],[20]			53,164	[6],[15],[23]
Investments at Fair Value		$ 54,269	[7],[18],[20]			$ 53,871	[15],[23]
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Main Street Rural, Inc. Senior Secured, Maturity Date July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee
Investment Holding [Line Items]
Maturity Date	[1]	2027-07		2027-07
Investments Maturity Month and Year	[1]	2027-07		2027-07
Investment, Basis Spread, Variable Rate	[1],[11]	1.95%		1.95%
Investment, Interest Rate, Floor	[1],[11]	9.95%		9.95%
Principal Amount	[1]	$ 17,500
Investment cost	[1],[2]	17,331
Investments at Fair Value	[1]	$ 17,331
Investment Exit Fee	[1],[11]	6.85%		6.85%
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Modern Life, Inc. Senior Secured, Maturity Date February 2027, Prime + 2.75%, Floor rate 8.75%, 3.00% Exit Fee
Investment Holding [Line Items]
Maturity Date	[8],[9]	2027-02		2027-02
Investments Maturity Month and Year	[8],[9]	2027-02		2027-02
Investment, Basis Spread, Variable Rate	[8],[9],[11]	2.75%		2.75%
Investment, Interest Rate, Floor	[8],[9],[11]	8.75%		8.75%
Principal Amount	[8],[9]	$ 13,000
Investment cost	[2],[8],[9]	12,765
Investments at Fair Value	[8],[9]	$ 12,765
Investment Exit Fee	[8],[9],[11]	3.00%		3.00%
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Oak Street Health, Inc. Senior Secured, Maturity Date October 2027, Prime + 2.45%, Floor rate 7.95%, Cap rate 9.45%, PIK Interest 1.00%, 4.95% Exit Fee
Investment Holding [Line Items]
Maturity Date	[10],[15],[27]					2027-10		2027-10
Investments Maturity Month and Year	[10],[15],[27]					2027-10		2027-10
Investment, Basis Spread, Variable Rate	[10],[12],[15],[27]					2.45%		2.45%
Investment, Interest Rate, Floor	[10],[12],[15],[27]					7.95%		7.95%
Investment, Interest Rate, Cap	[10],[12],[15],[27]					9.45%		9.45%
Investment, Interest Rate, Paid in Kind	[10],[12],[15],[27]					1.00%		1.00%
Principal Amount	[10],[15],[27]					$ 33,808
Investment cost	[6],[10],[15],[27]					33,651
Investments at Fair Value	[10],[15],[27]					$ 33,651
Investment Exit Fee	[10],[12],[15],[27]					4.95%		4.95%
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Vida Health, Inc. Senior Secured, Maturity Date March 2026, Prime + 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee
Investment Holding [Line Items]
Maturity Date	[9],[18]	2026-03		2026-03
Investments Maturity Month and Year	[9],[18]	2026-03		2026-03
Investment, Basis Spread, Variable Rate	[9],[11],[18]	1.00%		1.00%
Investment, Interest Rate, Floor	[9],[11],[18]	9.20%		9.20%
Investment, Interest Rate, Cap	[9],[11],[18]	10.20%		10.20%
Principal Amount	[9],[18]	$ 20,000
Investment cost	[2],[9],[18]	19,810
Investments at Fair Value	[9],[18]	$ 19,359
Investment Exit Fee	[9],[11],[18]	4.95%		4.95%
Investment, Identifier [Axis]: Debt Investments Information Services (3.72%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					3.72%		3.72%
Investment cost	[6]					$ 52,619
Investments at Fair Value						$ 52,075
Investment, Identifier [Axis]: Debt Investments Information Services (4.25%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	4.25%		4.25%
Investment cost	[2]	$ 66,699
Investments at Fair Value		$ 67,371
Investment, Identifier [Axis]: Debt Investments Information Services and Capella Space Corp. Senior Secured, Maturity Date November 2025, Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee
Investment Holding [Line Items]
Maturity Date		2025-11	[1],[7],[13]	2025-11	[1],[7],[13]	2025-11	[14],[15],[31]	2025-11	[14],[15],[31]
Investments Maturity Month and Year		2025-11	[1],[7],[13]	2025-11	[1],[7],[13]	2025-11	[14],[15],[31]	2025-11	[14],[15],[31]
Investment, Basis Spread, Variable Rate		5.00%	[1],[7],[11]	5.00%	[1],[7],[11]	5.00%	[12],[14],[15],[31]	5.00%	[12],[14],[15],[31]
Investment, Interest Rate, Floor		8.25%	[1],[7],[11]	8.25%	[1],[7],[11]	8.25%	[12],[14],[15],[31]	8.25%	[12],[14],[15],[31]
Investment, Interest Rate, Paid in Kind		1.10%	[1],[7],[11]	1.10%	[1],[7],[11]	1.10%	[12],[14],[15],[31]	1.10%	[12],[14],[15],[31]
Principal Amount		$ 20,362	[1],[7]			$ 20,250	[14],[15],[31]
Investment cost		20,826	[1],[2],[7]			20,506	[6],[14],[15],[31]
Investments at Fair Value		$ 20,949	[1],[7]			$ 20,574	[14],[15],[31]
Investment Exit Fee		7.00%	[1],[7],[11]	7.00%	[1],[7],[11]	7.00%	[12],[14],[15],[31]	7.00%	[12],[14],[15],[31]
Investment, Identifier [Axis]: Debt Investments Information Services and Saama Technologies, LLC Senior Secured, Maturity Date July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 2.95% Exit Fee
Investment Holding [Line Items]
Maturity Date	[9]	2027-07		2027-07
Investments Maturity Month and Year	[9]	2027-07		2027-07
Investment, Basis Spread, Variable Rate	[9],[11]	0.70%		0.70%
Investment, Interest Rate, Floor	[9],[11]	8.95%		8.95%
Investment, Interest Rate, Paid in Kind	[9],[11]	2.00%		2.00%
Principal Amount	[9]	$ 11,625
Investment cost	[2],[9]	11,480
Investments at Fair Value	[9]	$ 11,480
Investment Exit Fee	[9],[11]	2.95%		2.95%
Investment, Identifier [Axis]: Debt Investments Information Services and Signal Media Limited, Senior Secured, Maturity Date June 2025, Prime + 5.50%, Floor rate 9.00%, Cap rate 12.00%, 3.45% Exit Fee
Investment Holding [Line Items]
Maturity Date		2025-06	[9],[25],[26]	2025-06	[9],[25],[26]	2025-06	[10],[27],[28]	2025-06	[10],[27],[28]
Investments Maturity Month and Year		2025-06	[9],[25],[26]	2025-06	[9],[25],[26]	2025-06	[10],[27],[28]	2025-06	[10],[27],[28]
Investment, Basis Spread, Variable Rate		5.50%	[9],[11],[25],[26]	5.50%	[9],[11],[25],[26]	5.50%	[10],[12],[27],[28]	5.50%	[10],[12],[27],[28]
Investment, Interest Rate, Floor		9.00%	[9],[11],[25],[26]	9.00%	[9],[11],[25],[26]	9.00%	[10],[12],[27],[28]	9.00%	[10],[12],[27],[28]
Investment, Interest Rate, Cap		12.00%	[9],[11],[25],[26]	12.00%	[9],[11],[25],[26]	12.00%	[10],[12],[27],[28]	12.00%	[10],[12],[27],[28]
Principal Amount		$ 3,000	[9],[25],[26]			$ 750	[10],[27],[28]
Investment cost		2,970	[2],[9],[25],[26]			742	[6],[10],[27],[28]
Investments at Fair Value		$ 2,955	[9],[25],[26]			$ 738	[10],[27],[28]
Investment Exit Fee		3.45%	[9],[11],[25],[26]	3.45%	[9],[11],[25],[26]	3.45%	[10],[12],[27],[28]	3.45%	[10],[12],[27],[28]
Investment, Identifier [Axis]: Debt Investments Information Services and Yipit, LLC, Senior Secured, Maturity Date September 2026, 1-month SOFR + 9.03%, Floor rate 10.13%
Investment Holding [Line Items]
Maturity Date	[9],[19]	2026-09		2026-09
Investments Maturity Month and Year	[9],[19]	2026-09		2026-09
Investment, Basis Spread, Variable Rate	[9],[11],[19]	9.03%		9.03%
Investment, Interest Rate, Floor	[9],[11],[19]	10.03%		10.03%
Principal Amount	[9],[19]	$ 31,875
Investment cost	[2],[9],[19]	31,423
Investments at Fair Value	[9],[19]	$ 31,987
Investment, Identifier [Axis]: Debt Investments Information Services and Yipit, LLC, Senior Secured, Maturity Date September 2026, 1-month SOFR + 9.08%, Floor rate 10.08%
Investment Holding [Line Items]
Maturity Date	[10],[17]					2026-09		2026-09
Investments Maturity Month and Year	[10],[17]					2026-09		2026-09
Investment, Basis Spread, Variable Rate	[10],[12],[17]					9.08%		9.08%
Investment, Interest Rate, Floor	[10],[12],[17]					10.08%		10.08%
Principal Amount	[10],[17]					$ 31,875
Investment cost	[6],[10],[17]					31,371
Investments at Fair Value	[10],[17]					$ 30,763
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology (2.94%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	2.94%		2.94%
Investment cost	[2]	$ 44,357
Investments at Fair Value		$ 46,549
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology (2.99%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					2.99%		2.99%
Investment cost	[6]					$ 41,568
Investments at Fair Value						$ 41,953
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and Bright Machines, Inc. Senior Secured, Maturity Date April 2025, Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee
Investment Holding [Line Items]
Maturity Date		2025-04	[8]	2025-04	[8]	2025-04	[22]	2025-04	[22]
Investments Maturity Month and Year		2025-04	[8]	2025-04	[8]	2025-04	[22]	2025-04	[22]
Investment, Basis Spread, Variable Rate		4.00%	[8],[11]	4.00%	[8],[11]	4.00%	[12],[22]	4.00%	[12],[22]
Investment, Interest Rate, Floor		9.50%	[8],[11]	9.50%	[8],[11]	9.50%	[12],[22]	9.50%	[12],[22]
Principal Amount		$ 10,231	[8]			$ 11,050	[22]
Investment cost		10,252	[2],[8]			10,832	[6],[22]
Investments at Fair Value		$ 10,356	[8]			$ 10,832	[22]
Investment Exit Fee		5.00%	[8],[11]	5.00%	[8],[11]	5.00%	[12],[22]	5.00%	[12],[22]
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and MacroFab, Inc. Senior Secured, Maturity Date March 2026, Prime + 4.35%, Floor rate 7.60%, PIK Interest 1.25%, 4.50% Exit Fee
Investment Holding [Line Items]
Maturity Date		2026-03	[7]	2026-03	[7]	2026-03	[10],[15]	2026-03	[10],[15]
Investments Maturity Month and Year		2026-03	[7]	2026-03	[7]	2026-03	[10],[15]	2026-03	[10],[15]
Investment, Basis Spread, Variable Rate		4.35%	[7],[11]	4.35%	[7],[11]	4.35%	[10],[12],[15]	4.35%	[10],[12],[15]
Investment, Interest Rate, Floor		7.60%	[7],[11]	7.60%	[7],[11]	7.60%	[10],[12],[15]	7.60%	[10],[12],[15]
Investment, Interest Rate, Paid in Kind		1.25%	[7],[11]	1.25%	[7],[11]	1.25%	[10],[12],[15]	1.25%	[10],[12],[15]
Principal Amount		$ 20,254	[7]			$ 17,137	[10],[15]
Investment cost		19,995	[2],[7]			16,766	[6],[10],[15]
Investments at Fair Value		$ 21,608	[7]			$ 16,917	[10],[15]
Investment Exit Fee		4.50%	[7],[11]	4.50%	[7],[11]	4.50%	[10],[12],[15]	4.50%	[10],[12],[15]
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and Ouster, Inc. Senior Secured, Maturity Date May 2026, Prime + 6.15%, Floor rate 9.40%, 7.45% Exit Fee
Investment Holding [Line Items]
Maturity Date		2026-05	[8],[25]	2026-05	[8],[25]	2026-05	[22],[27]	2026-05	[22],[27]
Investments Maturity Month and Year		2026-05	[8],[25]	2026-05	[8],[25]	2026-05	[22],[27]	2026-05	[22],[27]
Investment, Basis Spread, Variable Rate		6.15%	[8],[11],[25]	6.15%	[8],[11],[25]	6.15%	[12],[22],[27]	6.15%	[12],[22],[27]
Investment, Interest Rate, Floor		9.40%	[8],[11],[25]	9.40%	[8],[11],[25]	9.40%	[12],[22],[27]	9.40%	[12],[22],[27]
Principal Amount		$ 14,000	[8],[25]			$ 14,000	[22],[27]
Investment cost		14,110	[2],[8],[25]			13,970	[6],[22],[27]
Investments at Fair Value		$ 14,585	[8],[25]			$ 14,204	[22],[27]
Investment Exit Fee		7.45%	[8],[11],[25]	7.45%	[8],[11],[25]	7.45%	[12],[22],[27]	7.45%	[12],[22],[27]
Investment, Identifier [Axis]: Debt Investments Media/Content/Info (0.73%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.73%		0.73%
Investment cost	[2]	$ 11,418
Investments at Fair Value		11,497
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc.
Investment Holding [Line Items]
Principal Amount		11,501
Investment cost	[2]	11,418
Investments at Fair Value		$ 11,497
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date December 2025, Prime + 3.50%, Floor rate 9.00%, 1.00% Exit Fee
Investment Holding [Line Items]
Maturity Date	[13]	2025-12		2025-12
Investments Maturity Month and Year	[13]	2025-12		2025-12
Investment, Basis Spread, Variable Rate	[11],[13]	3.50%		3.50%
Investment, Interest Rate, Floor	[11],[13]	9.00%		9.00%
Principal Amount	[13]	$ 1,667
Investment cost	[2],[13]	1,656
Investments at Fair Value	[13]	$ 1,664
Investment Exit Fee	[11],[13]	1.00%		1.00%
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date March 2026, Prime + 3.50%, Floor rate 9.00%, 1.00% Exit Fee
Investment Holding [Line Items]
Maturity Date	[13]	2026-03		2026-03
Investments Maturity Month and Year	[13]	2026-03		2026-03
Investment, Basis Spread, Variable Rate	[11],[13]	3.50%		3.50%
Investment, Interest Rate, Floor	[11],[13]	9.00%		9.00%
Principal Amount	[13]	$ 1,667
Investment cost	[2],[13]	1,648
Investments at Fair Value	[13]	$ 1,648
Investment Exit Fee	[11],[13]	1.00%		1.00%
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date September 2025, Prime + 3.50%, Floor rate 9.00%, 1.00% Exit Fee
Investment Holding [Line Items]
Maturity Date	[13]	2025-09		2025-09
Investments Maturity Month and Year	[13]	2025-09		2025-09
Investment, Basis Spread, Variable Rate	[11],[13]	3.50%		3.50%
Investment, Interest Rate, Floor	[11],[13]	9.00%		9.00%
Principal Amount	[13]	$ 1,500
Investment cost	[2],[13]	1,495
Investments at Fair Value	[13]	$ 1,503
Investment Exit Fee	[11],[13]	1.00%		1.00%
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date September 2026, Prime + 3.50%, Floor rate 9.00%, 1.00% Exit Fee
Investment Holding [Line Items]
Maturity Date	[13]	2026-09		2026-09
Investments Maturity Month and Year	[13]	2026-09		2026-09
Investment, Basis Spread, Variable Rate	[11],[13]	3.50%		3.50%
Investment, Interest Rate, Floor	[11],[13]	9.00%		9.00%
Principal Amount	[13]	$ 6,667
Investment cost	[2],[13]	6,619
Investments at Fair Value	[13]	$ 6,682
Investment Exit Fee	[11],[13]	1.00%		1.00%
Investment, Identifier [Axis]: Debt Investments Semiconductors (1.51%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					1.51%		1.51%
Investment cost	[6]					$ 19,639
Investments at Fair Value						$ 21,192
Investment, Identifier [Axis]: Debt Investments Semiconductors and Fungible, Inc. Senior Secured, Maturity Date December 2024, Prime + 5.00%, Floor rate 8.25%, 4.95% Exit Fee
Investment Holding [Line Items]
Maturity Date	[14],[31]					2024-12		2024-12
Investments Maturity Month and Year	[14],[31]					2024-12		2024-12
Investment, Basis Spread, Variable Rate	[12],[14],[31]					5.00%		5.00%
Investment, Interest Rate, Floor	[12],[14],[31]					8.25%		8.25%
Principal Amount	[14],[31]					$ 20,000
Investment cost	[6],[14],[31]					19,639
Investments at Fair Value	[14],[31]					$ 21,192
Investment Exit Fee	[12],[14],[31]					4.95%		4.95%
Investment, Identifier [Axis]: Debt Investments Software (53.63%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	53.63%		53.63%
Investment cost	[2]	$ 842,249
Investments at Fair Value		$ 850,278
Investment, Identifier [Axis]: Debt Investments Software (54.28%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					54.28%		54.28%
Investment cost	[6]					$ 762,371
Investments at Fair Value						760,679
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC
Investment Holding [Line Items]
Principal Amount						13,176
Investment cost	[6]					13,035
Investments at Fair Value						$ 12,998
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 6.57%, Floor rate 7.57%
Investment Holding [Line Items]
Maturity Date	[17]					2025-02		2025-02
Investments Maturity Month and Year	[17]					2025-02		2025-02
Investment, Basis Spread, Variable Rate	[12],[17]					6.57%		6.57%
Investment, Interest Rate, Floor	[12],[17]					7.57%		7.57%
Principal Amount	[17]					$ 2,750
Investment cost	[6],[17]					2,744
Investments at Fair Value	[17]					$ 2,681
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.28%, Floor rate 10.28%
Investment Holding [Line Items]
Maturity Date	[16],[17]					2025-02		2025-02
Investments Maturity Month and Year	[16],[17]					2025-02		2025-02
Investment, Basis Spread, Variable Rate	[12],[16],[17]					9.28%		9.28%
Investment, Interest Rate, Floor	[12],[16],[17]					10.28%		10.28%
Principal Amount	[16],[17]					$ 10,426
Investment cost	[6],[16],[17]					10,291
Investments at Fair Value	[16],[17]					$ 10,317
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 6-month SOFR + 9.27%, Floor rate 10.27%
Investment Holding [Line Items]
Maturity Date	[9],[18],[19]	2025-02		2025-02
Investments Maturity Month and Year	[9],[18],[19]	2025-02		2025-02
Investment, Basis Spread, Variable Rate	[9],[11],[18],[19]	9.27%		9.27%
Investment, Interest Rate, Floor	[9],[11],[18],[19]	10.27%		10.27%
Principal Amount	[9],[18],[19]	$ 13,174
Investment cost	[2],[9],[18],[19]	13,061
Investments at Fair Value	[9],[18],[19]	$ 13,016
Investment, Identifier [Axis]: Debt Investments Software and Agilence, Inc. Senior Secured, Maturity Date October 2026, 1-month BSBY + 9.00%, Floor rate 10.00%
Investment Holding [Line Items]
Maturity Date		2026-10	[9],[19],[20]	2026-10	[9],[19],[20]	2026-10	[10],[17],[23]	2026-10	[10],[17],[23]
Investments Maturity Month and Year		2026-10	[9],[19],[20]	2026-10	[9],[19],[20]	2026-10	[10],[17],[23]	2026-10	[10],[17],[23]
Investment, Basis Spread, Variable Rate		9.00%	[9],[11],[19],[20]	9.00%	[9],[11],[19],[20]	9.00%	[10],[12],[17],[23]	9.00%	[10],[12],[17],[23]
Investment, Interest Rate, Floor		10.00%	[9],[11],[19],[20]	10.00%	[9],[11],[19],[20]	10.00%	[10],[12],[17],[23]	10.00%	[10],[12],[17],[23]
Principal Amount		$ 9,259	[9],[19],[20]			$ 9,306	[10],[17],[23]
Investment cost		9,063	[2],[9],[19],[20]			9,088	[6],[10],[17],[23]
Investments at Fair Value		$ 9,093	[9],[19],[20]			$ 8,977	[10],[17],[23]
Investment, Identifier [Axis]: Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 7.89%, Floor rate 8.89%
Investment Holding [Line Items]
Maturity Date	[10],[17]					2028-05		2028-05
Investments Maturity Month and Year	[10],[17]					2028-05		2028-05
Investment, Basis Spread, Variable Rate	[10],[12],[17]					7.89%		7.89%
Investment, Interest Rate, Floor	[10],[12],[17]					8.89%		8.89%
Principal Amount	[10],[17]					$ 20,463
Investment cost	[6],[10],[17]					19,999
Investments at Fair Value	[10],[17]					$ 20,123
Investment, Identifier [Axis]: Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 8.14%, Floor rate 9.14%
Investment Holding [Line Items]
Maturity Date	[8],[9],[19]	2028-05		2028-05
Investments Maturity Month and Year	[8],[9],[19]	2028-05		2028-05
Investment, Basis Spread, Variable Rate	[8],[9],[11],[19]	8.14%		8.14%
Investment, Interest Rate, Floor	[8],[9],[11],[19]	9.14%		9.14%
Principal Amount	[8],[9],[19]	$ 20,908
Investment cost	[2],[8],[9],[19]	20,475
Investments at Fair Value	[8],[9],[19]	$ 21,158
Investment, Identifier [Axis]: Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 1-month BSBY + 8.99%, Floor rate 10.00%
Investment Holding [Line Items]
Maturity Date	[10],[22]					2027-02		2027-02
Investments Maturity Month and Year	[10],[22]					2027-02		2027-02
Investment, Basis Spread, Variable Rate	[10],[12],[22]					8.99%		8.99%
Investment, Interest Rate, Floor	[10],[12],[22]					10.00%		10.00%
Principal Amount	[10],[22]					$ 8,500
Investment cost	[6],[10],[22]					8,292
Investments at Fair Value	[10],[22]					$ 8,176
Investment, Identifier [Axis]: Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 1-month BSBY + 8.99%, Floor rate 9.99%
Investment Holding [Line Items]
Maturity Date	[8],[9]	2027-02		2027-02
Investments Maturity Month and Year	[8],[9]	2027-02		2027-02
Investment, Basis Spread, Variable Rate	[8],[9],[11]	8.99%		8.99%
Investment, Interest Rate, Floor	[8],[9],[11]	9.99%		9.99%
Principal Amount	[8],[9]	$ 8,479
Investment cost	[2],[8],[9]	8,290
Investments at Fair Value	[8],[9]	$ 8,319
Investment, Identifier [Axis]: Debt Investments Software and Automation Anywhere, Inc. Senior Secured, Maturity Date September 2027, Prime + 4.25%, Floor rate 9.00%, 2.50% Exit Fee
Investment Holding [Line Items]
Maturity Date		2027-09	[9],[13],[18]	2027-09	[9],[13],[18]	2027-09	[10],[14],[16]	2027-09	[10],[14],[16]
Investments Maturity Month and Year		2027-09	[9],[13],[18]	2027-09	[9],[13],[18]	2027-09	[10],[14],[16]	2027-09	[10],[14],[16]
Investment, Basis Spread, Variable Rate		4.25%	[9],[11],[13],[18]	4.25%	[9],[11],[13],[18]	4.25%	[10],[12],[14],[16]	4.25%	[10],[12],[14],[16]
Investment, Interest Rate, Floor		9.00%	[9],[11],[13],[18]	9.00%	[9],[11],[13],[18]	9.00%	[10],[12],[14],[16]	9.00%	[10],[12],[14],[16]
Principal Amount		$ 19,600	[9],[13],[18]			$ 19,600	[10],[14],[16]
Investment cost		19,197	[2],[9],[13],[18]			19,059	[6],[10],[14],[16]
Investments at Fair Value		$ 19,782	[9],[13],[18]			$ 19,059	[10],[14],[16]
Investment Exit Fee		2.50%	[9],[11],[13],[18]	2.50%	[9],[11],[13],[18]	2.50%	[10],[12],[14],[16]	2.50%	[10],[12],[14],[16]
Investment, Identifier [Axis]: Debt Investments Software and Babel Street, Senior Secured, Maturity Date December 2027, 3-month SOFR + 7.89%, Floor rate 8.89%
Investment Holding [Line Items]
Maturity Date		2027-12	[1],[9],[19]	2027-12	[1],[9],[19]	2027-12	[10],[17],[31]	2027-12	[10],[17],[31]
Investments Maturity Month and Year		2027-12	[1],[9],[19]	2027-12	[1],[9],[19]	2027-12	[10],[17],[31]	2027-12	[10],[17],[31]
Investment, Basis Spread, Variable Rate		7.89%	[1],[9],[11],[19]	7.89%	[1],[9],[11],[19]	7.89%	[10],[12],[17],[31]	7.89%	[10],[12],[17],[31]
Investment, Interest Rate, Floor		8.89%	[1],[9],[11],[19]	8.89%	[1],[9],[11],[19]	8.89%	[10],[12],[17],[31]	8.89%	[10],[12],[17],[31]
Principal Amount		$ 45,000	[1],[9],[19]			$ 45,000	[10],[17],[31]
Investment cost		43,889	[1],[2],[9],[19]			43,801	[6],[10],[17],[31]
Investments at Fair Value		$ 44,387	[1],[9],[19]			$ 43,801	[10],[17],[31]
Investment, Identifier [Axis]: Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date April 2025, PRIME + 3.70%, Floor rate 6.95%, PIK Interest 1.00%, 3.95% Exit Fee
Investment Holding [Line Items]
Maturity Date	[10],[15],[22],[31]					2025-04		2025-04
Investments Maturity Month and Year	[10],[15],[22],[31]					2025-04		2025-04
Investment, Basis Spread, Variable Rate	[10],[12],[15],[22],[31]					3.70%		3.70%
Investment, Interest Rate, Floor	[10],[12],[15],[22],[31]					6.95%		6.95%
Investment, Interest Rate, Paid in Kind	[10],[12],[15],[22],[31]					1.00%		1.00%
Principal Amount	[10],[15],[22],[31]					$ 20,166
Investment cost	[6],[10],[15],[22],[31]					20,242
Investments at Fair Value	[10],[15],[22],[31]					$ 20,138
Investment Exit Fee	[10],[12],[15],[22],[31]					3.95%		3.95%
Investment, Identifier [Axis]: Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date April 2026, PRIME + 3.70%, Floor rate 9.20%, PIK Interest 1.00%, 3.95% Exit Fee
Investment Holding [Line Items]
Maturity Date	[1],[7],[8],[9]	2026-04		2026-04
Investments Maturity Month and Year	[1],[7],[8],[9]	2026-04		2026-04
Investment, Basis Spread, Variable Rate	[1],[7],[8],[9],[11]	3.70%		3.70%
Investment, Interest Rate, Floor	[1],[7],[8],[9],[11]	9.20%		9.20%
Investment, Interest Rate, Paid in Kind	[1],[7],[8],[9],[11]	1.00%		1.00%
Principal Amount	[1],[7],[8],[9]	$ 30,268
Investment cost	[1],[2],[7],[8],[9]	30,313
Investments at Fair Value	[1],[7],[8],[9]	$ 30,184
Investment Exit Fee	[1],[7],[8],[9],[11]	3.95%		3.95%
Investment, Identifier [Axis]: Debt Investments Software and Campaign Monitor Limited, Senior Secured, Maturity Date November 2025, 3-month SOFR + 8.90%, Floor rate 9.90%
Investment Holding [Line Items]
Maturity Date	[8],[13]	2025-11		2025-11
Investments Maturity Month and Year	[8],[13]	2025-11		2025-11
Investment, Basis Spread, Variable Rate	[8],[11],[13]	8.90%		8.90%
Investment, Interest Rate, Floor	[8],[11],[13]	9.90%		9.90%
Principal Amount	[8],[13]	$ 33,000
Investment cost	[2],[8],[13]	32,640
Investments at Fair Value	[8],[13]	$ 33,000
Investment, Identifier [Axis]: Debt Investments Software and Campaign Monitor Limited, Senior Secured, Maturity Date November 2025, 6-month SOFR + 8.90%, Floor rate 9.90%
Investment Holding [Line Items]
Maturity Date	[14],[22]					2025-11		2025-11
Investments Maturity Month and Year	[14],[22]					2025-11		2025-11
Investment, Basis Spread, Variable Rate	[12],[14],[22]					8.90%		8.90%
Investment, Interest Rate, Floor	[12],[14],[22]					9.90%		9.90%
Principal Amount	[14],[22]					$ 33,000
Investment cost	[6],[14],[22]					32,578
Investments at Fair Value	[14],[22]					$ 33,000
Investment, Identifier [Axis]: Debt Investments Software and Catchpoint Systems, Inc., Senior Secured, Maturity Date June 2026, 1-month SOFR + 8.76%, Floor rate 9.76%
Investment Holding [Line Items]
Maturity Date	[19]	2026-06		2026-06
Investments Maturity Month and Year	[19]	2026-06		2026-06
Investment, Basis Spread, Variable Rate	[11],[19]	8.76%		8.76%
Investment, Interest Rate, Floor	[11],[19]	9.76%		9.76%
Principal Amount	[19]	$ 10,124
Investment cost	[2],[19]	9,952
Investments at Fair Value	[19]	$ 10,081
Investment, Identifier [Axis]: Debt Investments Software and Catchpoint Systems, Inc., Senior Secured, Maturity Date June 2026, 3-month SOFR + 8.86%, Floor rate 9.76%
Investment Holding [Line Items]
Maturity Date	[17]					2026-06		2026-06
Investments Maturity Month and Year	[17]					2026-06		2026-06
Investment, Basis Spread, Variable Rate	[12],[17]					8.86%		8.86%
Investment, Interest Rate, Floor	[12],[17]					9.76%		9.76%
Principal Amount	[17]					$ 10,175
Investment cost	[6],[17]					9,980
Investments at Fair Value	[17]					$ 9,996
Investment, Identifier [Axis]: Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 6-month LIBOR + 8.89%, Floor rate 9.89%
Investment Holding [Line Items]
Maturity Date	[9],[19]	2026-09		2026-09
Investments Maturity Month and Year	[9],[19]	2026-09		2026-09
Investment, Basis Spread, Variable Rate	[9],[11],[19]	8.89%		8.89%
Investment, Interest Rate, Floor	[9],[11],[19]	9.89%		9.89%
Principal Amount	[9],[19]	$ 22,973
Investment cost	[2],[9],[19]	22,547
Investments at Fair Value	[9],[19]	$ 23,145
Investment, Identifier [Axis]: Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 6-month LIBOR + 9.67%, Floor rate 10.67%
Investment Holding [Line Items]
Maturity Date	[10],[17]					2026-09		2026-09
Investments Maturity Month and Year	[10],[17]					2026-09		2026-09
Investment, Basis Spread, Variable Rate	[10],[12],[17]					9.67%		9.67%
Investment, Interest Rate, Floor	[10],[12],[17]					10.67%		10.67%
Principal Amount	[10],[17]					$ 21,445
Investment cost	[6],[10],[17]					21,003
Investments at Fair Value	[10],[17]					$ 21,050
Investment, Identifier [Axis]: Debt Investments Software and CloudBolt Software, Inc., Senior Secured, Maturity Date October 2024, Prime + 6.70%, Floor rate 9.95%, 3.45% Exit Fee
Investment Holding [Line Items]
Maturity Date	[14],[16]					2024-10		2024-10
Investments Maturity Month and Year	[14],[16]					2024-10		2024-10
Investment, Basis Spread, Variable Rate	[12],[14],[16]					6.70%		6.70%
Investment, Interest Rate, Floor	[12],[14],[16]					9.95%		9.95%
Principal Amount	[14],[16]					$ 10,000
Investment cost	[6],[14],[16]					10,069
Investments at Fair Value	[14],[16]					$ 10,498
Investment Exit Fee	[12],[14],[16]					3.45%		3.45%
Investment, Identifier [Axis]: Debt Investments Software and Constructor Corporation, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.44%, Floor rate 9.44%
Investment Holding [Line Items]
Maturity Date	[8],[9],[19]	2027-07		2027-07
Investments Maturity Month and Year	[8],[9],[19]	2027-07		2027-07
Investment, Basis Spread, Variable Rate	[8],[9],[11],[19]	8.44%		8.44%
Investment, Interest Rate, Floor	[8],[9],[11],[19]	9.44%		9.44%
Principal Amount	[8],[9],[19]	$ 4,688
Investment cost	[2],[8],[9],[19]	4,582
Investments at Fair Value	[8],[9],[19]	$ 4,736
Investment, Identifier [Axis]: Debt Investments Software and Constructor.io Corporation, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.44%, Floor rate 9.44%
Investment Holding [Line Items]
Maturity Date	[10],[17]					2027-07		2027-07
Investments Maturity Month and Year	[10],[17]					2027-07		2027-07
Investment, Basis Spread, Variable Rate	[10],[12],[17]					8.44%		8.44%
Investment, Interest Rate, Floor	[10],[12],[17]					9.44%		9.44%
Principal Amount	[10],[17]					$ 4,688
Investment cost	[6],[10],[17]					4,573
Investments at Fair Value	[10],[17]					$ 4,573
Investment, Identifier [Axis]: Debt Investments Software and Convoy, Inc., Senior Secured, Maturity Date March 2026, Prime + 3.20%, Floor rate 6.45%, PIK Interest 1.95%, 4.55% Exit Fee
Investment Holding [Line Items]
Maturity Date		2026-03	[7],[13]	2026-03	[7],[13]	2026-03	[14],[15],[24]	2026-03	[14],[15],[24]
Investments Maturity Month and Year		2026-03	[7],[13]	2026-03	[7],[13]	2026-03	[14],[15],[24]	2026-03	[14],[15],[24]
Investment, Basis Spread, Variable Rate		3.20%	[7],[11],[13]	3.20%	[7],[11],[13]	3.20%	[12],[14],[15],[24]	3.20%	[12],[14],[15],[24]
Investment, Interest Rate, Floor		6.45%	[7],[11],[13]	6.45%	[7],[11],[13]	6.45%	[12],[14],[15],[24]	6.45%	[12],[14],[15],[24]
Investment, Interest Rate, Paid in Kind		1.95%	[7],[11],[13]	1.95%	[7],[11],[13]	1.95%	[12],[14],[15],[24]	1.95%	[12],[14],[15],[24]
Principal Amount		$ 74,719	[7],[13]			$ 73,987	[14],[15],[24]
Investment cost		74,304	[2],[7],[13]			73,060	[6],[14],[15],[24]
Investments at Fair Value		$ 74,805	[7],[13]			$ 73,498	[14],[15],[24]
Investment Exit Fee		4.55%	[7],[11],[13]	4.55%	[7],[11],[13]	4.55%	[12],[14],[15],[24]	4.55%	[12],[14],[15],[24]
Investment, Identifier [Axis]: Debt Investments Software and Copper CRM, Inc, Senior Secured, Maturity Date March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 4.32% Exit Fee
Investment Holding [Line Items]
Maturity Date	[7],[18]	2025-03		2025-03
Investments Maturity Month and Year	[7],[18]	2025-03		2025-03
Investment, Basis Spread, Variable Rate	[7],[11],[18]	4.50%		4.50%
Investment, Interest Rate, Floor	[7],[11],[18]	8.25%		8.25%
Investment, Interest Rate, Cap	[7],[11],[18]	10.25%		10.25%
Investment, Interest Rate, Paid in Kind	[7],[11],[18]	1.95%		1.95%
Principal Amount	[7],[18]	$ 9,848
Investment cost	[2],[7],[18]	9,937
Investments at Fair Value	[7],[18]	$ 9,645
Investment Exit Fee	[7],[11],[18]	4.32%		4.32%
Investment, Identifier [Axis]: Debt Investments Software and Copper CRM, Inc, Senior Secured, Maturity Date March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 4.50% Exit Fee
Investment Holding [Line Items]
Maturity Date	[15],[16]					2025-03		2025-03
Investments Maturity Month and Year	[15],[16]					2025-03		2025-03
Investment, Basis Spread, Variable Rate	[12],[15],[16]					4.50%		4.50%
Investment, Interest Rate, Floor	[12],[15],[16]					8.25%		8.25%
Investment, Interest Rate, Cap	[12],[15],[16]					10.25%		10.25%
Investment, Interest Rate, Paid in Kind	[12],[15],[16]					1.95%		1.95%
Principal Amount	[15],[16]					$ 10,144
Investment cost	[6],[15],[16]					10,150
Investments at Fair Value	[15],[16]					$ 9,820
Investment Exit Fee	[12],[15],[16]					4.50%		4.50%
Investment, Identifier [Axis]: Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee
Investment Holding [Line Items]
Maturity Date		2025-10	[9],[20],[25],[26]	2025-10	[9],[20],[25],[26]	2025-10	[10],[23],[27],[28]	2025-10	[10],[23],[27],[28]
Investments Maturity Month and Year		2025-10	[9],[20],[25],[26]	2025-10	[9],[20],[25],[26]	2025-10	[10],[23],[27],[28]	2025-10	[10],[23],[27],[28]
Investment, Basis Spread, Variable Rate		5.20%	[9],[11],[20],[25],[26]	5.20%	[9],[11],[20],[25],[26]	5.20%	[10],[12],[23],[27],[28]	5.20%	[10],[12],[23],[27],[28]
Investment, Interest Rate, Floor		9.95%	[9],[11],[20],[25],[26]	9.95%	[9],[11],[20],[25],[26]	9.95%	[10],[12],[23],[27],[28]	9.95%	[10],[12],[23],[27],[28]
Principal Amount		$ 5,500	[9],[20],[25],[26]			$ 5,000	[10],[23],[27],[28]
Investment cost		5,489	[2],[9],[20],[25],[26]			4,949	[6],[10],[23]
Investments at Fair Value		$ 5,629	[9],[20],[25],[26]			$ 4,949	[10],[23],[27],[28]
Investment Exit Fee		4.95%	[9],[11],[20],[25],[26]	4.95%	[9],[11],[20],[25],[26]	4.95%	[10],[12],[23],[27],[28]	4.95%	[10],[12],[23],[27],[28]
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc.
Investment Holding [Line Items]
Principal Amount		$ 10,528
Investment cost	[2]	10,323
Investments at Fair Value		$ 10,161
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 12.11%, Floor rate 13.11%
Investment Holding [Line Items]
Maturity Date	[9]	2026-08		2026-08
Investments Maturity Month and Year	[9]	2026-08		2026-08
Investment, Basis Spread, Variable Rate	[9],[11]	12.11%		12.11%
Investment, Interest Rate, Floor	[9],[11]	13.11%		13.11%
Principal Amount	[9]	$ 2,553
Investment cost	[2],[9]	2,493
Investments at Fair Value	[9]	$ 2,604
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 8.38%, Floor rate 9.38%
Investment Holding [Line Items]
Maturity Date	[8],[9]	2026-08		2026-08
Investments Maturity Month and Year	[8],[9]	2026-08		2026-08
Investment, Basis Spread, Variable Rate	[8],[9],[11]	8.38%		8.38%
Investment, Interest Rate, Floor	[8],[9],[11]	9.38%		9.38%
Principal Amount	[8],[9]	$ 7,975
Investment cost	[2],[8],[9]	7,830
Investments at Fair Value	[8],[9]	$ 7,557
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 9.53%, Floor rate 10.28%
Investment Holding [Line Items]
Maturity Date	[10],[22]					2026-08		2026-08
Investments Maturity Month and Year	[10],[22]					2026-08		2026-08
Investment, Basis Spread, Variable Rate	[10],[12],[22]					9.53%		9.53%
Investment, Interest Rate, Floor	[10],[12],[22]					10.28%		10.28%
Principal Amount	[10],[22]					$ 10,528
Investment cost	[6],[10],[22]					10,298
Investments at Fair Value	[10],[22]					$ 10,114
Investment, Identifier [Axis]: Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date July 2025, Prime + 3.05%, Floor rate 7.55%, PIK Interest 1.10%, 2.39% Exit Fee
Investment Holding [Line Items]
Maturity Date	[8],[13],[18]	2025-07		2025-07
Investments Maturity Month and Year	[8],[13],[18]	2025-07		2025-07
Investment, Basis Spread, Variable Rate	[7],[8],[11],[13],[18]	3.05%		3.05%
Investment, Interest Rate, Floor	[7],[8],[11],[13],[18]	7.55%		7.55%
Investment, Interest Rate, Paid in Kind	[7],[8],[11],[13],[18]	1.10%		1.10%
Principal Amount	[7],[8],[13],[18]	$ 42,611
Investment cost	[2],[7],[8],[13],[18]	42,648
Investments at Fair Value	[7],[8],[13],[18]	$ 42,749
Investment Exit Fee	[7],[8],[11],[13],[18]	2.39%		2.39%
Investment, Identifier [Axis]: Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date July 2025, Prime + 3.05%, Floor rate 7.55%, PIK Interest 1.10%, 4.95% Exit Fee
Investment Holding [Line Items]
Maturity Date	[10],[14],[15],[16],[22]					2025-07		2025-07
Investments Maturity Month and Year	[10],[14],[15],[16],[22]					2025-07		2025-07
Investment, Basis Spread, Variable Rate	[10],[12],[14],[15],[16],[22]					3.05%		3.05%
Investment, Interest Rate, Floor	[10],[12],[14],[15],[16],[22]					7.55%		7.55%
Investment, Interest Rate, Paid in Kind	[10],[12],[14],[15],[16],[22]					1.10%		1.10%
Principal Amount	[10],[14],[15],[16],[22]					$ 31,930
Investment cost	[6],[10],[14],[15],[16],[22]					32,346
Investments at Fair Value	[10],[14],[15],[16],[22]					$ 32,012
Investment Exit Fee	[10],[12],[14],[15],[16],[22]					4.95%		4.95%
Investment, Identifier [Axis]: Debt Investments Software and Demandbase, Inc., Senior Secured, Maturity Date August 2025, Prime + 2.25%, Floor rate 5.50%, PIK Interest 3.00%, 5.00% Exit Fee
Investment Holding [Line Items]
Maturity Date	[10],[14],[15],[22]					2025-08		2025-08
Investments Maturity Month and Year	[10],[14],[15],[22]					2025-08		2025-08
Investment, Basis Spread, Variable Rate	[10],[12],[14],[15],[22]					2.25%		2.25%
Investment, Interest Rate, Floor	[10],[12],[14],[15],[22]					5.50%		5.50%
Investment, Interest Rate, Paid in Kind	[10],[12],[14],[15],[22]					3.00%		3.00%
Principal Amount	[10],[14],[15],[22]					$ 28,503
Investment cost	[6],[10],[14],[15],[22]					28,442
Investments at Fair Value	[10],[14],[15],[22]					$ 28,664
Investment Exit Fee	[10],[12],[14],[15],[22]					5.00%		5.00%
Investment, Identifier [Axis]: Debt Investments Software and Dispatch Technologies, Inc., Senior Secured, Maturity Date April 2028, 3-month SOFR + 8.01%, Floor rate 8.76%
Investment Holding [Line Items]
Maturity Date		2028-04	[9],[19]	2028-04	[9],[19]	2028-04	[10],[17]	2028-04	[10],[17]
Investments Maturity Month and Year		2028-04	[9],[19]	2028-04	[9],[19]	2028-04	[10],[17]	2028-04	[10],[17]
Investment, Basis Spread, Variable Rate		8.01%	[9],[11],[19]	8.01%	[9],[11],[19]	8.01%	[10],[12],[17]	8.01%	[10],[12],[17]
Investment, Interest Rate, Floor		8.76%	[9],[11],[19]	8.76%	[9],[11],[19]	8.76%	[10],[12],[17]	8.76%	[10],[12],[17]
Principal Amount		$ 7,500	[9],[19]			$ 7,500	[10],[17]
Investment cost		7,309	[2],[9],[19]			7,295	[6],[10],[17]
Investments at Fair Value		$ 7,414	[9],[19]			$ 7,339	[10],[17]
Investment, Identifier [Axis]: Debt Investments Software and Eigen Technologies Ltd., Senior Secured, Maturity Date April 2025, Prime + 5.10%, Floor rate 8.35%, 2.95% Exit Fee
Investment Holding [Line Items]
Maturity Date		2025-04	[25],[26]	2025-04	[25],[26]	2025-04	[27],[28]	2025-04	[27],[28]
Investments Maturity Month and Year		2025-04	[25],[26]	2025-04	[25],[26]	2025-04	[27],[28]	2025-04	[27],[28]
Investment, Basis Spread, Variable Rate		5.10%	[11],[25],[26]	5.10%	[11],[25],[26]	5.10%	[12],[27],[28]	5.10%	[12],[27],[28]
Investment, Interest Rate, Floor		8.35%	[11],[25],[26]	8.35%	[11],[25],[26]	8.35%	[12],[27],[28]	8.35%	[12],[27],[28]
Principal Amount		$ 3,750	[25],[26]			$ 3,750	[27],[28]
Investment cost		3,772	[2],[25],[26]			3,744	[6],[27],[28]
Investments at Fair Value		$ 3,746	[25],[26]			$ 3,746	[27],[28]
Investment Exit Fee		2.95%	[11],[25],[26]	2.95%	[11],[25],[26]	2.95%	[12],[27],[28]	2.95%	[12],[27],[28]
Investment, Identifier [Axis]: Debt Investments Software and Elation Health, Inc., Senior Secured, Maturity Date March 2026, Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee
Investment Holding [Line Items]
Maturity Date		2026-03	[7],[9],[13]	2026-03	[7],[9],[13]	2026-03	[10],[14],[15]	2026-03	[10],[14],[15]
Investments Maturity Month and Year		2026-03	[7],[9],[13]	2026-03	[7],[9],[13]	2026-03	[10],[14],[15]	2026-03	[10],[14],[15]
Investment, Basis Spread, Variable Rate		4.25%	[7],[9],[11],[13]	4.25%	[7],[9],[11],[13]	4.25%	[10],[12],[14],[15]	4.25%	[10],[12],[14],[15]
Investment, Interest Rate, Floor		9.00%	[7],[9],[11],[13]	9.00%	[7],[9],[11],[13]	9.00%	[10],[12],[14],[15]	9.00%	[10],[12],[14],[15]
Investment, Interest Rate, Paid in Kind		1.95%	[7],[9],[11],[13]	1.95%	[7],[9],[11],[13]	1.95%	[10],[12],[14],[15]	1.95%	[10],[12],[14],[15]
Principal Amount		$ 5,071	[7],[9],[13]			$ 5,021	[10],[14],[15]
Investment cost		4,935	[2],[7],[9],[13]			4,839	[6],[10],[14],[15]
Investments at Fair Value		$ 5,059	[7],[9],[13]			$ 4,839	[10],[14],[15]
Investment Exit Fee		3.95%	[7],[9],[11],[13]	3.95%	[7],[9],[11],[13]	3.95%	[10],[12],[14]	3.95%	[10],[12],[14]
Investment, Identifier [Axis]: Debt Investments Software and Enmark Systems, Inc., Senior Secured, Maturity Date September 2026, 3-month LIBOR + 6.77%, Floor rate 7.77%, PIK Interest 2.16%
Investment Holding [Line Items]
Maturity Date	[10],[15],[16],[17]					2026-09		2026-09
Investments Maturity Month and Year	[10],[15],[16],[17]					2026-09		2026-09
Investment, Basis Spread, Variable Rate	[10],[12],[15],[16],[17]					6.77%		6.77%
Investment, Interest Rate, Floor	[10],[12],[15],[16],[17]					7.77%		7.77%
Investment, Interest Rate, Paid in Kind	[10],[12],[15],[16],[17]					2.16%		2.16%
Principal Amount	[10],[15],[16],[17]					$ 8,223
Investment cost	[6],[10],[15],[16],[17]					8,054
Investments at Fair Value	[10],[15],[16],[17]					$ 8,043
Investment, Identifier [Axis]: Debt Investments Software and Enmark Systems, Inc., Senior Secured, Maturity Date September 2026, 3-month SOFR + 6.75%, Floor rate 7.75%, PIK Interest 2.14%
Investment Holding [Line Items]
Maturity Date	[7],[9],[18],[19]	2026-09		2026-09
Investments Maturity Month and Year	[7],[9],[18],[19]	2026-09		2026-09
Investment, Basis Spread, Variable Rate	[7],[9],[11],[18],[19]	6.75%		6.75%
Investment, Interest Rate, Floor	[7],[9],[11],[18],[19]	7.75%		7.75%
Investment, Interest Rate, Paid in Kind	[7],[9],[11],[18],[19]	2.14%		2.14%
Principal Amount	[7],[9],[18],[19]	$ 8,313
Investment cost	[2],[7],[9],[18],[19]	8,161
Investments at Fair Value	[7],[9],[18],[19]	$ 8,263
Investment, Identifier [Axis]: Debt Investments Software and Esentire, Inc., Senior Secured, Maturity Date May 2024, 3-month LIBOR + 9.96%, Floor rate 10.96%
Investment Holding [Line Items]
Maturity Date	[16],[17],[27],[28]					2024-05		2024-05
Investments Maturity Month and Year	[16],[17],[27],[28]					2024-05		2024-05
Investment, Basis Spread, Variable Rate	[12],[16],[17],[27],[28]					9.96%		9.96%
Investment, Interest Rate, Floor	[12],[16],[17],[27],[28]					10.96%		10.96%
Principal Amount	[16],[17],[27],[28]					$ 8,436
Investment cost	[6],[16],[17],[27]					8,361
Investments at Fair Value	[16],[17],[27],[28]					$ 8,376
Investment, Identifier [Axis]: Debt Investments Software and Esme Learning Solutions, Inc., Senior Secured, Maturity Date February 2025, Prime + 5.50%, Floor rate 8.75%, PIK Interest 1.50%, 3.00% Exit Fee
Investment Holding [Line Items]
Maturity Date	[15],[35]					2025-02		2025-02
Investments Maturity Month and Year	[15],[35]					2025-02		2025-02
Investment, Basis Spread, Variable Rate	[12],[15],[35]					5.50%		5.50%
Investment, Interest Rate, Floor	[12],[15],[35]					8.75%		8.75%
Investment, Interest Rate, Paid in Kind	[12],[15],[35]					1.50%		1.50%
Principal Amount	[15],[35]					$ 4,892
Investment cost	[6],[15],[35]					4,737
Investments at Fair Value	[15],[35]					$ 1,671
Investment Exit Fee	[12],[15],[35]					3.00%		3.00%
Investment, Identifier [Axis]: Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.70%, Floor rate 8.70%
Investment Holding [Line Items]
Maturity Date	[9],[19]	2027-10		2027-10
Investments Maturity Month and Year	[9],[19]	2027-10		2027-10
Investment, Basis Spread, Variable Rate	[9],[11],[19]	7.70%		7.70%
Investment, Interest Rate, Floor	[9],[11],[19]	8.70%		8.70%
Principal Amount	[9],[19]	$ 5,948
Investment cost	[2],[9],[19]	5,785
Investments at Fair Value	[9],[19]	$ 5,859
Investment, Identifier [Axis]: Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.79%, Floor rate 8.70%
Investment Holding [Line Items]
Maturity Date	[10],[17]					2027-10		2027-10
Investments Maturity Month and Year	[10],[17]					2027-10		2027-10
Investment, Basis Spread, Variable Rate	[10],[12],[17]					7.79%		7.79%
Investment, Interest Rate, Floor	[10],[12],[17]					8.70%		8.70%
Principal Amount	[10],[17]					$ 5,948
Investment cost	[6],[10],[17]					5,771
Investments at Fair Value	[10],[17]					$ 5,771
Investment, Identifier [Axis]: Debt Investments Software and Fortified Health Security, Senior Secured, Maturity Date December 2027, 6-month SOFR + 7.54%, Floor rate 8.54%
Investment Holding [Line Items]
Maturity Date	[9],[19],[20]	2027-12		2027-12
Investments Maturity Month and Year	[9],[19],[20]	2027-12		2027-12
Investment, Basis Spread, Variable Rate	[9],[11],[19],[20]	7.54%		7.54%
Investment, Interest Rate, Floor	[9],[11],[19],[20]	8.54%		8.54%
Principal Amount	[9],[18],[19]	$ 7,000
Investment cost	[2],[9],[18],[19]	6,837
Investments at Fair Value	[9],[18],[19]	$ 6,796
Investment, Identifier [Axis]: Debt Investments Software and Fortified Health Security, Senior Secured, Maturity Date December 2027, 6-month SOFR + 7.79%, Floor rate 8.54%
Investment Holding [Line Items]
Maturity Date	[10],[17]					2027-12		2027-12
Investments Maturity Month and Year	[10],[17]					2027-12		2027-12
Investment, Basis Spread, Variable Rate	[10],[12],[17]					7.79%		7.79%
Investment, Interest Rate, Floor	[10],[12],[17]					8.54%		8.54%
Principal Amount	[10],[17]					$ 7,000
Investment cost	[6],[10],[17]					6,824
Investments at Fair Value	[10],[17]					$ 6,824
Investment, Identifier [Axis]: Debt Investments Software and Ikon Science Limited, Senior Secured, Maturity Date October 2024, 3-month Eurodollar + 9.00%, Floor rate 10.00%
Investment Holding [Line Items]
Maturity Date		2024-10	[9],[19],[25],[26]	2024-10	[9],[19],[25],[26]	2024-10	[10],[17],[27],[28]	2024-10	[10],[17],[27],[28]
Investments Maturity Month and Year		2024-10	[9],[19],[25],[26]	2024-10	[9],[19],[25],[26]	2024-10	[10],[17],[27],[28]	2024-10	[10],[17],[27],[28]
Investment, Basis Spread, Variable Rate		9.00%	[9],[11],[19],[25],[26]	9.00%	[9],[11],[19],[25],[26]	9.00%	[10],[12],[17],[27],[28]	9.00%	[10],[12],[17],[27],[28]
Investment, Interest Rate, Floor		10.00%	[9],[11],[19],[25],[26]	10.00%	[9],[11],[19],[25],[26]	10.00%	[10],[12],[17],[27],[28]	10.00%	[10],[12],[17],[27],[28]
Principal Amount		$ 6,388	[9],[19],[25],[26]			$ 6,563	[10],[17],[27],[28]
Investment cost		6,284	[2],[9],[19],[25],[26]			6,422	[6],[10],[17],[27],[28]
Investments at Fair Value		$ 6,363	[9],[19],[25],[26]			$ 6,484	[10],[17],[27],[28]
Investment, Identifier [Axis]: Debt Investments Software and Imperva, Inc., Senior Secured, Maturity Date January 2027, 3-month LIBOR + 7.75%, Floor rate 8.75%
Investment Holding [Line Items]
Maturity Date		2027-01	[13]	2027-01	[13]	2027-01	[14]	2027-01	[14]
Investments Maturity Month and Year		2027-01	[13]	2027-01	[13]	2027-01	[14]	2027-01	[14]
Investment, Basis Spread, Variable Rate		7.75%	[11],[13]	7.75%	[11],[13]	7.75%	[12],[14]	7.75%	[12],[14]
Investment, Interest Rate, Floor		8.75%	[11],[13]	8.75%	[11],[13]	8.75%	[12],[14]	8.75%	[12],[14]
Principal Amount		$ 20,000	[13]			$ 20,000	[14]
Investment cost		19,887	[2],[13]			19,875	[6],[14]
Investments at Fair Value		$ 20,200	[13]			$ 20,200	[14]
Investment, Identifier [Axis]: Debt Investments Software and Kazoo, Inc. (p.k.a. YouEarnedIt, Inc.), Senior Secured, Maturity Date July 2023, 3-month SOFR + 10.14%, Floor rate 11.14%
Investment Holding [Line Items]
Maturity Date	[17]					2023-07		2023-07
Investments Maturity Month and Year	[17]					2023-07		2023-07
Investment, Basis Spread, Variable Rate	[12],[17]					10.14%		10.14%
Investment, Interest Rate, Floor	[12],[17]					11.14%		11.14%
Principal Amount	[17]					$ 10,681
Investment cost	[6],[17]					10,593
Investments at Fair Value	[17]					$ 10,593
Investment, Identifier [Axis]: Debt Investments Software and Khoros (p.k.a Lithium Technologies), Senior Secured, Maturity Date January 2024, 3-month SOFR + 8.00%, Floor rate 9.00%
Investment Holding [Line Items]
Maturity Date		2024-01	[9]	2024-01	[9]	2024-01	[10]	2024-01	[10]
Investments Maturity Month and Year		2024-01	[9]	2024-01	[9]	2024-01	[10]	2024-01	[10]
Investment, Basis Spread, Variable Rate		8.00%	[9],[11]	8.00%	[9],[11]	8.00%	[10],[12]	8.00%	[10],[12]
Investment, Interest Rate, Floor		9.00%	[9],[11]	9.00%	[9],[11]	9.00%	[10],[12]	9.00%	[10],[12]
Principal Amount		$ 57,113	[9]			$ 56,208	[10]
Investment cost		57,037	[2],[9]			56,062	[6],[10]
Investments at Fair Value		$ 57,037	[9]			$ 55,520	[10]
Investment, Identifier [Axis]: Debt Investments Software and Kore.ai, Inc., Senior Secured, Maturity Date April 2027, Prime + 1.50%, Floor rate 9.25%, PIK Interest 2.20%, 2.25% Exit Fee
Investment Holding [Line Items]
Maturity Date	[7]	2027-04		2027-04
Investments Maturity Month and Year	[7]	2027-04		2027-04
Investment, Basis Spread, Variable Rate	[7],[11]	1.50%		1.50%
Investment, Interest Rate, Floor	[7],[11]	9.25%		9.25%
Investment, Interest Rate, Paid in Kind	[7],[11]	2.20%		2.20%
Principal Amount	[7]	$ 30,114
Investment cost	[2],[7]	29,707
Investments at Fair Value	[7]	$ 29,503
Investment Exit Fee	[7],[11]	2.25%		2.25%
Investment, Identifier [Axis]: Debt Investments Software and Leapwork ApS., Senior Secured, Maturity Date February 2026, Prime + 0.25%, Floor rate 7.25%, PIK Interest 1.95%, 2.70% Exit Fee
Investment Holding [Line Items]
Maturity Date	[7],[9],[20],[25],[26]	2026-02		2026-02
Investments Maturity Month and Year	[7],[9],[20],[25],[26]	2026-02		2026-02
Investment, Basis Spread, Variable Rate	[7],[9],[11],[20],[25],[26]	0.25%		0.25%
Investment, Interest Rate, Floor	[7],[9],[11],[20],[25],[26]	7.25%		7.25%
Investment, Interest Rate, Paid in Kind	[7],[9],[11],[20],[25],[26]	1.95%		1.95%
Principal Amount	[7],[9],[20],[25],[26]	$ 3,776
Investment cost	[2],[7],[9],[20],[25],[26]	3,751
Investments at Fair Value	[7],[9],[20],[25],[26]	$ 3,751
Investment Exit Fee	[7],[9],[11],[20],[25],[26]	2.70%		2.70%
Investment, Identifier [Axis]: Debt Investments Software and Loftware, Inc., Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.88%, Floor rate 8.88%
Investment Holding [Line Items]
Maturity Date	[9],[19]	2028-03		2028-03
Investments Maturity Month and Year	[9],[19]	2028-03		2028-03
Investment, Basis Spread, Variable Rate	[9],[11],[19]	7.88%		7.88%
Investment, Interest Rate, Floor	[9],[11],[19]	8.88%		8.88%
Principal Amount	[9],[19]	$ 25,900
Investment cost	[2],[9],[19]	25,278
Investments at Fair Value	[9],[19]	$ 25,278
Investment, Identifier [Axis]: Debt Investments Software and LogicSource, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.93%, Floor rate 9.93%
Investment Holding [Line Items]
Maturity Date		2027-07	[9]	2027-07	[9]	2027-07	[10]	2027-07	[10]
Investments Maturity Month and Year		2027-07	[9]	2027-07	[9]	2027-07	[10]	2027-07	[10]
Investment, Basis Spread, Variable Rate		8.93%	[9],[11]	8.93%	[9],[11]	8.93%	[10],[12]	8.93%	[10],[12]
Investment, Interest Rate, Floor		9.93%	[9],[11]	9.93%	[9],[11]	9.93%	[10],[12]	9.93%	[10],[12]
Principal Amount		$ 13,300	[9]			$ 13,300	[10]
Investment cost		13,050	[2],[9]			13,028	[6],[10]
Investments at Fair Value		$ 13,287	[9]			$ 13,028	[10]
Investment, Identifier [Axis]: Debt Investments Software and Logicworks, Senior Secured, Maturity Date January 2024, Prime + 7.50%, Floor rate 10.75%
Investment Holding [Line Items]
Maturity Date	[23]					2024-01		2024-01
Investments Maturity Month and Year	[23]					2024-01		2024-01
Investment, Basis Spread, Variable Rate	[12],[23]					7.50%		7.50%
Investment, Interest Rate, Floor	[12],[23]					10.75%		10.75%
Principal Amount	[23]					$ 14,500
Investment cost	[6],[23]					14,398
Investments at Fair Value	[23]					$ 14,473
Investment, Identifier [Axis]: Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 3-month LIBOR + 9.06%, Floor rate 10.06%
Investment Holding [Line Items]
Maturity Date		2025-12	[19]	2025-12	[19]	2025-12	[10],[17]	2025-12	[10],[17]
Investments Maturity Month and Year		2025-12	[19]	2025-12	[19]	2025-12	[10],[17]	2025-12	[10],[17]
Investment, Basis Spread, Variable Rate		9.06%	[11],[19]	9.06%	[11],[19]	9.06%	[10],[12],[17]	9.06%	[10],[12],[17]
Investment, Interest Rate, Floor		10.06%	[11],[19]	10.06%	[11],[19]	10.06%	[10],[12],[17]	10.06%	[10],[12],[17]
Principal Amount		$ 18,366	[19]			$ 17,915	[10],[17]
Investment cost		18,059	[2],[19]			17,556	[6],[10],[17]
Investments at Fair Value		$ 17,821	[19]			$ 17,474	[10],[17]
Investment, Identifier [Axis]: Debt Investments Software and Nextroll, Inc., Senior Secured, Maturity Date July 2023, Prime + 3.75%, Floor rate 7.75%, PIK Interest 2.95%, 1.95% Exit Fee
Investment Holding [Line Items]
Maturity Date	[15],[23]					2023-07		2023-07
Investments Maturity Month and Year	[15],[23]					2023-07		2023-07
Investment, Basis Spread, Variable Rate	[12],[15],[23]					3.75%		3.75%
Investment, Interest Rate, Floor	[12],[15],[23]					7.75%		7.75%
Investment, Interest Rate, Paid in Kind	[12],[15],[23]					2.95%		2.95%
Principal Amount	[15],[23]					$ 22,211
Investment cost	[6],[15],[23]					22,284
Investments at Fair Value	[15],[23]					$ 22,284
Investment Exit Fee	[12],[15],[23]					1.95%		1.95%
Investment, Identifier [Axis]: Debt Investments Software and Nuvolo Technologies Corporation, Senior Secured, Maturity Date July 2025, Prime + 5.25%, Floor rate 8.50%, 2.42% Exit Fee
Investment Holding [Line Items]
Maturity Date	[10],[14],[22],[23]					2025-07		2025-07
Investments Maturity Month and Year	[10],[14],[22],[23]					2025-07		2025-07
Investment, Basis Spread, Variable Rate	[10],[12],[14],[22],[23]					5.25%		5.25%
Investment, Interest Rate, Floor	[10],[12],[14],[22],[23]					8.50%		8.50%
Principal Amount	[10],[14],[22],[23]					$ 22,500
Investment cost	[6],[10],[14],[22],[23]					22,508
Investments at Fair Value	[10],[14],[22],[23]					$ 22,817
Investment Exit Fee	[10],[12],[14],[22],[23]					2.42%		2.42%
Investment, Identifier [Axis]: Debt Investments Software and Nuvolo Technologies Corporation, Senior Secured, Maturity Date July 2026, Prime + 5.25%, Floor rate 8.50%, 2.42% Exit Fee
Investment Holding [Line Items]
Maturity Date	[8],[9],[13],[20]	2026-07		2026-07
Investments Maturity Month and Year	[8],[9],[13],[20]	2026-07		2026-07
Investment, Basis Spread, Variable Rate	[8],[9],[11],[13],[20]	5.25%		5.25%
Investment, Interest Rate, Floor	[8],[9],[11],[13],[20]	8.50%		8.50%
Principal Amount	[8],[9],[13],[20]	$ 22,500
Investment cost	[2],[8],[9],[13],[20]	22,644
Investments at Fair Value	[8],[9],[13],[20]	$ 22,975
Investment Exit Fee	[8],[9],[11],[13],[20]	2.42%		2.42%
Investment, Identifier [Axis]: Debt Investments Software and Omeda Holdings, LLC, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.05%, Floor rate 9.05%
Investment Holding [Line Items]
Maturity Date		2027-07	[9],[18],[19]	2027-07	[9],[18],[19]	2027-07	[10],[17]	2027-07	[10],[17]
Investments Maturity Month and Year		2027-07	[9],[18],[19]	2027-07	[9],[18],[19]	2027-07	[10],[17]	2027-07	[10],[17]
Investment, Basis Spread, Variable Rate		8.05%	[9],[11],[18],[19]	8.05%	[9],[11],[18],[19]	8.05%	[10],[12],[17]	8.05%	[10],[12],[17]
Investment, Interest Rate, Floor		9.05%	[9],[11],[18],[19]	9.05%	[9],[11],[18],[19]	9.05%	[10],[12],[17]	9.05%	[10],[12],[17]
Principal Amount		$ 7,519	[9],[18],[19]			$ 7,500	[10],[17]
Investment cost		7,299	[2],[9],[18],[19]			7,261	[6],[10],[17]
Investments at Fair Value		$ 7,398	[9],[18],[19]			$ 7,261	[10],[17]
Investment, Identifier [Axis]: Debt Investments Software and Riviera Partners LLC, Senior Secured, Maturity Date April 2027, 6-month SOFR + 7.53%, Floor rate 8.53%
Investment Holding [Line Items]
Maturity Date		2027-04	[9],[19]	2027-04	[9],[19]	2027-04	[10],[17]	2027-04	[10],[17]
Investments Maturity Month and Year		2027-04	[9],[19]	2027-04	[9],[19]	2027-04	[10],[17]	2027-04	[10],[17]
Investment, Basis Spread, Variable Rate		7.53%	[9],[11],[19]	7.53%	[9],[11],[19]	7.53%	[10],[12],[17]	7.53%	[10],[12],[17]
Investment, Interest Rate, Floor		8.53%	[9],[11],[19]	8.53%	[9],[11],[19]	8.53%	[10],[12],[17]	8.53%	[10],[12],[17]
Principal Amount		$ 25,988	[9],[19]			$ 26,184	[10],[17]
Investment cost		25,477	[2],[9],[19]			25,622	[6],[10],[17]
Investments at Fair Value		$ 24,871	[9],[19]			$ 25,487	[10],[17]
Investment, Identifier [Axis]: Debt Investments Software and Salary.com, LLC, Senior Secured, Maturity Date September 2027, 3-month SOFR + 8.00%, Floor rate 9.00%
Investment Holding [Line Items]
Maturity Date	[19]	2027-09		2027-09
Investments Maturity Month and Year	[19]	2027-09		2027-09
Investment, Basis Spread, Variable Rate	[11],[19]	8.00%		8.00%
Investment, Interest Rate, Floor	[11],[19]	9.00%		9.00%
Principal Amount	[19]	$ 17,910
Investment cost	[2],[19]	17,591
Investments at Fair Value	[19]	$ 17,577
Investment, Identifier [Axis]: Debt Investments Software and Salary.com, LLC, Senior Secured, Maturity Date September 2027, 6-month SOFR + 8.00%, Floor rate 9.00%
Investment Holding [Line Items]
Maturity Date	[17]					2027-09		2027-09
Investments Maturity Month and Year	[17]					2027-09		2027-09
Investment, Basis Spread, Variable Rate	[12],[17]					8.00%		8.00%
Investment, Interest Rate, Floor	[12],[17]					9.00%		9.00%
Principal Amount	[17]					$ 18,000
Investment cost	[6],[17]					17,654
Investments at Fair Value	[17]					$ 17,654
Investment, Identifier [Axis]: Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 3-month LIBOR + 9.00%, Floor rate 10.00%
Investment Holding [Line Items]
Maturity Date	[10],[17]					2026-12		2026-12
Investments Maturity Month and Year	[10],[17]					2026-12		2026-12
Investment, Basis Spread, Variable Rate	[10],[12],[17]					9.00%		9.00%
Investment, Interest Rate, Floor	[10],[12],[17]					10.00%		10.00%
Principal Amount	[10],[17]					$ 5,985
Investment cost	[6],[10],[17]					5,841
Investments at Fair Value	[10],[17]					$ 5,830
Investment, Identifier [Axis]: Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 6-month SOFR + 8.95%, Floor rate 9.95%
Investment Holding [Line Items]
Maturity Date	[9],[19]	2026-12		2026-12
Investments Maturity Month and Year	[9],[19]	2026-12		2026-12
Investment, Basis Spread, Variable Rate	[9],[11],[19]	8.95%		8.95%
Investment, Interest Rate, Floor	[9],[11],[19]	9.95%		9.95%
Principal Amount	[9],[19]	$ 6,000
Investment cost	[2],[9],[19]	5,868
Investments at Fair Value	[9],[19]	$ 5,739
Investment, Identifier [Axis]: Debt Investments Software and Simon Data, Inc., Senior Secured, Maturity Date March 2027, Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 2.95% Exit Fee
Investment Holding [Line Items]
Maturity Date	[7]	2027-03		2027-03
Investments Maturity Month and Year	[7]	2027-03		2027-03
Investment, Basis Spread, Variable Rate	[7],[11]	1.00%		1.00%
Investment, Interest Rate, Floor	[7],[11]	8.75%		8.75%
Investment, Interest Rate, Paid in Kind	[7],[11]	1.95%		1.95%
Principal Amount	[7]	$ 15,058
Investment cost	[2],[7]	14,980
Investments at Fair Value	[7]	$ 14,962
Investment Exit Fee	[7],[11]	2.95%		2.95%
Investment, Identifier [Axis]: Debt Investments Software and Sisense Ltd., Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 2.55% Exit Fee
Investment Holding [Line Items]
Maturity Date	[25],[26]	2027-07		2027-07
Investments Maturity Month and Year	[25],[26]	2027-07		2027-07
Investment, Basis Spread, Variable Rate	[11],[25],[26]	1.50%		1.50%
Investment, Interest Rate, Floor	[11],[25],[26]	9.50%		9.50%
Investment, Interest Rate, Paid in Kind	[11],[25],[26]	1.95%		1.95%
Principal Amount	[25],[26]	$ 34,500
Investment cost	[2],[25],[26]	33,984
Investments at Fair Value	[25],[26]	$ 33,984
Investment Exit Fee	[11],[25],[26]	2.55%		2.55%
Investment, Identifier [Axis]: Debt Investments Software and Streamline Healthcare Solutions, Senior Secured, Maturity Date March 2028, 1-month SOFR + 7.25%, Floor rate 8.25%
Investment Holding [Line Items]
Maturity Date	[9],[19]	2028-03		2028-03
Investments Maturity Month and Year	[9],[19]	2028-03		2028-03
Investment, Basis Spread, Variable Rate	[9],[11],[19]	7.25%		7.25%
Investment, Interest Rate, Floor	[9],[11],[19]	8.25%		8.25%
Principal Amount	[9],[19]	$ 13,200
Investment cost	[2],[9],[19]	12,931
Investments at Fair Value	[9],[19]	$ 12,932
Investment, Identifier [Axis]: Debt Investments Software and Sumo Logic, Inc., Senior Secured, Maturity Date May 2030, 3-month SOFR + 6.50%, Floor rate 7.50%
Investment Holding [Line Items]
Maturity Date	[9]	2030-05		2030-05
Investments Maturity Month and Year	[9]	2030-05		2030-05
Investment, Basis Spread, Variable Rate	[9],[11]	6.50%		6.50%
Investment, Interest Rate, Floor	[9],[11]	7.50%		7.50%
Principal Amount	[9]	$ 23,000
Investment cost	[2],[9]	22,432
Investments at Fair Value	[9]	$ 22,432
Investment, Identifier [Axis]: Debt Investments Software and Tact.ai Technologies, Inc., Senior Secured, Maturity Date February 2024, Prime + 4.00%, Floor rate 8.75%, PIK Interest 2.00%, 5.50% Exit Fee
Investment Holding [Line Items]
Maturity Date		2024-02	[7]	2024-02	[7]	2024-02	[15]	2024-02	[15]
Investments Maturity Month and Year		2024-02	[7]	2024-02	[7]	2024-02	[15]	2024-02	[15]
Investment, Basis Spread, Variable Rate		4.00%	[7],[11]	4.00%	[7],[11]	4.00%	[12],[15]	4.00%	[12],[15]
Investment, Interest Rate, Floor		8.75%	[7],[11]	8.75%	[7],[11]	8.75%	[12],[15]	8.75%	[12],[15]
Investment, Interest Rate, Paid in Kind		2.00%	[7],[11]	2.00%	[7],[11]	2.00%	[12],[15]	2.00%	[12],[15]
Principal Amount		$ 2,672	[7]			$ 4,250	[15]
Investment cost		2,657	[2],[7]			4,481	[6],[15]
Investments at Fair Value		$ 2,657	[7]			$ 4,446	[15]
Investment Exit Fee		5.50%	[7],[11]	5.50%	[7],[11]	5.50%	[12],[15]	5.50%	[12],[15]
Investment, Identifier [Axis]: Debt Investments Software and ThreatConnect, Inc., Senior Secured, Maturity Date May 2026, 6-month LIBOR + 9.00%, Floor rate 10.00%
Investment Holding [Line Items]
Maturity Date	[10],[17]					2026-05		2026-05
Investments Maturity Month and Year	[10],[17]					2026-05		2026-05
Investment, Basis Spread, Variable Rate	[10],[12],[17]					9.00%		9.00%
Investment, Interest Rate, Floor	[10],[12],[17]					10.00%		10.00%
Principal Amount	[10],[17]					$ 11,032
Investment cost	[6],[10],[17]					10,778
Investments at Fair Value	[10],[17]					$ 10,793
Investment, Identifier [Axis]: Debt Investments Software and ThreatConnect, Inc., Senior Secured, Maturity Date May 2026, 6-month SOFR + 9.00%, Floor rate 10.00%
Investment Holding [Line Items]
Maturity Date	[9],[19]	2026-05		2026-05
Investments Maturity Month and Year	[9],[19]	2026-05		2026-05
Investment, Basis Spread, Variable Rate	[9],[11],[19]	9.00%		9.00%
Investment, Interest Rate, Floor	[9],[11],[19]	10.00%		10.00%
Principal Amount	[9],[19]	$ 10,976
Investment cost	[2],[9],[19]	10,753
Investments at Fair Value	[9],[19]	$ 10,823
Investment, Identifier [Axis]: Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2027, Prime + 0.45%, Floor rate 7.95%, PIK Interest 2.00%, 3.75% Exit Fee
Investment Holding [Line Items]
Maturity Date	[7],[9],[25],[26]	2027-04		2027-04
Investments Maturity Month and Year	[7],[9],[25],[26]	2027-04		2027-04
Investment, Basis Spread, Variable Rate	[7],[9],[11],[25],[26]	0.45%		0.45%
Investment, Interest Rate, Floor	[7],[9],[11],[25],[26]	7.95%		7.95%
Investment, Interest Rate, Paid in Kind	[7],[9],[11],[25],[26]	2.00%		2.00%
Principal Amount	[7],[9],[25],[26]	$ 10,541
Investment cost	[2],[7],[9],[25],[26]	10,416
Investments at Fair Value	[7],[9],[25],[26]	$ 10,416
Investment Exit Fee	[7],[9],[11],[25],[26]	3.75%		3.75%
Investment, Identifier [Axis]: Debt Investments Software and VideoAmp, Inc., Senior Secured, Maturity Date February 2025, Prime + 3.70%, Floor rate 6.95%, PIK Interest 1.25%, 5.25% Exit Fee
Investment Holding [Line Items]
Maturity Date		2025-02	[1],[7],[13]	2025-02	[1],[7],[13]	2025-02	[14],[15],[31]	2025-02	[14],[15],[31]
Investments Maturity Month and Year		2025-02	[1],[7],[13]	2025-02	[1],[7],[13]	2025-02	[14],[15],[31]	2025-02	[14],[15],[31]
Investment, Basis Spread, Variable Rate		3.70%	[1],[7],[11],[13]	3.70%	[1],[7],[11],[13]	3.70%	[12],[14],[15],[31]	3.70%	[12],[14],[15],[31]
Investment, Interest Rate, Floor		6.95%	[1],[7],[11],[13]	6.95%	[1],[7],[11],[13]	6.95%	[12],[14],[15],[31]	6.95%	[12],[14],[15],[31]
Investment, Interest Rate, Paid in Kind		1.25%	[1],[7],[11],[13]	1.25%	[1],[7],[11],[13]	1.25%	[12],[14],[15],[31]	1.25%	[12],[14],[15],[31]
Principal Amount		$ 63,585	[1],[7],[13]			$ 63,187	[14],[15],[31]
Investment cost		63,830	[1],[2],[7],[13]			62,640	[6],[14],[31]
Investments at Fair Value		$ 68,207	[1],[7],[13]			$ 63,429	[14],[15],[31]
Investment Exit Fee		5.25%	[1],[7],[11],[13]	5.25%	[1],[7],[11],[13]	5.25%	[12],[14],[15],[31]	5.25%	[12],[14],[15],[31]
Investment, Identifier [Axis]: Debt Investments Software and Zappi, Inc., Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.03%, Floor rate 9.03%
Investment Holding [Line Items]
Maturity Date		2027-12	[9],[19],[25],[26]	2027-12	[9],[19],[25],[26]	2027-12	[10],[17],[27],[28]	2027-12	[10],[17],[27],[28]
Investments Maturity Month and Year		2027-12	[9],[19],[25],[26]	2027-12	[9],[19],[25],[26]	2027-12	[10],[17],[27],[28]	2027-12	[10],[17],[27],[28]
Investment, Basis Spread, Variable Rate		8.03%	[9],[11],[19],[25],[26]	8.03%	[9],[11],[19],[25],[26]	8.03%	[10],[12],[17],[27],[28]	8.03%	[10],[12],[17],[27],[28]
Investment, Interest Rate, Floor		9.03%	[9],[11],[19],[25],[26]	9.03%	[9],[11],[19],[25],[26]	9.03%	[10],[12],[17],[27],[28]	9.03%	[10],[12],[17],[27],[28]
Principal Amount		$ 9,000	[9],[19],[25],[26]			$ 9,000	[10],[17],[27],[28]
Investment cost		8,797	[2],[9],[19],[25],[26]			8,779	[6],[10],[17],[27],[28]
Investments at Fair Value		$ 8,803	[9],[19],[25],[26]			$ 8,779	[10],[17],[27],[28]
Investment, Identifier [Axis]: Debt Investments Software and Zimperium, Inc., Senior Secured, Maturity Date May 2027, 3-month SOFR + 8.31%, Floor rate 9.31%
Investment Holding [Line Items]
Maturity Date		2027-05	[9],[19]	2027-05	[9],[19]	2027-05	[10],[17]	2027-05	[10],[17]
Investments Maturity Month and Year		2027-05	[9],[19]	2027-05	[9],[19]	2027-05	[10],[17]	2027-05	[10],[17]
Investment, Basis Spread, Variable Rate		8.31%	[9],[11],[19]	8.31%	[9],[11],[19]	8.31%	[10],[12],[17]	8.31%	[10],[12],[17]
Investment, Interest Rate, Floor		9.31%	[9],[11],[19]	9.31%	[9],[11],[19]	9.31%	[10],[12],[17]	9.31%	[10],[12],[17]
Principal Amount		$ 16,313	[9],[19]			$ 16,313	[10],[17]
Investment cost		16,028	[2],[9],[19]			16,000	[6],[10],[17]
Investments at Fair Value		$ 16,235	[9],[19]			$ 16,072	[10],[17]
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology (0.38%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.38%		0.38%
Investment cost	[2]	$ 5,929
Investments at Fair Value		$ 5,947
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology (0.50%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.50%		0.50%
Investment cost	[6]					$ 7,222
Investments at Fair Value						$ 7,014
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, Maturity Date May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.95% Exit Fee
Investment Holding [Line Items]
Maturity Date		2025-05	[7],[8]	2025-05	[7],[8]	2025-05	[15],[22]	2025-05	[15],[22]
Investments Maturity Month and Year		2025-05	[7],[8]	2025-05	[7],[8]	2025-05	[15],[22]	2025-05	[15],[22]
Investment, Basis Spread, Variable Rate		4.70%	[7],[8],[11]	4.70%	[7],[8],[11]	4.70%	[12],[15],[22]	4.70%	[12],[15],[22]
Investment, Interest Rate, Floor		7.95%	[7],[8],[11]	7.95%	[7],[8],[11]	7.95%	[12],[15],[22]	7.95%	[12],[15],[22]
Investment, Interest Rate, Paid in Kind		1.45%	[7],[8],[11]	1.45%	[7],[8],[11]	1.45%	[12],[15],[22]	1.45%	[12],[15],[22]
Principal Amount		$ 4,067	[7],[8]			$ 4,037	[15],[22]
Investment cost		4,053	[2],[7],[8]			3,985	[6],[15],[22]
Investments at Fair Value		$ 4,091	[7],[8]			$ 4,008	[15],[22]
Investment Exit Fee		3.95%	[7],[8],[11]	3.95%	[7],[8],[11]	3.95%	[12],[15],[22]	3.95%	[12],[15],[22]
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Senior Secured, Maturity Date December 2024, PIK Interest 10.00%
Investment Holding [Line Items]
Maturity Date	[15]					2024-12		2024-12
Investments Maturity Month and Year	[15]					2024-12		2024-12
Investment, Interest Rate, Paid in Kind	[12],[15]					10.00%		10.00%
Principal Amount	[15]					$ 3,237
Investment cost	[6],[15]					3,237
Investments at Fair Value	[15]					$ 3,006
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Senior Secured, Maturity Date June 2027, FIXED 10.00%
Investment Holding [Line Items]
Maturity Date	[7]	2027-06		2027-06
Investments Maturity Month and Year	[7]	2027-06		2027-06
Investment, Interest Rate, Paid in Kind	[11]	10.00%		10.00%
Principal Amount	[7]	$ 1,876
Investment cost	[2],[7]	1,876
Investments at Fair Value	[7]	$ 1,856
Investment, Identifier [Axis]: Equity Investments (8.59%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	8.59%		8.59%
Investment cost	[2]	$ 140,925
Investments at Fair Value		$ 136,180
Investment, Identifier [Axis]: Equity Investments (9.56%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					9.56%		9.56%
Investment cost	[6]					$ 153,173
Investments at Fair Value						$ 133,972
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products (0.02%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.02%		0.02%
Investment cost	[2]	$ 663
Investments at Fair Value		325
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products (0.04%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.04%		0.04%
Investment cost	[6]					$ 663
Investments at Fair Value						498
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock
Investment Holding [Line Items]
Investment cost		433	[2],[39]			433	[6],[40]
Investments at Fair Value		$ 22	[39]			$ 24	[40]
Shares | shares		12,260	[39]	12,260	[39]	61,300	[40]	61,300	[40]
Investments Owned Acquisition Date		Apr. 30, 2021	[3]	Apr. 30, 2021	[3]	Apr. 30, 2021	[40]	Apr. 30, 2021	[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units
Investment Holding [Line Items]
Investment cost		$ 13	[2]			$ 13	[6]
Investments at Fair Value		$ 144				$ 226
Shares | shares		42,137		42,137		42,137		42,137
Investments Owned Acquisition Date		Apr. 30, 2010	[3]	Apr. 30, 2010	[3]	Apr. 30, 2010	[40]	Apr. 30, 2010	[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and TFG Holding, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 89	[2]			$ 89	[6]
Investments at Fair Value		$ 72				$ 116
Shares | shares		42,989		42,989		42,989		42,989
Investments Owned Acquisition Date		Apr. 30, 2010	[3]	Apr. 30, 2010	[3]	Apr. 30, 2010	[40]	Apr. 30, 2010	[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and TechStyle, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 128	[2]			$ 128	[6]
Investments at Fair Value		$ 87				$ 132
Shares | shares		42,989		42,989		42,989		42,989
Investments Owned Acquisition Date		Apr. 30, 2010	[3]	Apr. 30, 2010	[3]	Apr. 30, 2010	[40]	Apr. 30, 2010	[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services (0.57%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.57%		0.57%
Investment cost	[6]					$ 13,488
Investments at Fair Value						7,995
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services (0.61%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.61%		0.61%
Investment cost	[2]	$ 13,171
Investments at Fair Value		9,737
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-4
Investment Holding [Line Items]
Investment cost		1,151	[2],[25],[26]			1,151	[6],[27],[28]
Investments at Fair Value		$ 511	[25],[26]			$ 257	[27],[28]
Shares | shares		199,742	[25],[26]	199,742	[25],[26]	199,742	[27],[28]	199,742	[27],[28]
Investments Owned Acquisition Date		Dec. 15, 2021	[25],[26],[39]	Dec. 15, 2021	[25],[26],[39]	Dec. 15, 2021	[27],[28],[40]	Dec. 15, 2021	[27],[28],[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and DoorDash, Inc., Equity, Acquisition Date 12/20/2018, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 946	[2],[39]			$ 945	[6],[40]
Investments at Fair Value		$ 6,267	[39]			$ 4,003	[40]
Shares | shares		81,996	[39]	81,996	[39]	81,996	[40]	81,996	[40]
Investments Owned Acquisition Date		Dec. 20, 2018	[3],[39]	Dec. 20, 2018	[3],[39]	Dec. 20, 2018	[40]	Dec. 20, 2018	[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 5,263	[2],[39]			$ 5,263	[6],[40]
Investments at Fair Value		$ 966	[39]			$ 1,110	[40]
Shares | shares		100,738	[39]	100,738	[39]	100,738	[40]	100,738	[40]
Investments Owned Acquisition Date		Dec. 26, 2018	[3],[39]	Dec. 26, 2018	[3],[39]	Dec. 26, 2018	[40]	Dec. 26, 2018	[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 1,000	[2],[39]			$ 1,000	[6],[40]
Investments at Fair Value		$ 417	[39]			$ 225	[40]
Shares | shares		100,000	[39]	100,000	[39]	100,000	[40]	100,000	[40]
Investments Owned Acquisition Date		Sep. 17, 2021	[3],[39]	Sep. 17, 2021	[3],[39]	Sep. 17, 2021	[40]	Sep. 17, 2021	[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A
Investment Holding [Line Items]
Investment cost		$ 1,663	[2]			$ 1,663	[6]
Investments at Fair Value		$ 450				$ 372
Shares | shares		286,080		286,080		286,080		286,080
Investments Owned Acquisition Date		Oct. 25, 2016	[3]	Oct. 25, 2016	[3]	Oct. 25, 2016	[40]	Oct. 25, 2016	[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-1
Investment Holding [Line Items]
Investment cost		$ 632	[2]			$ 632	[6]
Investments at Fair Value		$ 171				$ 141
Shares | shares		108,710		108,710		108,710		108,710
Investments Owned Acquisition Date		Oct. 25, 2016	[3]	Oct. 25, 2016	[3]	Oct. 25, 2016	[40]	Oct. 25, 2016	[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 577	[2],[39]			$ 577	[6],[40]
Investments at Fair Value		$ 289	[39]			$ 266	[40]
Shares | shares		48,365	[39]	48,365	[39]	48,365	[40]	48,365	[40]
Investments Owned Acquisition Date		Jun. 28, 2013	[3],[39]	Jun. 28, 2013	[3],[39]	Jun. 28, 2013	[40]	Jun. 28, 2013	[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Reischling Press, Inc., Acquisition Date 7/31/2020, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 39	[2]			$ 39	[6]
Investments at Fair Value		$ 0				$ 0
Shares | shares		3,095		3,095		3,095		3,095
Investments Owned Acquisition Date		Jul. 31, 2020	[3]	Jul. 31, 2020	[3]	Jul. 31, 2020	[40]	Jul. 31, 2020	[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Preferred Series B-2
Investment Holding [Line Items]
Investment cost		$ 1,000	[2]			$ 1,000	[6]
Investments at Fair Value		$ 666				$ 805
Shares | shares		7,063		7,063		7,063		7,063
Investments Owned Acquisition Date		Jan. 24, 2022	[3]	Jan. 24, 2022	[3]	Jan. 24, 2022	[40]	Jan. 24, 2022	[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Acquisition Date 5/23/2018, Series Common Stock
Investment Holding [Line Items]
Investments at Fair Value						$ 0
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 900	[2],[32]			$ 900	[6],[34]
Investments at Fair Value	[32]	$ 0
Shares | shares		414,994,863	[32]	414,994,863	[32]	414,994,863	[34]	414,994,863	[34]
Investments Owned Acquisition Date		May 23, 2018	[3],[32]	May 23, 2018	[3],[32]	May 23, 2018	[34],[40]	May 23, 2018	[34],[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB
Investment Holding [Line Items]
Investment cost		$ 0	[2],[32]			$ 0	[6],[34]
Investments at Fair Value						$ 0
Shares | shares		1,000,000	[32]	1,000,000	[32]	1,000,000	[34]	1,000,000	[34]
Investments Owned Acquisition Date		Jun. 06, 2016	[3],[32]	Jun. 06, 2016	[3],[32]	Jun. 06, 2016	[34],[40]	Jun. 06, 2016	[34],[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total OfferUp, Inc.
Investment Holding [Line Items]
Investment cost		$ 2,295	[2]			$ 2,295	[6]
Investments at Fair Value		$ 621				$ 513
Shares | shares		394,790		394,790		394,790		394,790
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total Tectura Corporation
Investment Holding [Line Items]
Investment cost		$ 900	[2]			$ 900	[6]
Investments at Fair Value		$ 0				$ 0
Shares | shares		415,994,863		415,994,863		415,994,863		415,994,863
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Uber Technologies, Inc., Acquisition Date 12/1/2020, Series Common Stock
Investment Holding [Line Items]
Investment cost	[6],[40]					$ 318
Investments at Fair Value	[40]					$ 816
Shares | shares	[40]					32,991		32,991
Investments Owned Acquisition Date	[40]					Dec. 01, 2020		Dec. 01, 2020
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services (2.49%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					2.49%		2.49%
Investment cost	[6]					$ 28,444
Investments at Fair Value						34,869
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services (2.98%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	2.98%		2.98%
Investment cost	[2]	$ 29,444
Investments at Fair Value		47,313
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Equity, Acquisition Date 3/1/2018, Series Common Stock
Investment Holding [Line Items]
Investment cost	[6],[34]					1,884
Investments at Fair Value	[34]					$ 1,107
Shares | shares	[34]					830,000		830,000
Investments Owned Acquisition Date	[34],[40]					Mar. 01, 2018		Mar. 01, 2018
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Equity, Acquisition Date 3/1/2018, Series Preferred Series A
Investment Holding [Line Items]
Investment cost	[6],[34]					$ 26,122
Investments at Fair Value	[34]					$ 14,137
Shares | shares	[34]					10,602,752		10,602,752
Investments Owned Acquisition Date	[34],[40]					Mar. 01, 2018		Mar. 01, 2018
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/1/2018, Series Member Units
Investment Holding [Line Items]
Investment cost	[2],[32],[36]	29,006
Investments at Fair Value	[32],[36]	$ 19,779
Shares | shares	[32],[36]	1		1
Investments Owned Acquisition Date	[3],[32],[36]	Mar. 01, 2018		Mar. 01, 2018
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units
Investment Holding [Line Items]
Investment cost		$ 35	[2],[32]			$ 35	[6],[34]
Investments at Fair Value		$ 27,161	[32]			$ 19,153	[34]
Shares | shares		1	[32]	1	[32]	1	[34]	1	[34]
Investments Owned Acquisition Date		Mar. 26, 2021	[3],[32]	Mar. 26, 2021	[3],[32]	Mar. 26, 2021	[34],[40]	Mar. 26, 2021	[34],[40]
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-2
Investment Holding [Line Items]
Investment cost		$ 403	[2]			$ 403	[6]
Investments at Fair Value		$ 373				$ 472
Shares | shares		210,282		210,282		210,282		210,282
Investments Owned Acquisition Date		Sep. 30, 2021	[3]	Sep. 30, 2021	[3]	Sep. 30, 2021	[40]	Sep. 30, 2021	[40]
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services, Gibraltar Business Capital, LLC
Investment Holding [Line Items]
Investment cost	[6]					$ 28,006
Investments at Fair Value						$ 15,244
Shares | shares						11,432,752		11,432,752
Investment, Identifier [Axis]: Equity Investments Drug Delivery (0.00%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.00%		0.00%
Investment cost	[2]	$ 3,638
Investments at Fair Value		23
Investment, Identifier [Axis]: Equity Investments Drug Delivery (0.01%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.01%		0.01%
Investment cost	[6]					$ 3,638
Investments at Fair Value						89
Investment, Identifier [Axis]: Equity Investments Drug Delivery and AcelRx Pharmaceuticals, Inc., Equity, Acquisition Date 12/10/2018, Series Common Stock
Investment Holding [Line Items]
Investment cost		1,329	[2],[39]			1,329	[6],[40]
Investments at Fair Value		$ 10	[39]			$ 20	[40]
Shares | shares		8,836	[39]	8,836	[39]	8,836	[40]	8,836	[40]
Investments Owned Acquisition Date		Dec. 10, 2018	[3],[39]	Dec. 10, 2018	[3],[39]	Dec. 10, 2018	[40]	Dec. 10, 2018	[40]
Investment, Identifier [Axis]: Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 1,500	[2],[39]			$ 1,500	[6],[40]
Investments at Fair Value		$ 1	[39]			$ 3	[40]
Shares | shares		680	[39]	680	[39]	13,600	[40]	13,600	[40]
Investments Owned Acquisition Date		Mar. 28, 2014	[3],[39]	Mar. 28, 2014	[3],[39]	Mar. 28, 2014	[40]	Mar. 28, 2014	[40]
Investment, Identifier [Axis]: Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D
Investment Holding [Line Items]
Investment cost		$ 500	[2]			$ 500	[6]
Investments at Fair Value						$ 33
Shares | shares		165,000		165,000		165,000		165,000
Investments Owned Acquisition Date		Dec. 08, 2015	[3]	Dec. 08, 2015	[3]	Dec. 08, 2015	[40]	Dec. 08, 2015	[40]
Investment, Identifier [Axis]: Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 309	[2],[39]			$ 309	[6],[40]
Investments at Fair Value		$ 12	[39]			$ 33	[40]
Shares | shares		2,498	[39]	2,498	[39]	2,498	[40]	2,498	[40]
Investments Owned Acquisition Date		Apr. 06, 2015	[3],[39]	Apr. 06, 2015	[3],[39]	Apr. 06, 2015	[40]	Apr. 06, 2015	[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development (2.20%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	2.20%		2.20%
Investment cost	[2]	$ 40,305
Investments at Fair Value		34,933
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development (2.66%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					2.66%		2.66%
Investment cost	[6]					$ 43,971
Investments at Fair Value						37,315
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Akero Therapeutics, Inc., Equity, Acquisition Date 9/19/2022, Series Common Stock
Investment Holding [Line Items]
Investment cost	[6],[27],[40]					1,000
Investments at Fair Value	[27],[40]					$ 2,108
Shares | shares	[27],[40]					38,461		38,461
Investments Owned Acquisition Date	[27],[40]					Sep. 19, 2022		Sep. 19, 2022
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Albireo Pharma, Inc., Equity, Acquisition Date 9/14/2020, Series Common Stock
Investment Holding [Line Items]
Investment cost	[6],[27],[40]					$ 1,000
Investments at Fair Value	[27],[40]					$ 540
Shares | shares	[27],[40]					25,000		25,000
Investments Owned Acquisition Date	[27],[40]					Sep. 14, 2020		Sep. 14, 2020
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Applied Molecular Transport, Equity, Acquisition Date 4/6/2021, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 42	[2],[25],[39]			$ 42	[6],[27],[40]
Investments at Fair Value	[27],[40]					$ 0
Shares | shares		1,000	[25],[39]	1,000	[25],[39]	1,000	[27],[40]	1,000	[27],[40]
Investments Owned Acquisition Date		Apr. 06, 2021	[3],[25],[39]	Apr. 06, 2021	[3],[25],[39]	Apr. 06, 2021	[27],[40]	Apr. 06, 2021	[27],[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 1,000	[2],[39]			$ 1,000	[6],[40]
Investments at Fair Value		$ 4	[39]			$ 50	[40]
Shares | shares		9,923	[39]	9,923	[39]	9,924	[40]	9,924	[40]
Investments Owned Acquisition Date		Aug. 19, 2014	[3],[39]	Aug. 19, 2014	[3],[39]	Aug. 19, 2014	[40]	Aug. 19, 2014	[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Aveo Pharmaceuticals, Inc., Equity, Acquisition Date 7/31/2011, Series Common Stock
Investment Holding [Line Items]
Investment cost	[6],[40]					$ 1,715
Investments at Fair Value	[40]					$ 2,843
Shares | shares	[40]					190,179		190,179
Investments Owned Acquisition Date	[40]					Jul. 31, 2011		Jul. 31, 2011
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 4,165	[2],[21],[25],[39]			$ 4,165	[6],[24],[27],[40]
Investments at Fair Value		$ 9,128	[21],[25],[39]			$ 9,797	[24],[27],[40]
Shares | shares		127,021	[21],[25],[39]	127,021	[21],[25],[39]	127,021	[24],[27],[40]	127,021	[24],[27],[40]
Investments Owned Acquisition Date		May 09, 2022	[3],[21],[25],[39]	May 09, 2022	[3],[21],[25],[39]	May 09, 2022	[24],[27],[40]	May 09, 2022	[24],[27],[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/5/2020, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 1,871	[2],[25],[26],[39]			$ 1,871	[6],[27],[28],[40]
Investments at Fair Value		$ 2,503	[25],[26],[39]			$ 2,904	[27],[28],[40]
Shares | shares		98,100	[25],[26],[39]	98,100	[25],[26],[39]	98,100	[27],[28],[40]	98,100	[27],[28],[40]
Investments Owned Acquisition Date		Oct. 05, 2020	[3],[25],[26],[39]	Oct. 05, 2020	[3],[25],[26],[39]	Oct. 05, 2020	[28],[40]	Oct. 05, 2020	[28],[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock
Investment Holding [Line Items]
Investment cost	[2],[39]	$ 2,255
Investments at Fair Value	[39]	$ 3,979
Shares | shares	[39]	231,329		231,329
Investments Owned Acquisition Date	[3],[39]	Jun. 21, 2018		Jun. 21, 2018
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Concert Pharmaceuticals, Inc., Equity, Acquisition Date 2/13/2019, Series Common Stock
Investment Holding [Line Items]
Investment cost	[6],[27],[40]					$ 1,367
Investments at Fair Value	[27],[40]					$ 413
Shares | shares	[27],[40]					70,796		70,796
Investments Owned Acquisition Date	[27],[40]					Feb. 13, 2019		Feb. 13, 2019
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock
Investment Holding [Line Items]
Investment cost	[6],[40]					$ 1,000
Investments at Fair Value	[40]					$ 11
Shares | shares	[40]					13,550		13,550
Investments Owned Acquisition Date	[40]					Jan. 08, 2015		Jan. 08, 2015
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 550	[2],[25],[39]			$ 550	[6],[27],[40]
Investments at Fair Value		$ 258	[25],[39]			$ 213	[27],[40]
Shares | shares		20,000	[25],[39]	20,000	[25],[39]	20,000	[27],[40]	20,000	[27],[40]
Investments Owned Acquisition Date		Jul. 22, 2015	[3],[25],[39]	Jul. 22, 2015	[3],[25],[39]	Jul. 22, 2015	[27],[40]	Jul. 22, 2015	[27],[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, Acquisition Date 10/26/2022, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 1,000	[2],[39]			$ 1,000	[6],[40]
Investments at Fair Value		$ 863	[39]			$ 1,527	[40]
Shares | shares		442,477	[39]	442,477	[39]	442,477	[40]	442,477	[40]
Investments Owned Acquisition Date		Oct. 26, 2022	[3],[39]	Oct. 26, 2022	[3],[39]	Oct. 26, 2022	[40]	Oct. 26, 2022	[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B
Investment Holding [Line Items]
Investment cost		$ 4,250	[1],[2]			$ 4,250	[6],[31]
Investments at Fair Value		$ 1,131	[1]			$ 2,233	[31]
Shares | shares		3,466,840	[1]	3,466,840	[1]	3,466,840	[31]	3,466,840	[31]
Investments Owned Acquisition Date		May 07, 2021	[1],[3]	May 07, 2021	[1],[3]	May 07, 2021	[31],[40]	May 07, 2021	[31],[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and HilleVax, Inc, Equity, Acquisition Date 5/3/2022, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 4,000	[2],[39]			$ 4,000	[6],[40]
Investments at Fair Value		$ 4,044	[39]			$ 3,937	[40]
Shares | shares		235,295	[39]	235,295	[39]	235,295	[40]	235,295	[40]
Investments Owned Acquisition Date		May 03, 2022	[3],[39]	May 03, 2022	[3],[39]	May 03, 2022	[40]	May 03, 2022	[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, Acquisition Date 3/31/2021, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 800	[2],[25],[39]			$ 800	[6],[27],[40]
Investments at Fair Value		$ 7	[25],[39]			$ 5	[27],[40]
Shares | shares		43,243	[25],[39]	43,243	[25],[39]	43,243	[27],[40]	43,243	[27],[40]
Investments Owned Acquisition Date		Mar. 31, 2021	[3],[25],[39]	Mar. 31, 2021	[3],[25],[39]	Mar. 31, 2021	[27],[40]	Mar. 31, 2021	[27],[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Kura Oncology, Inc., Equity, Acquisition Date 6/16/2023, Series Common Stock
Investment Holding [Line Items]
Investment cost	[2],[25],[39]	$ 550
Investments at Fair Value	[25],[39]	$ 506
Shares | shares	[25],[39]	47,826		47,826
Investments Owned Acquisition Date	[3],[39]	Jun. 16, 2023		Jun. 16, 2023
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C
Investment Holding [Line Items]
Investment cost		$ 2,000	[2],[25],[26]			$ 2,000	[6],[27],[28]
Investments at Fair Value		$ 763	[25],[39]			$ 1,476	[27],[28]
Shares | shares		983	[25],[26]	983	[25],[26]	983	[27],[28]	983	[27],[28]
Investments Owned Acquisition Date		Dec. 15, 2021	[3],[25],[26]	Dec. 15, 2021	[3],[25],[26]	Dec. 15, 2021	[27],[28],[40]	Dec. 15, 2021	[27],[28],[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Paratek Pharmaceuticals, Inc., Equity, Acquisition Date 2/26/2007, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 2,744	[2],[39]			$ 2,744	[6],[40]
Investments at Fair Value		$ 169	[39]			$ 143	[40]
Shares | shares		76,362	[39]	76,362	[39]	76,362	[40]	76,362	[40]
Investments Owned Acquisition Date		Feb. 26, 2007	[3],[39]	Feb. 26, 2007	[3],[39]	Feb. 26, 2007	[40]	Feb. 26, 2007	[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Equity, Acquisition Date 6/9/2023, Series Common Stock
Investment Holding [Line Items]
Investment cost	[2],[21],[25],[39]	$ 1,730
Investments at Fair Value	[21],[25],[39]	$ 2,108
Shares | shares	[21],[25],[39]	147,233		147,233
Investments Owned Acquisition Date	[3],[39]	Jun. 09, 2023		Jun. 09, 2023
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 1,500	[2],[39]			$ 1,500	[6],[40]
Investments at Fair Value		$ 19	[39]			$ 18	[40]
Shares | shares		944	[39]	944	[39]	944	[40]	944	[40]
Investments Owned Acquisition Date		Aug. 22, 2007	[3],[39]	Aug. 22, 2007	[3],[39]	Aug. 22, 2007	[40]	Aug. 22, 2007	[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 202	[2],[39]			$ 203	[6],[40]
Investments at Fair Value		$ 36	[39]			$ 17	[40]
Shares | shares		11,119	[39]	11,119	[39]	11,119	[40]	11,119	[40]
Investments Owned Acquisition Date		Aug. 11, 2015	[3],[39]	Aug. 11, 2015	[3],[39]	Aug. 11, 2015	[40]	Aug. 11, 2015	[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, Acquisition Date 2/2/2017, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 1,269	[2],[39]			$ 1,269	[6],[40]
Investments at Fair Value		$ 7	[39]			$ 7	[40]
Shares | shares		16,228	[39]	16,228	[39]	16,228	[40]	16,228	[40]
Investments Owned Acquisition Date		Feb. 02, 2017	[3],[39]	Feb. 02, 2017	[3],[39]	Feb. 02, 2017	[40]	Feb. 02, 2017	[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, Acquisition Date 5/5/2022, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 2,100	[2],[25],[39]			$ 2,100	[6],[27],[40]
Investments at Fair Value		$ 2,811	[25],[39]			$ 2,280	[27],[40]
Shares | shares		155,555	[25],[39]	155,555	[25],[39]	155,555	[27],[40]	155,555	[27],[40]
Investments Owned Acquisition Date		May 05, 2022	[3],[25],[39]	May 05, 2022	[3],[25],[39]	May 05, 2022	[27],[40]	May 05, 2022	[27],[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Tricida, Inc., Equity, Acquisition Date 2/28/2018, Series Common Stock
Investment Holding [Line Items]
Investment cost	[6],[40]					$ 863
Investments at Fair Value	[40]					$ 11
Shares | shares	[40]					68,816		68,816
Investments Owned Acquisition Date	[40]					Feb. 28, 2018		Feb. 28, 2018
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C
Investment Holding [Line Items]
Investment cost		$ 1,000	[2]			$ 1,000	[6]
Investments at Fair Value		$ 1,070				$ 1,012
Shares | shares		170,102		170,102		170,102		170,102
Investments Owned Acquisition Date		Oct. 31, 2022	[3]	Oct. 31, 2022	[3]	Oct. 31, 2022	[40]	Oct. 31, 2022	[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B
Investment Holding [Line Items]
Investment cost		$ 3,000	[2]			$ 3,000	[6]
Investments at Fair Value		$ 2,280				$ 2,063
Shares | shares		510,308		510,308		510,308		510,308
Investments Owned Acquisition Date		Dec. 11, 2020	[3]	Dec. 11, 2020	[3]	Dec. 11, 2020	[40]	Dec. 11, 2020	[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 2,945	[2],[39]			$ 2,945	[6],[40]
Investments at Fair Value		$ 3,038	[39]			$ 1,555	[40]
Shares | shares		1,566,064	[39]	1,566,064	[39]	1,566,064	[40]	1,566,064	[40]
Investments Owned Acquisition Date		Nov. 26, 2019	[3],[39]	Nov. 26, 2019	[3],[39]	Nov. 26, 2019	[40]	Nov. 26, 2019	[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 332	[2],[25],[26],[39]			$ 332	[6],[24],[27],[28],[40]
Investments at Fair Value		$ 197	[25],[26],[39]			$ 389	[24],[27],[28],[40]
Shares | shares		17,175	[25],[26],[39]	17,175	[25],[26],[39]	17,175	[24],[27],[28],[40]	17,175	[24],[27],[28],[40]
Investments Owned Acquisition Date		Jan. 31, 2019	[3],[25],[26],[39]	Jan. 31, 2019	[3],[25],[26],[39]	Jan. 31, 2019	[24],[27],[28],[40]	Jan. 31, 2019	[24],[27],[28],[40]
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development, Valo Health LLC
Investment Holding [Line Items]
Investment cost		$ 4,000	[2]			$ 4,000	[6]
Investments at Fair Value		$ 3,350				$ 3,075
Shares | shares		680,410		680,410		680,410		680,410
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware (0.07%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.07%		0.07%
Investment cost	[2]	$ 2,150
Investments at Fair Value		1,123
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware (0.11%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.11%		0.11%
Investment cost	[6]					$ 2,150
Investments at Fair Value						1,521
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F
Investment Holding [Line Items]
Investment cost		650	[2]			650	[6]
Investments at Fair Value		$ 512				$ 606
Shares | shares		15,116		15,116		15,116		15,116
Investments Owned Acquisition Date		Nov. 17, 2022	[3]	Nov. 17, 2022	[3]	Nov. 17, 2022	[40]	Nov. 17, 2022	[40]
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E
Investment Holding [Line Items]
Investment cost		$ 1,500	[2]			$ 1,500	[6]
Investments at Fair Value		$ 611				$ 915
Shares | shares		248,900		248,900		248,900		248,900
Investments Owned Acquisition Date		Mar. 08, 2022	[3]	Mar. 08, 2022	[3]	Mar. 08, 2022	[40]	Mar. 08, 2022	[40]
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other (0.15%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.15%		0.15%
Investment cost	[2]	$ 6,782
Investments at Fair Value		2,313
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other (0.21%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.21%		0.21%
Investment cost	[6]					$ 6,781
Investments at Fair Value						2,894
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock
Investment Holding [Line Items]
Investment cost		5,095	[2],[39]			5,094	[6],[40]
Investments at Fair Value		$ 1,446	[39]			$ 1,784	[40]
Shares | shares		825,732	[39]	825,732	[39]	825,732	[40]	825,732	[40]
Investments Owned Acquisition Date		Mar. 11, 2019	[3],[39]	Mar. 11, 2019	[3],[39]	Mar. 11, 2019	[40]	Mar. 11, 2019	[40]
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C
Investment Holding [Line Items]
Investment cost		$ 1,687	[2]			$ 1,687	[6]
Investments at Fair Value		$ 867				$ 1,110
Shares | shares		217,880		217,880		217,880		217,880
Investments Owned Acquisition Date		Mar. 30, 2021	[3]	Mar. 30, 2021	[3]	Mar. 30, 2021	[40]	Mar. 30, 2021	[40]
Investment, Identifier [Axis]: Equity Investments Information Services (0.34%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.34%		0.34%
Investment cost	[2]	$ 4,440
Investments at Fair Value		5,469
Investment, Identifier [Axis]: Equity Investments Information Services (0.58%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.58%		0.58%
Investment cost	[6]					$ 4,440
Investments at Fair Value						8,175
Investment, Identifier [Axis]: Equity Investments Information Services and Planet Labs, Inc., Equity, Acquisition Date 6/21/2019, Series Common Stock
Investment Holding [Line Items]
Investment cost		615	[2],[39]			615	[6],[40]
Investments at Fair Value		$ 1,764	[39]			$ 2,383	[40]
Shares | shares		547,880	[39]	547,880	[39]	547,880	[40]	547,880	[40]
Investments Owned Acquisition Date		Jun. 21, 2019	[3],[39]	Jun. 21, 2019	[3],[39]	Jun. 21, 2019	[40]	Jun. 21, 2019	[40]
Investment, Identifier [Axis]: Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E
Investment Holding [Line Items]
Investment cost		$ 3,825	[2]			$ 3,825	[6]
Investments at Fair Value		$ 3,705				$ 3,375
Shares | shares		41,021		41,021		41,021		41,021
Investments Owned Acquisition Date		Dec. 30, 2021	[3],[39]	Dec. 30, 2021	[3],[39]	Dec. 30, 2021	[40]	Dec. 30, 2021	[40]
Investment, Identifier [Axis]: Equity Investments Information Services and Zeta Global Corp., Equity, Acquisition Date 11/20/2007, Series Common Stock
Investment Holding [Line Items]
Investment cost	[6],[40]					$ 0
Investments at Fair Value	[40]					$ 2,417
Shares | shares	[40]					295,861		295,861
Investments Owned Acquisition Date	[40]					Nov. 20, 2007		Nov. 20, 2007
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment (0.02%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.02%		0.02%
Investment cost	[2]	$ 2,953
Investments at Fair Value		369
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment (0.07%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.07%		0.07%
Investment cost	[6]					$ 2,953
Investments at Fair Value						915
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units
Investment Holding [Line Items]
Investment cost	[6],[34]					0
Investments at Fair Value		$ 5	[32]			$ 6	[34]
Shares | shares		180,000	[32]	180,000	[32]	180,000	[34]	180,000	[34]
Investments Owned Acquisition Date		Oct. 15, 2021	[3],[32]	Oct. 15, 2021	[3],[32]	Oct. 15, 2021	[34],[40]	Oct. 15, 2021	[34],[40]
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2
Investment Holding [Line Items]
Investment cost	[2],[32]	$ 250
Investments at Fair Value	[32]	$ 292
Shares | shares	[32]	5,000,000		5,000,000
Investments Owned Acquisition Date	[3],[32]	Oct. 15, 2021		Oct. 15, 2021
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Flowonix Medical Incorporated, Equity, Acquisition Date 11/3/2014, Series Preferred Series AA
Investment Holding [Line Items]
Investment cost		$ 1,500	[2]			$ 1,499	[6]
Investments at Fair Value						$ 0
Shares | shares		221,893		221,893		221,893		221,893
Investments Owned Acquisition Date		Nov. 03, 2014	[3]	Nov. 03, 2014	[3]	Nov. 03, 2014	[40]	Nov. 03, 2014	[40]
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Gelesis, Inc., Equity, Acquisition Date 11/30/2009, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 871	[2],[39]			$ 871	[6],[40]
Investments at Fair Value		$ 59	[39]			$ 433	[40]
Shares | shares		1,490,700	[39]	1,490,700	[39]	1,490,700	[40]	1,490,700	[40]
Investments Owned Acquisition Date		Nov. 30, 2009	[3]	Nov. 30, 2009	[3]	Nov. 30, 2009	[40]	Nov. 30, 2009	[40]
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and ViewRay, Inc., Equity, Acquisition Date 12/16/2013, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 332	[2],[39]			$ 333	[6],[40]
Investments at Fair Value		$ 13	[39]			$ 163	[40]
Shares | shares		36,457	[39]	36,457	[39]	36,457	[40]	36,457	[40]
Investments Owned Acquisition Date		Dec. 16, 2013	[3]	Dec. 16, 2013	[3]	Dec. 16, 2013	[40]	Dec. 16, 2013	[40]
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment, Coronado Aesthetics, LLC
Investment Holding [Line Items]
Investment cost		$ 250	[2]			$ 250	[6]
Investments at Fair Value		$ 297				$ 319
Shares | shares		5,180,000		5,180,000		5,180,000		5,180,000
Investment, Identifier [Axis]: Equity Investments Semiconductors (0.01%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.01%		0.01%
Investment cost	[6]					$ 160
Investments at Fair Value						205
Investment, Identifier [Axis]: Equity Investments Semiconductors (0.02%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.02%		0.02%
Investment cost	[2]	$ 160
Investments at Fair Value		368
Investment, Identifier [Axis]: Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C
Investment Holding [Line Items]
Investment cost		160	[2]			160	[6]
Investments at Fair Value		$ 368				$ 205
Shares | shares		277,995		277,995		277,995		277,995
Investments Owned Acquisition Date		Jul. 01, 2011	[3]	Jul. 01, 2011	[3]	Jul. 01, 2011	[40]	Jul. 01, 2011	[40]
Investment, Identifier [Axis]: Equity Investments Software (1.83%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	1.83%		1.83%
Investment cost	[2]	$ 25,711
Investments at Fair Value		28,941
Investment, Identifier [Axis]: Equity Investments Software (2.07%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					2.07%		2.07%
Investment cost	[6]					$ 32,498
Investments at Fair Value						28,966
Investment, Identifier [Axis]: Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock
Investment Holding [Line Items]
Investment cost		1,000	[2]			1,000	[6]
Investments at Fair Value		$ 965				$ 793
Shares | shares		1,000,000		1,000,000		1,000,000		1,000,000
Investments Owned Acquisition Date		Aug. 09, 2021	[3]	Aug. 09, 2021	[3]	Aug. 09, 2021	[40]	Aug. 09, 2021	[40]
Investment, Identifier [Axis]: Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note
Investment Holding [Line Items]
Investment cost		$ 2,406	[2],[41]			$ 3,000	[6],[42]
Investments at Fair Value		$ 2,406	[41]			$ 3,000	[42]
Shares | shares		3	[41]	3	[41]	3	[42]	3	[42]
Investments Owned Acquisition Date		Mar. 24, 2021	[3],[41]	Mar. 24, 2021	[3],[41]	Mar. 24, 2021	[40],[42]	Mar. 24, 2021	[40],[42]
Investment, Identifier [Axis]: Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-3
Investment Holding [Line Items]
Investment cost		$ 51	[2]			$ 51	[6]
Investments at Fair Value		$ 0				$ 6
Shares | shares		53,614		53,614		53,614		53,614
Investments Owned Acquisition Date		Oct. 26, 2012	[3]	Oct. 26, 2012	[3]	Oct. 26, 2012	[40]	Oct. 26, 2012	[40]
Investment, Identifier [Axis]: Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D
Investment Holding [Line Items]
Investment cost		$ 500	[2],[25],[26]			$ 500	[6],[27],[28]
Investments at Fair Value		$ 736	[25],[26]			$ 732	[27],[28]
Shares | shares		108,500	[25],[26]	108,500	[25],[26]	108,500	[27],[28]	108,500	[27],[28]
Investments Owned Acquisition Date		Nov. 20, 2018	[3],[25],[26]	Nov. 20, 2018	[3],[25],[26]	Nov. 20, 2018	[27],[28],[40]	Nov. 20, 2018	[27],[28],[40]
Investment, Identifier [Axis]: Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C
Investment Holding [Line Items]
Investment cost		$ 138	[2],[25],[26]			$ 138	[6],[27],[28]
Investments at Fair Value		$ 263	[25],[26]			$ 258	[27],[28]
Shares | shares		41,000	[25],[26]	41,000	[25],[26]	41,000	[27],[28]	41,000	[27],[28]
Investments Owned Acquisition Date		Dec. 22, 2020	[3],[25],[26]	Dec. 22, 2020	[3],[25],[26]	Dec. 22, 2020	[27],[28],[40]	Dec. 22, 2020	[27],[28],[40]
Investment, Identifier [Axis]: Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 4,284	[2]			$ 4,284	[6]
Investments at Fair Value		$ 565				$ 503
Shares | shares		20,000		20,000		20,000		20,000
Investments Owned Acquisition Date		Nov. 29, 2018	[3]	Nov. 29, 2018	[3]	Nov. 29, 2018	[40]	Nov. 29, 2018	[40]
Investment, Identifier [Axis]: Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 2
Investment Holding [Line Items]
Investment cost		$ 1,000	[2]			$ 1,000	[6]
Investments at Fair Value		$ 1,706				$ 1,764
Shares | shares		458,841		458,841		458,841		458,841
Investments Owned Acquisition Date		Oct. 22, 2015	[3]	Oct. 22, 2015	[3]	Oct. 22, 2015	[40]	Oct. 22, 2015	[40]
Investment, Identifier [Axis]: Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 3
Investment Holding [Line Items]
Investment cost		$ 300	[2]			$ 300	[6]
Investments at Fair Value		$ 377				$ 395
Shares | shares		93,620		93,620		93,620		93,620
Investments Owned Acquisition Date		Aug. 24, 2017	[3]	Aug. 24, 2017	[3]	Aug. 24, 2017	[40]	Aug. 24, 2017	[40]
Investment, Identifier [Axis]: Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 307	[2]			$ 307	[6]
Investments at Fair Value						$ 0
Shares | shares		190		190		190		190
Investments Owned Acquisition Date		Jan. 18, 2013	[3]	Jan. 18, 2013	[3]	Jan. 18, 2013	[40]	Jan. 18, 2013	[40]
Investment, Identifier [Axis]: Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 265	[2]			$ 265	[6]
Investments at Fair Value		$ 18				$ 24
Shares | shares		38,461		38,461		38,461		38,461
Investments Owned Acquisition Date		Dec. 04, 2020	[3]	Dec. 04, 2020	[3]	Dec. 04, 2020	[40]	Dec. 04, 2020	[40]
Investment, Identifier [Axis]: Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 4,854	[2],[39]			$ 4,854	[6],[40]
Investments at Fair Value		$ 3,323	[39]			$ 2,100	[40]
Shares | shares		1,019,255	[39]	1,019,255	[39]	1,019,255	[40]	1,019,255	[40]
Investments Owned Acquisition Date		Aug. 01, 2018	[3],[39]	Aug. 01, 2018	[3],[39]	Aug. 01, 2018	[40]	Aug. 01, 2018	[40]
Investment, Identifier [Axis]: Equity Investments Software and Palantir Technologies, Equity, Acquisition Date 9/23/2020, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 6,225	[2],[39]			$ 8,670	[6],[40]
Investments at Fair Value		$ 15,611	[39]			$ 9,106	[40]
Shares | shares		1,018,337	[39]	1,018,337	[39]	1,418,337	[40]	1,418,337	[40]
Investments Owned Acquisition Date		Sep. 23, 2020	[3],[39]	Sep. 23, 2020	[3],[39]	Sep. 23, 2020	[40]	Sep. 23, 2020	[40]
Investment, Identifier [Axis]: Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E
Investment Holding [Line Items]
Investment cost		$ 2,000	[2]			$ 2,000	[6]
Investments at Fair Value		$ 1,922				$ 1,940
Shares | shares		580,983		580,983		580,983		580,983
Investments Owned Acquisition Date		Nov. 25, 2020	[3]	Nov. 25, 2020	[3]	Nov. 25, 2020	[40]	Nov. 25, 2020	[40]
Investment, Identifier [Axis]: Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F
Investment Holding [Line Items]
Investment cost		$ 280	[2]			$ 280	[6]
Investments at Fair Value		$ 211				$ 221
Shares | shares		52,956		52,956		52,956		52,956
Investments Owned Acquisition Date		Aug. 12, 2021	[3]	Aug. 12, 2021	[3]	Aug. 12, 2021	[40]	Aug. 12, 2021	[40]
Investment, Identifier [Axis]: Equity Investments Software and Sprinklr, Inc., Equity, Acquisition Date 3/22/2017, Series Common Stock
Investment Holding [Line Items]
Investment cost	[6],[40]					$ 3,748
Investments at Fair Value	[40]					$ 5,719
Shares | shares	[40]					700,000		700,000
Investments Owned Acquisition Date	[40]					Mar. 22, 2017		Mar. 22, 2017
Investment, Identifier [Axis]: Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E
Investment Holding [Line Items]
Investment cost		$ 2,000	[2]			$ 2,000	[6]
Investments at Fair Value		$ 548				$ 1,023
Shares | shares		952,562		952,562		952,562		952,562
Investments Owned Acquisition Date		Jul. 08, 2021	[3]	Jul. 08, 2021	[3]	Jul. 08, 2021	[40]	Jul. 08, 2021	[40]
Investment, Identifier [Axis]: Equity Investments Software and ZeroFox, Inc., Equity, Acquisition Date 5/7/2020, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 101	[2],[39]			$ 101	[6],[40],[43]
Investments at Fair Value		$ 290	[39]			$ 1,382	[40],[43]
Shares | shares		289,992	[39]	289,992	[39]	289,992	[40],[43]	289,992	[40],[43]
Investments Owned Acquisition Date		May 07, 2020	[3],[39]	May 07, 2020	[3],[39]	May 07, 2020	[40],[43]	May 07, 2020	[40],[43]
Investment, Identifier [Axis]: Equity Investments Software, Contentful Global, Inc.
Investment Holding [Line Items]
Investment cost		$ 638	[2]			$ 638	[6]
Investments at Fair Value		$ 999				$ 990
Shares | shares		149,500		149,500		149,500		149,500
Investment, Identifier [Axis]: Equity Investments Software, Druva Holdings, Inc.
Investment Holding [Line Items]
Investment cost		$ 1,300	[2]			$ 1,300	[6]
Investments at Fair Value		$ 2,083				$ 2,159
Shares | shares		552,461		552,461		552,461		552,461
Investment, Identifier [Axis]: Equity Investments Software, SingleStore, Inc.
Investment Holding [Line Items]
Investment cost		$ 2,280	[2]			$ 2,280	[6]
Investments at Fair Value		$ 2,133				$ 2,161
Shares | shares		633,939		633,939		633,939		633,939
Investment, Identifier [Axis]: Equity Investments Surgical Devices (0.18%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.18%		0.18%
Investment cost	[6]					$ 2,479
Investments at Fair Value						2,546
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 1/18/2007, Series Preferred Series B
Investment Holding [Line Items]
Investment cost	[6]					250
Investments at Fair Value						$ 0
Shares | shares						219,298		219,298
Investments Owned Acquisition Date	[40]					Jan. 18, 2007		Jan. 18, 2007
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 12/18/2018, Series Preferred Series F
Investment Holding [Line Items]
Investment cost	[6]					$ 118
Investments at Fair Value						$ 0
Shares | shares						1,523,693		1,523,693
Investments Owned Acquisition Date	[40]					Dec. 18, 2018		Dec. 18, 2018
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 12/18/2018, Series Preferred Series F-1
Investment Holding [Line Items]
Investment cost	[6]					$ 150
Investments at Fair Value						$ 0
Shares | shares						2,418,125		2,418,125
Investments Owned Acquisition Date	[40]					Dec. 18, 2018		Dec. 18, 2018
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 2/8/2013, Series Preferred Series D
Investment Holding [Line Items]
Investment cost	[6]					$ 712
Investments at Fair Value						$ 0
Shares | shares						1,991,157		1,991,157
Investments Owned Acquisition Date	[40]					Feb. 08, 2013		Feb. 08, 2013
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 6/16/2010, Series Preferred Series C
Investment Holding [Line Items]
Investment cost	[6]					$ 282
Investments at Fair Value						$ 0
Shares | shares						656,538		656,538
Investments Owned Acquisition Date	[40]					Jun. 16, 2010		Jun. 16, 2010
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 7/14/2015, Series Preferred Series E
Investment Holding [Line Items]
Investment cost	[6]					$ 429
Investments at Fair Value						$ 0
Shares | shares						2,786,367		2,786,367
Investments Owned Acquisition Date	[40]					Jul. 14, 2015		Jul. 14, 2015
Investment, Identifier [Axis]: Equity Investments Surgical Devices and TransMedics Group, Inc., Equity, Acquisition Date 11/7/2012, Series Common Stock
Investment Holding [Line Items]
Investment cost	[6],[40]					$ 538
Investments at Fair Value	[40]					$ 2,546
Shares | shares	[40]					50,000		50,000
Investments Owned Acquisition Date	[40]					Nov. 07, 2012		Nov. 07, 2012
Investment, Identifier [Axis]: Equity Investments Surgical Devices, Gynesonics, Inc.
Investment Holding [Line Items]
Investment cost	[6]					$ 1,941
Investments at Fair Value						$ 0
Shares | shares						9,595,178		9,595,178
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology (0.33%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.33%		0.33%
Investment cost	[2]	$ 11,508
Investments at Fair Value		5,266
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology (0.57%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.57%		0.57%
Investment cost	[6]					$ 11,508
Investments at Fair Value						7,984
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Equity, Acquisition Date 9/13/2012, Series Preferred Series C-1
Investment Holding [Line Items]
Investment cost		711	[2]			711	[6]
Investments at Fair Value		$ 1,024				$ 995
Shares | shares		187,265		187,265		187,265		187,265
Investments Owned Acquisition Date		Sep. 13, 2012	[3]	Sep. 13, 2012	[3]	Sep. 13, 2012	[40]	Sep. 13, 2012	[40]
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-1
Investment Holding [Line Items]
Investment cost		$ 2,000	[2]			$ 2,000	[6]
Investments at Fair Value		$ 867				$ 2,173
Shares | shares		188,611		188,611		188,611		188,611
Investments Owned Acquisition Date		May 10, 2019	[3]	May 10, 2019	[3]	May 10, 2019	[40]	May 10, 2019	[40]
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 500	[2]			$ 500	[6]
Investments at Fair Value						$ 0
Shares | shares		1,035		1,035		1,035		1,035
Investments Owned Acquisition Date		Jun. 01, 2015	[3]	Jun. 01, 2015	[3]	Jun. 01, 2015	[40]	Jun. 01, 2015	[40]
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and NantEnergy, LLC, Equity, Acquisition Date 8/31/2013, Series Common Units
Investment Holding [Line Items]
Investment cost		$ 102	[2]			$ 102	[6]
Investments at Fair Value						$ 0
Shares | shares		59,665		59,665		59,665		59,665
Investments Owned Acquisition Date		Aug. 31, 2013	[3]	Aug. 31, 2013	[3]	Aug. 31, 2013	[40]	Aug. 31, 2013	[40]
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Equity, Acquisition Date 12/10/2020, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 3,153	[2],[39]			$ 3,153	[6],[40],[43]
Investments at Fair Value		$ 417	[39]			$ 634	[40],[43]
Shares | shares		304,487	[39]	304,487	[39]	304,486	[40],[43]	304,486	[40],[43]
Investments Owned Acquisition Date		Dec. 10, 2020	[3],[39]	Dec. 10, 2020	[3],[39]	Dec. 10, 2020	[40],[43]	Dec. 10, 2020	[40],[43]
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D
Investment Holding [Line Items]
Investment cost		$ 4,500	[2]			$ 4,500	[6]
Investments at Fair Value		$ 2,409				$ 2,456
Shares | shares		593,080		593,080		593,080		593,080
Investments Owned Acquisition Date		Jun. 28, 2021	[3]	Jun. 28, 2021	[3]	Jun. 28, 2021	[40]	Jun. 28, 2021	[40]
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Proterra, Inc., Equity, Acquisition Date 5/28/2015, Series Common Stock
Investment Holding [Line Items]
Investment cost		$ 542	[2],[39]			$ 542	[6],[40]
Investments at Fair Value		$ 549	[39]			$ 1,726	[40]
Shares | shares		457,841	[39]	457,841	[39]	457,841	[40]	457,841	[40]
Investments Owned Acquisition Date		May 28, 2015	[3],[39]	May 28, 2015	[3],[39]	May 28, 2015	[40]	May 28, 2015	[40]
Investment, Identifier [Axis]: Equity Investments and Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock
Investment Holding [Line Items]
Investment cost	[6],[40]					$ 2,255
Investments at Fair Value	[40]					$ 1,763
Shares | shares	[40]					231,329		231,329
Investments Owned Acquisition Date	[40]					Jun. 21, 2018		Jun. 21, 2018
Investment, Identifier [Axis]: Equity Investments and Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock
Investment Holding [Line Items]
Investment cost	[2],[39]	$ 1,000
Investments at Fair Value	[39]	$ 12
Shares | shares	[39]	13,550		13,550
Investments Owned Acquisition Date	[3],[39]	Jan. 08, 2015		Jan. 08, 2015
Investment, Identifier [Axis]: Equity Investments and Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2
Investment Holding [Line Items]
Investment cost	[6],[34]					$ 250
Investments at Fair Value	[34]					$ 313
Shares | shares	[34]					5,000,000		5,000,000
Investments Owned Acquisition Date	[34],[40]					Oct. 15, 2021		Oct. 15, 2021
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments (0.27%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.27%		0.27%
Investment cost	[2]	$ 4,135
Investments at Fair Value		$ 4,353
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments (0.28%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.28%		0.28%
Investment cost	[6]					$ 3,499
Investments at Fair Value						$ 3,893
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development (0.25%)
Investment Holding [Line Items]
Investment owned, percent of net assets		0.25%	[4]	0.25%	[4]	0.25%	[5]	0.25%	[5]
Investment cost		$ 3,754	[2]			$ 3,118	[6]
Investments at Fair Value		4,004				3,518
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/2020
Investment Holding [Line Items]
Investment cost		3,271	[2],[9],[25],[26]			2,699	[6],[10],[27],[28]
Investments at Fair Value		$ 3,239	[9],[25],[26]			$ 3,080	[10],[27],[28]
Investments Owned Acquisition Date		Nov. 16, 2020	[3],[9],[25],[26]	Nov. 16, 2020	[3],[9],[25],[26]	Nov. 16, 2020	[10],[27],[28],[40]	Nov. 16, 2020	[10],[27],[28],[40]
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/2022
Investment Holding [Line Items]
Investment cost		$ 483	[2],[9],[25],[26]			$ 419	[6],[10],[27],[28]
Investments at Fair Value		$ 765	[9],[25],[26]			$ 438	[10],[27],[28]
Investments Owned Acquisition Date		Jun. 23, 2022	[3],[9],[25],[26]	Jun. 23, 2022	[3],[9],[25],[26]	Jun. 23, 2022	[10],[27],[28],[40]	Jun. 23, 2022	[10],[27],[28],[40]
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software (0.02%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.02%		0.02%
Investment cost	[2]	$ 381
Investments at Fair Value		349
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software (0.03%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.03%		0.03%
Investment cost	[6]					$ 381
Investments at Fair Value						$ 375
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022
Investment Holding [Line Items]
Investment cost	[2],[25],[26]	381
Investments at Fair Value	[25],[26]	$ 349
Investments Owned Acquisition Date	[3],[25],[26]	Jul. 21, 2022		Jul. 21, 2022
Investment, Identifier [Axis]: Investments (196.33%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	196.33%		196.33%
Investment cost	[2]	$ 3,114,097
Investments at Fair Value		$ 3,112,789
Investment, Identifier [Axis]: Investments (211.49%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					211.49%		211.49%
Investment cost	[6]					$ 3,005,696
Investments at Fair Value						$ 2,963,955
Investment, Identifier [Axis]: Investments in Securities (196.05%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	196.05%		196.05%
Investment cost	[2]	$ 3,109,962
Investments at Fair Value		$ 3,108,436
Investment, Identifier [Axis]: Investments in Securities (211.21%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					211.21%		211.21%
Investment cost	[6]					$ 3,002,197
Investments at Fair Value						$ 2,960,062
Investment, Identifier [Axis]: Warrant Investments (2.16%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	2.16%		2.16%
Investment cost	[2]	$ 32,085
Investments at Fair Value		$ 34,314
Investment, Identifier [Axis]: Warrant Investments (2.19%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					2.19%		2.19%
Investment cost	[6]					$ 30,964
Investments at Fair Value						$ 30,646
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools (0.03%)
Investment Holding [Line Items]
Investment owned, percent of net assets		0.03%	[4]	0.03%	[4]	0.03%	[5]	0.03%	[5]
Investment cost		$ 485	[2]			$ 485	[6]
Investments at Fair Value		441				486
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Preferred Series B
Investment Holding [Line Items]
Investment cost		24	[2]			24	[6]
Investments at Fair Value		$ 11				$ 23
Shares | shares		15,399		15,399		15,399		15,399
Investments Owned Acquisition Date		Jun. 21, 2022	[3]	Jun. 21, 2022	[3]	Jun. 21, 2022	[40]	Jun. 21, 2022	[40]
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 461	[2]			$ 461	[6]
Investments at Fair Value		$ 430				$ 463
Shares | shares		53,418		53,418		53,418		53,418
Investments Owned Acquisition Date		Dec. 23, 2022	[3]	Dec. 23, 2022	[3]	Dec. 23, 2022	[40]	Dec. 23, 2022	[40]
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking (0.01%)
Investment Holding [Line Items]
Investment owned, percent of net assets		0.01%	[4]	0.01%	[4]	0.01%	[5]	0.01%	[5]
Investment cost		$ 123	[2]			$ 541	[6]
Investments at Fair Value		124				99
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Common Stock
Investment Holding [Line Items]
Investment cost		123	[2]			123	[6]
Investments at Fair Value		$ 124				$ 99
Shares | shares		229,611		229,611		229,611		229,611
Investments Owned Acquisition Date		Jun. 28, 2022	[3]	Jun. 28, 2022	[3]	Jun. 28, 2022	[40]	Jun. 28, 2022	[40]
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking and Spring Mobile Solutions, Inc., Warrant, Acquisition Date 4/19/2013, Common Stock
Investment Holding [Line Items]
Investment cost	[6]					$ 418
Investments at Fair Value						$ 0
Shares | shares						2,834,375		2,834,375
Investments Owned Acquisition Date	[40]					Apr. 19, 2013		Apr. 19, 2013
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products (0.06%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.06%		0.06%
Investment cost	[2]	$ 1,712
Investments at Fair Value		969
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products (0.17%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.17%		0.17%
Investment cost	[6]					$ 1,712
Investments at Fair Value						2,323
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Common Stock
Investment Holding [Line Items]
Investment cost		$ 228	[2]			228	[6]
Investments at Fair Value						$ 0
Shares | shares		1,662,441		1,662,441		1,662,441		1,662,441
Investments Owned Acquisition Date		Jun. 03, 2014	[3]	Jun. 03, 2014	[3]	Jun. 03, 2014	[40]	Jun. 03, 2014	[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Savage X Holding, LLC, Warrant, Acquisition Date 6/27/2014, Class A Units
Investment Holding [Line Items]
Investment cost	[6]					$ 0
Investments at Fair Value		$ 60				$ 1,103
Shares | shares		206,185		206,185		206,185		206,185
Investments Owned Acquisition Date		Jun. 27, 2014	[3]	Jun. 27, 2014	[3]	Jun. 27, 2014	[40]	Jun. 27, 2014	[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and TFG Holding, Inc., Warrant, Acquisition Date 6/27/2014, Common Stock
Investment Holding [Line Items]
Investment cost	[6]					$ 0
Investments at Fair Value						$ 0
Shares | shares		206,185		206,185		206,185		206,185
Investments Owned Acquisition Date		Jun. 27, 2014	[3]	Jun. 27, 2014	[3]	Jun. 27, 2014	[40]	Jun. 27, 2014	[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and TechStyle, Inc., Warrant, Acquisition Date 7/16/2013, Preferred Series B
Investment Holding [Line Items]
Investment cost		$ 1,101	[2]			$ 1,101	[6]
Investments at Fair Value		$ 513				$ 745
Shares | shares		206,185		206,185		206,185		206,185
Investments Owned Acquisition Date		Jul. 16, 2013	[3]	Jul. 16, 2013	[3]	Jul. 16, 2013	[40]	Jul. 16, 2013	[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and The Neat Company, Warrant, Acquisition Date 8/13/2014, Common Stock
Investment Holding [Line Items]
Investment cost		$ 365	[2]			$ 365	[6]
Investments at Fair Value						$ 0
Shares | shares		54,054		54,054		54,054		54,054
Investments Owned Acquisition Date		Aug. 13, 2014	[3]	Aug. 13, 2014	[3]	Aug. 13, 2014	[40]	Aug. 13, 2014	[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Preferred Series C
Investment Holding [Line Items]
Investment cost		$ 18	[2]			$ 18	[6]
Investments at Fair Value		$ 396				$ 475
Shares | shares		686,270		686,270		686,270		686,270
Investments Owned Acquisition Date		Jun. 27, 2018	[3]	Jun. 27, 2018	[3]	Jun. 27, 2018	[40]	Jun. 27, 2018	[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services (0.19%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.19%		0.19%
Investment cost	[6]					$ 4,248
Investments at Fair Value						2,639
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services (0.20%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.20%		0.20%
Investment cost	[2]	$ 4,175
Investments at Fair Value		3,197
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Common Stock
Investment Holding [Line Items]
Investment cost		164	[2],[25],[26]			164	[6],[27],[28]
Investments at Fair Value		$ 53	[25],[26]			$ 34	[27],[28]
Shares | shares		174,163	[25],[26]	174,163	[25],[26]	174,163	[27],[28]	174,163	[27],[28]
Investments Owned Acquisition Date		Dec. 14, 2021	[3],[25],[26]	Dec. 14, 2021	[3],[25],[26]	Dec. 14, 2021	[27],[28],[40]	Dec. 14, 2021	[27],[28],[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Common Stock
Investment Holding [Line Items]
Investment cost		$ 20	[2]			$ 20	[6]
Investments at Fair Value						$ 0
Shares | shares		529,661		529,661		529,661		529,661
Investments Owned Acquisition Date		Oct. 29, 2019	[3]	Oct. 29, 2019	[3]	Oct. 29, 2019	[40]	Oct. 29, 2019	[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Common Stock
Investment Holding [Line Items]
Investment cost		$ 116	[1],[2]			$ 116	[6],[31]
Investments at Fair Value		$ 147	[1]			$ 127	[31]
Shares | shares		11,806	[1]	11,806	[1]	11,806	[31]	11,806	[31]
Investments Owned Acquisition Date		Mar. 12, 2021	[1],[3]	Mar. 12, 2021	[1],[3]	Mar. 12, 2021	[31],[40]	Mar. 12, 2021	[31],[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Preferred Series D
Investment Holding [Line Items]
Investment cost		$ 39	[2]			$ 39	[6]
Investments at Fair Value		$ 40				$ 19
Shares | shares		127,032		127,032		127,032		127,032
Investments Owned Acquisition Date		Mar. 29, 2019	[3]	Mar. 29, 2019	[3]	Mar. 29, 2019	[40]	Mar. 29, 2019	[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Provi, Warrant, Acquisition Date 12/22/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 166	[1],[2]			$ 166	[6],[31]
Investments at Fair Value		$ 143	[1]			$ 155	[31]
Shares | shares		117,042	[1]	117,042	[1]	117,042	[31]	117,042	[31]
Investments Owned Acquisition Date		Dec. 22, 2022	[1],[3]	Dec. 22, 2022	[1],[3]	Dec. 22, 2022	[31],[40]	Dec. 22, 2022	[31],[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Common Stock
Investment Holding [Line Items]
Investment cost		$ 470	[1],[2]			$ 470	[6],[31]
Investments at Fair Value		$ 143	[1]			$ 308	[31]
Shares | shares		13,106	[1]	13,106	[1]	13,106	[31]	13,106	[31]
Investments Owned Acquisition Date		Mar. 12, 2021	[1],[3]	Mar. 12, 2021	[1],[3]	Mar. 12, 2021	[31],[40]	Mar. 12, 2021	[31],[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and RumbleON, Inc., Warrant, Acquisition Date 10/30/2018, Common Stock
Investment Holding [Line Items]
Investment cost	[2],[39]	$ 15
Shares | shares	[39]	1,048		1,048
Investments Owned Acquisition Date	[3],[39]	Oct. 30, 2018		Oct. 30, 2018
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and RumbleON, Inc., Warrant, Acquisition Date 4/30/2018, Common Stock
Investment Holding [Line Items]
Investment cost	[6],[40]					$ 88
Investments at Fair Value	[40]					$ 0
Shares | shares	[40]					5,139		5,139
Investments Owned Acquisition Date	[40]					Apr. 30, 2018		Apr. 30, 2018
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Common Stock
Investment Holding [Line Items]
Investment cost		$ 842	[2],[20],[21]			$ 842	[6],[23],[24]
Investments at Fair Value		$ 2,122	[20],[21]			$ 1,332	[23],[24]
Shares | shares		1,379,761	[20],[21]	1,379,761	[20],[21]	1,379,761	[23],[24]	1,379,761	[23],[24]
Investments Owned Acquisition Date		Jun. 12, 2019	[3],[20],[21]	Jun. 12, 2019	[3],[20],[21]	Jun. 12, 2019	[23],[24],[40]	Jun. 12, 2019	[23],[24],[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc.
Investment Holding [Line Items]
Investment cost		$ 140	[2]			$ 140	[6]
Investments at Fair Value		$ 30				$ 43
Shares | shares		2,051,587		2,051,587		2,051,587		2,051,587
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 57	[2]			$ 57	[6]
Investments at Fair Value		$ 27				$ 43
Shares | shares		1,607,143		1,607,143		1,607,143		1,607,143
Investments Owned Acquisition Date		Nov. 14, 2022	[3]	Nov. 14, 2022	[3]	Nov. 14, 2022	[40]	Nov. 14, 2022	[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Preferred Series B
Investment Holding [Line Items]
Investment cost		$ 83	[2]			$ 83	[6]
Investments at Fair Value		$ 3				$ 0
Shares | shares		444,444		444,444		444,444		444,444
Investments Owned Acquisition Date		Aug. 23, 2019	[3]	Aug. 23, 2019	[3]	Aug. 23, 2019	[40]	Aug. 23, 2019	[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc.
Investment Holding [Line Items]
Investment cost		$ 860	[2]			$ 860	[6]
Investments at Fair Value		$ 45				$ 118
Shares | shares		3,611,537		3,611,537		3,611,537		3,611,537
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Common Stock
Investment Holding [Line Items]
Investment cost		$ 16	[2]			$ 16	[6]
Investments at Fair Value		$ 15				$ 43
Shares | shares		600,000		600,000		600,000		600,000
Investments Owned Acquisition Date		Apr. 20, 2020	[3]	Apr. 20, 2020	[3]	Apr. 20, 2020	[40]	Apr. 20, 2020	[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Preferred Series A
Investment Holding [Line Items]
Investment cost		$ 782	[2]			$ 782	[6]
Investments at Fair Value		$ 20				$ 50
Shares | shares		1,800,000		1,800,000		1,800,000		1,800,000
Investments Owned Acquisition Date		Jun. 30, 2016	[3]	Jun. 30, 2016	[3]	Jun. 30, 2016	[40]	Jun. 30, 2016	[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Preferred Series B
Investment Holding [Line Items]
Investment cost		$ 62	[2]			$ 62	[6]
Investments at Fair Value		$ 10				$ 25
Shares | shares		1,211,537		1,211,537		1,211,537		1,211,537
Investments Owned Acquisition Date		Aug. 01, 2018	[3]	Aug. 01, 2018	[3]	Aug. 01, 2018	[40]	Aug. 01, 2018	[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Common Stock
Investment Holding [Line Items]
Investment cost		$ 844	[2],[20]			$ 844	[6],[23]
Investments at Fair Value		$ 401	[20]			$ 280	[23]
Shares | shares		267,225	[20]	267,225	[20]	267,225	[23]	267,225	[23]
Investments Owned Acquisition Date		May 01, 2018	[3],[20]	May 01, 2018	[3],[20]	May 01, 2018	[23],[40]	May 01, 2018	[23],[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Udacity, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock
Investment Holding [Line Items]
Investment cost		$ 218	[2],[20]			$ 218	[6],[23]
Investments at Fair Value	[23]					$ 4
Shares | shares		486,359	[20]	486,359	[20]	486,359	[23]	486,359	[23]
Investments Owned Acquisition Date		Sep. 25, 2020	[3],[20]	Sep. 25, 2020	[3],[20]	Sep. 25, 2020	[23],[40]	Sep. 25, 2020	[23],[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 126	[2]			$ 126	[6]
Investments at Fair Value		$ 21				$ 25
Shares | shares		98,428		98,428		98,428		98,428
Investments Owned Acquisition Date		Mar. 31, 2022	[3]	Mar. 31, 2022	[3]	Mar. 31, 2022	[40]	Mar. 31, 2022	[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited
Investment Holding [Line Items]
Investment cost		$ 155	[2]			$ 155	[6]
Investments at Fair Value		$ 52				$ 194
Shares | shares		79,083		79,083		79,083		79,083
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Preferred Series D
Investment Holding [Line Items]
Investment cost		$ 129	[2],[20],[21],[25],[26]			$ 129	[6],[23],[24],[27],[28]
Investments at Fair Value		$ 52	[20],[21],[25],[26]			$ 192	[23],[24],[27],[28]
Shares | shares		77,215	[20],[21],[25],[26]	77,215	[20],[21],[25],[26]	77,215	[23],[24],[27],[28]	77,215	[23],[24],[27],[28]
Investments Owned Acquisition Date		Feb. 11, 2021	[3],[20],[21],[25],[26]	Feb. 11, 2021	[3],[20],[21],[25],[26]	Feb. 11, 2021	[23],[24],[27],[28],[40]	Feb. 11, 2021	[23],[24],[27],[28],[40]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Preferred Series E
Investment Holding [Line Items]
Investment cost		$ 26	[2],[21],[25],[26]			$ 26	[6],[24],[27],[28]
Investments at Fair Value	[24],[27],[28]					$ 2
Shares | shares		1,868	[21],[25],[26]	1,868	[21],[25],[26]	1,868	[24],[27],[28]	1,868	[24],[27],[28]
Investments Owned Acquisition Date		Aug. 27, 2021	[3],[21],[25],[26]	Aug. 27, 2021	[3],[21],[25],[26]	Aug. 27, 2021	[24],[27],[28],[40]	Aug. 27, 2021	[24],[27],[28],[40]
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services (0.01%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	(0.01%)		(0.01%)
Investment cost	[2]	$ 214
Investments at Fair Value		167
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Common Stock
Investment Holding [Line Items]
Investment cost	[2]	214
Investments at Fair Value		$ 167
Shares | shares		522,930		522,930
Investments Owned Acquisition Date	[3]	Feb. 03, 2023		Feb. 03, 2023
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery (0.00%)
Investment Holding [Line Items]
Investment owned, percent of net assets		0.00%	[4]	0.00%	[4]	0.00%	[5]	0.00%	[5]
Investment cost		$ 465	[2]			$ 465	[6]
Investments at Fair Value		0				1
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 9/30/2015, Common Stock
Investment Holding [Line Items]
Investment cost		74	[2]			74	[6]
Investments at Fair Value		$ 0				$ 0
Shares | shares		110,882		110,882		110,882		110,882
Investments Owned Acquisition Date		Sep. 30, 2015	[3]	Sep. 30, 2015	[3]	Sep. 30, 2015	[40]	Sep. 30, 2015	[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and BioQ Pharma Incorporated, Warrant, Acquisition Date 10/27/2014, Common Stock
Investment Holding [Line Items]
Investment cost		$ 1	[2]			$ 1	[6]
Investments at Fair Value		$ 0				$ 0
Shares | shares		459,183		459,183		459,183		459,183
Investments Owned Acquisition Date		Oct. 27, 2014	[3]	Oct. 27, 2014	[3]	Oct. 27, 2014	[40]	Oct. 27, 2014	[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and PDS Biotechnology Corporation, Warrant, Acquisition Date 8/28/2014, Common Stock
Investment Holding [Line Items]
Investment cost		$ 390	[2],[39]			$ 390	[6],[40]
Investments at Fair Value		$ 0	[39]			$ 1	[40]
Shares | shares		3,929	[39]	3,929	[39]	3,929	[40]	3,929	[40]
Investments Owned Acquisition Date		Aug. 28, 2014	[3],[39]	Aug. 28, 2014	[3],[39]	Aug. 28, 2014	[40]	Aug. 28, 2014	[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development (0.60%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.60%		0.60%
Investment cost	[6]					$ 7,466
Investments at Fair Value						8,444
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development (0.68%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.68%		0.68%
Investment cost	[2]	$ 7,710
Investments at Fair Value		10,797
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and ADMA Biologics, Inc., Warrant, Acquisition Date 2/24/2014, Common Stock
Investment Holding [Line Items]
Investment cost		166	[2],[39]			166	[6],[40]
Investments at Fair Value		$ 7	[39]			$ 10	[40]
Shares | shares		58,000	[39]	58,000	[39]	58,000	[40]	58,000	[40]
Investments Owned Acquisition Date		Feb. 24, 2014	[3],[39]	Feb. 24, 2014	[3],[39]	Feb. 24, 2014	[40]	Feb. 24, 2014	[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Acacia Pharma Inc., Warrant, Acquisition Date 6/29/2018, Common Stock
Investment Holding [Line Items]
Investment cost	[6],[27],[28]					$ 304
Investments at Fair Value	[27],[28]					$ 0
Shares | shares	[27],[28]					201,330		201,330
Investments Owned Acquisition Date	[27],[28],[40]					Jun. 29, 2018		Jun. 29, 2018
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 175	[2],[25],[39]			$ 56	[6],[27],[40]
Investments at Fair Value		$ 702	[25],[39]			$ 674	[27],[40]
Shares | shares		22,949	[25],[39]	22,949	[25],[39]	18,360	[27],[40]	18,360	[27],[40]
Investments Owned Acquisition Date		Jun. 15, 2022	[3],[25],[39]	Jun. 15, 2022	[3],[25],[39]	Jun. 15, 2022	[27],[40]	Jun. 15, 2022	[27],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Albireo Pharma, Inc., Warrant, Acquisition Date 6/8/2020, Common Stock
Investment Holding [Line Items]
Investment cost	[6],[27],[40]					$ 61
Investments at Fair Value	[27],[40]					$ 31
Shares | shares	[27],[40]					5,311		5,311
Investments Owned Acquisition Date	[27],[40]					Jun. 08, 2020		Jun. 08, 2020
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Class A Units
Investment Holding [Line Items]
Investment cost	[6],[31]					$ 238
Investments at Fair Value	[31]					$ 256
Shares | shares	[31]					69,239		69,239
Investments Owned Acquisition Date	[31],[40]					Dec. 27, 2022		Dec. 27, 2022
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock
Investment Holding [Line Items]
Investment cost		$ 1,289	[2],[20],[21],[25],[39]			$ 880	[6],[23],[24],[27],[40]
Investments at Fair Value		$ 1,707	[20],[21],[25],[39]			$ 1,590	[23],[24],[27],[40]
Shares | shares		61,004	[20],[21],[25],[39]	61,004	[20],[21],[25],[39]	40,396	[23],[24],[27],[40]	40,396	[23],[24],[27],[40]
Investments Owned Acquisition Date		Sep. 25, 2020	[3],[20],[21],[25]	Sep. 25, 2020	[3],[20],[21],[25]	Sep. 25, 2020	[23],[24],[27],[40]	Sep. 25, 2020	[23],[24],[27],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and COMPASS Pathways plc, Warrant, Acquisition Date 6/30/2023, Ordinary Shares
Investment Holding [Line Items]
Investment cost	[2],[25],[26],[39]	$ 278
Investments at Fair Value	[25],[26],[39]	$ 278
Shares | shares	[25],[26],[39]	75,376		75,376
Investments Owned Acquisition Date	[3],[25],[26],[39]	Jun. 30, 2023		Jun. 30, 2023
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Preferred Series B
Investment Holding [Line Items]
Investment cost		$ 287	[1],[2]			$ 287	[6],[31]
Investments at Fair Value		$ 226	[1]			$ 318	[31]
Shares | shares		100,000	[1]	100,000	[1]	100,000	[31]	100,000	[31]
Investments Owned Acquisition Date		Dec. 08, 2021	[1],[3]	Dec. 08, 2021	[1],[3]	Dec. 08, 2021	[31],[40]	Dec. 08, 2021	[31],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Common Stock
Investment Holding [Line Items]
Investment cost		$ 37	[2],[39]			$ 37	[6],[40]
Investments at Fair Value	[40]					$ 3
Shares | shares		16,112	[39]	16,112	[39]	16,112	[40]	16,112	[40]
Investments Owned Acquisition Date		Sep. 14, 2020	[3],[39]	Sep. 14, 2020	[3],[39]	Sep. 14, 2020	[40]	Sep. 14, 2020	[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Curevo, Inc., Warrant, Acquisition Date 6/9/2023, Common Stock
Investment Holding [Line Items]
Investment cost	[1],[2]	$ 233
Investments at Fair Value	[1]	$ 219
Shares | shares	[1]	95,221		95,221
Investments Owned Acquisition Date	[1],[3]	Jun. 09, 2023		Jun. 09, 2023
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Dermavant Sciences Ltd., Warrant, Acquisition Date 5/31/2019, Common Stock
Investment Holding [Line Items]
Investment cost		$ 101	[2],[25],[26]			$ 101	[6],[27],[28]
Investments at Fair Value		$ 94	[25],[26]			$ 199	[27],[28]
Shares | shares		223,642	[25],[26]	223,642	[25],[26]	223,642	[27],[28]	223,642	[27],[28]
Investments Owned Acquisition Date		May 31, 2019	[3],[25],[26]	May 31, 2019	[3],[25],[26]	May 31, 2019	[27],[28],[40]	May 31, 2019	[27],[28],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Evofem Biosciences, Inc., Warrant, Acquisition Date 6/11/2014, Common Stock
Investment Holding [Line Items]
Investment cost		$ 266	[2],[39]			$ 266	[6],[40]
Investments at Fair Value	[40]					$ 0
Shares | shares		3	[39]	3	[39]	520	[40]	520	[40]
Investments Owned Acquisition Date		Jun. 11, 2014	[3],[39]	Jun. 11, 2014	[3],[39]	Jun. 11, 2014	[40]	Jun. 11, 2014	[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.), Warrant, Acquisition Date 2/18/2016, Common Stock
Investment Holding [Line Items]
Investment cost		$ 119	[2],[39]			$ 119	[6],[40]
Investments at Fair Value	[40]					$ 0
Shares | shares		201	[39]	201	[39]	200	[40]	200	[40]
Investments Owned Acquisition Date		Feb. 18, 2016	[3],[39]	Feb. 18, 2016	[3],[39]	Feb. 18, 2016	[40]	Feb. 18, 2016	[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Common Stock
Investment Holding [Line Items]
Investment cost		$ 110	[2],[39]			$ 110	[6],[40]
Investments at Fair Value	[40]					$ 0
Shares | shares		2,202	[39]	2,202	[39]	2,202	[40]	2,202	[40]
Investments Owned Acquisition Date		Dec. 20, 2019	[3],[39]	Dec. 20, 2019	[3],[39]	Dec. 20, 2019	[40]	Dec. 20, 2019	[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 88	[1],[2],[25],[39]			$ 88	[6],[27],[31],[40]
Investments at Fair Value		$ 41	[1],[25],[39]			$ 59	[27],[31],[40]
Shares | shares		14,342	[1],[25],[39]	14,342	[1],[25],[39]	14,342	[27],[31],[40]	14,342	[27],[31],[40]
Investments Owned Acquisition Date		Nov. 02, 2022	[1],[3],[25],[39]	Nov. 02, 2022	[1],[3],[25],[39]	Nov. 02, 2022	[27],[31],[40]	Nov. 02, 2022	[27],[31],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 517	[2],[25],[39]			$ 177	[6],[27],[40]
Investments at Fair Value		$ 1,806	[25],[39]			$ 1,977	[27],[40]
Shares | shares		12,514	[25],[39]	12,514	[25],[39]	10,131	[27],[40]	10,131	[27],[40]
Investments Owned Acquisition Date		May 09, 2022	[3],[25],[39]	May 09, 2022	[3],[25],[39]	May 09, 2022	[27],[40]	May 09, 2022	[27],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Myovant Sciences, Ltd., Warrant, Acquisition Date 10/16/2017, Common Stock
Investment Holding [Line Items]
Investment cost	[6],[27],[28],[40]					$ 460
Investments at Fair Value	[27],[28],[40]					$ 958
Shares | shares	[27],[28],[40]					73,710		73,710
Investments Owned Acquisition Date	[27],[28],[40]					Oct. 16, 2017		Oct. 16, 2017
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Paratek Pharmaceuticals, Inc., Warrant, Acquisition Date 8/1/2018, Common Stock
Investment Holding [Line Items]
Investment cost		$ 520	[2],[39]			$ 520	[6],[40]
Investments at Fair Value		$ 86	[39]			$ 34	[40]
Shares | shares		426,866	[39]	426,866	[39]	426,866	[40]	426,866	[40]
Investments Owned Acquisition Date		Aug. 01, 2018	[3],[39]	Aug. 01, 2018	[3],[39]	Aug. 01, 2018	[40]	Aug. 01, 2018	[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Common Stock
Investment Holding [Line Items]
Investment cost		$ 848	[1],[2],[20],[21],[25],[39]			$ 848	[6],[23],[24],[27],[31],[40]
Investments at Fair Value		$ 216	[1],[20],[21],[25],[39]			$ 101	[23],[24],[27],[31],[40]
Shares | shares		64,687	[1],[20],[21],[25],[39]	64,687	[1],[20],[21],[25],[39]	64,687	[23],[24],[27],[31],[40]	64,687	[23],[24],[27],[31],[40]
Investments Owned Acquisition Date		Sep. 17, 2021	[1],[3],[20],[21],[25],[39]	Sep. 17, 2021	[1],[3],[20],[21],[25],[39]	Sep. 17, 2021	[23],[24],[27],[31],[40]	Sep. 17, 2021	[23],[24],[27],[31],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Provention Bio, Inc., Warrant, Acquisition Date 9/15/2022, Common Stock
Investment Holding [Line Items]
Investment cost	[6],[40]					$ 281
Investments at Fair Value	[40]					$ 677
Shares | shares	[40]					111,934		111,934
Investments Owned Acquisition Date	[40]					Sep. 15, 2022		Sep. 15, 2022
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Preferred Series E
Investment Holding [Line Items]
Investment cost		$ 20	[1],[2]			$ 20	[6],[31]
Investments at Fair Value		$ 9	[1]			$ 21	[31]
Shares | shares		475,510	[1]	475,510	[1]	475,510	[31]	475,510	[31]
Investments Owned Acquisition Date		Mar. 23, 2022	[1],[3],[39]	Mar. 23, 2022	[1],[3],[39]	Mar. 23, 2022	[31],[40]	Mar. 23, 2022	[31],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Common Stock
Investment Holding [Line Items]
Investment cost		$ 296	[2],[20],[39]			$ 296	[6],[23],[40]
Investments at Fair Value		$ 65	[20],[39]			$ 15	[23],[40]
Shares | shares		106,035	[20],[39]	106,035	[20],[39]	106,035	[23],[40]	106,035	[23],[40]
Investments Owned Acquisition Date		May 14, 2021	[3],[20],[39]	May 14, 2021	[3],[20],[39]	May 14, 2021	[23],[40]	May 14, 2021	[23],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 2/28/2019, Common Stock
Investment Holding [Line Items]
Investment cost		$ 1,284	[2],[20],[25],[39]			$ 1,033	[6],[23],[27],[40]
Investments at Fair Value		$ 4,046	[20],[25],[39]			$ 1,084	[23],[27],[40]
Shares | shares		264,226	[20],[25],[39]	264,226	[20],[25],[39]	231,613	[23],[27],[40]	231,613	[23],[27],[40]
Investments Owned Acquisition Date		Feb. 28, 2019	[3],[20],[25],[39]	Feb. 28, 2019	[3],[20],[25],[39]	Feb. 28, 2019	[23],[27],[40]	Feb. 28, 2019	[23],[27],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Tricida, Inc., Warrant, Acquisition Date 3/27/2019, Common Stock
Investment Holding [Line Items]
Investment cost	[6],[40]					$ 280
Investments at Fair Value	[40]					$ 1
Shares | shares	[40]					31,352		31,352
Investments Owned Acquisition Date	[40]					Mar. 27, 2019		Mar. 27, 2019
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Common Units
Investment Holding [Line Items]
Investment cost		$ 256	[2]			$ 256	[6]
Investments at Fair Value		$ 142				$ 127
Shares | shares		102,216		102,216		102,216		102,216
Investments Owned Acquisition Date		Jun. 15, 2020	[3]	Jun. 15, 2020	[3]	Jun. 15, 2020	[40]	Jun. 15, 2020	[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 12/9/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 510	[2],[39]			$ 510	[6],[40]
Investments at Fair Value		$ 931	[39]			$ 281	[40]
Shares | shares		1,392,787	[39]	1,392,787	[39]	1,392,787	[40]	1,392,787	[40]
Investments Owned Acquisition Date		Dec. 09, 2022	[3],[39]	Dec. 09, 2022	[3],[39]	Dec. 09, 2022	[40]	Dec. 09, 2022	[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/30/2021, Preferred Series 3
Investment Holding [Line Items]
Investment cost		$ 72	[2],[20],[25],[26]			$ 72	[6],[23],[27],[28]
Investments at Fair Value	[23],[27],[28]					$ 28
Shares | shares		133,692	[20],[25],[26]	133,692	[20],[25],[26]	133,692	[23],[27],[28]	133,692	[23],[27],[28]
Investments Owned Acquisition Date		Dec. 30, 2021	[3],[20],[25],[26]	Dec. 30, 2021	[3],[20],[25],[26]	Dec. 30, 2021	[23],[27],[28],[40]	Dec. 30, 2021	[23],[27],[28],[40]
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware (0.04%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.04%		0.04%
Investment cost	[2]	$ 692
Investments at Fair Value		662
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware (0.09%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.09%		0.09%
Investment cost	[6]					$ 692
Investments at Fair Value						1,273
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Common Stock
Investment Holding [Line Items]
Investment cost		101	[2],[39]			101	[6],[40]
Investments at Fair Value		$ 60	[39]			$ 86	[40]
Shares | shares		49,078	[39]	49,078	[39]	49,078	[40]	49,078	[40]
Investments Owned Acquisition Date		Mar. 15, 2017	[3],[39]	Mar. 15, 2017	[3],[39]	Mar. 15, 2017	[40]	Mar. 15, 2017	[40]
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 34	[2]			$ 34	[6]
Investments at Fair Value		$ 152				$ 212
Shares | shares		8,503		8,503		8,511		8,511
Investments Owned Acquisition Date		Jun. 21, 2022	[3]	Jun. 21, 2022	[3]	Jun. 21, 2022	[40]	Jun. 21, 2022	[40]
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Common Stock
Investment Holding [Line Items]
Investment cost		$ 557	[2]			$ 557	[6]
Investments at Fair Value		$ 450				$ 975
Shares | shares		622,255		622,255		622,255		622,255
Investments Owned Acquisition Date		Nov. 08, 2021	[3]	Nov. 08, 2021	[3]	Nov. 08, 2021	[40]	Nov. 08, 2021	[40]
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other (0.00%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.00%		0.00%
Investment cost	[6]					$ 114
Investments at Fair Value						14
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other (0.01%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.01%		0.01%
Investment cost	[2]	$ 284
Investments at Fair Value		175
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Modern Life, Inc., Warrant, Acquisition Date 3/30/2023, Common Stock
Investment Holding [Line Items]
Investment cost	[2]	164
Investments at Fair Value		$ 171
Shares | shares		37,618		37,618
Investments Owned Acquisition Date	[3]	Mar. 30, 2023		Mar. 30, 2023
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 120	[2]			114	[6]
Investments at Fair Value		$ 4				$ 14
Shares | shares		150,926		150,926		100,618		100,618
Investments Owned Acquisition Date		Mar. 28, 2022	[3]	Mar. 28, 2022	[3]	Mar. 28, 2022	[40]	Mar. 28, 2022	[40]
Investment, Identifier [Axis]: Warrant Investments and Information Services (0.03%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.03%		0.03%
Investment cost	[2]	$ 680
Investments at Fair Value		466
Investment, Identifier [Axis]: Warrant Investments and Information Services (0.04%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.04%		0.04%
Investment cost	[6]					$ 680
Investments at Fair Value						509
Investment, Identifier [Axis]: Warrant Investments and Information Services and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Common Stock
Investment Holding [Line Items]
Investment cost		207	[1],[2]			207	[6],[31]
Investments at Fair Value		$ 90	[1]			$ 114	[31]
Shares | shares		176,200	[1]	176,200	[1]	176,200	[31]	176,200	[31]
Investments Owned Acquisition Date		Oct. 21, 2021	[1],[3]	Oct. 21, 2021	[1],[3]	Oct. 21, 2021	[31],[40]	Oct. 21, 2021	[31],[40]
Investment, Identifier [Axis]: Warrant Investments and Information Services and INMOBI Inc., Warrant, Acquisition Date 11/19/2014, Common Stock
Investment Holding [Line Items]
Investment cost		$ 82	[2],[25],[26]			$ 82	[6],[27],[28]
Investments at Fair Value		$ 0	[25],[26]			$ 0	[27],[28]
Shares | shares		65,587	[25],[26]	65,587	[25],[26]	65,587	[27],[28]	65,587	[27],[28]
Investments Owned Acquisition Date		Nov. 19, 2014	[3],[25],[26]	Nov. 19, 2014	[3],[25],[26]	Nov. 19, 2014	[27],[28],[40]	Nov. 19, 2014	[27],[28],[40]
Investment, Identifier [Axis]: Warrant Investments and Information Services and NetBase Solutions, Inc., Warrant, Acquisition Date 8/22/2017, Preferred Series 1
Investment Holding [Line Items]
Investment cost		$ 356	[2]			$ 356	[6]
Investments at Fair Value		$ 357				$ 380
Shares | shares		60,000		60,000		60,000		60,000
Investments Owned Acquisition Date		Aug. 22, 2017	[3]	Aug. 22, 2017	[3]	Aug. 22, 2017	[40]	Aug. 22, 2017	[40]
Investment, Identifier [Axis]: Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 35	[2],[25],[26]			$ 35	[6],[27],[28]
Investments at Fair Value		$ 19	[25],[26]			$ 15	[27],[28]
Shares | shares		94,857	[25],[26]	94,857	[25],[26]	94,857	[27],[28]	94,857	[27],[28]
Investments Owned Acquisition Date		Jun. 29, 2022	[3],[25],[26]	Jun. 29, 2022	[3],[25],[26]	Jun. 29, 2022	[27],[28],[40]	Jun. 29, 2022	[27],[28],[40]
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology (0.19%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.19%		0.19%
Investment cost	[2]	$ 1,112
Investments at Fair Value		3,047
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology (0.30%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.30%		0.30%
Investment cost	[6]					$ 1,112
Investments at Fair Value						4,156
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock
Investment Holding [Line Items]
Investment cost		537	[2]			537	[6]
Investments at Fair Value		$ 726				$ 1,154
Shares | shares		392,308		392,308		392,308		392,308
Investments Owned Acquisition Date		Mar. 31, 2022	[3]	Mar. 31, 2022	[3]	Mar. 31, 2022	[40]	Mar. 31, 2022	[40]
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 528	[2]			$ 528	[6]
Investments at Fair Value		$ 1,242				$ 1,202
Shares | shares		1,111,111		1,111,111		1,111,111		1,111,111
Investments Owned Acquisition Date		Mar. 23, 2022	[3]	Mar. 23, 2022	[3]	Mar. 23, 2022	[40]	Mar. 23, 2022	[40]
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and Xometry, Inc., Warrant, Acquisition Date 5/9/2018, Common Stock
Investment Holding [Line Items]
Investment cost		$ 47	[2],[39]			$ 47	[6],[40]
Investments at Fair Value		$ 1,079	[39]			$ 1,800	[40]
Shares | shares		87,784	[39]	87,784	[39]	87,784	[40]	87,784	[40]
Investments Owned Acquisition Date		May 09, 2018	[3],[39]	May 09, 2018	[3],[39]	May 09, 2018	[40]	May 09, 2018	[40]
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info (0.00%)
Investment Holding [Line Items]
Investment owned, percent of net assets		0.00%	[4]	0.00%	[4]	0.00%	[5]	0.00%	[5]
Investment cost		$ 56	[2]			$ 35	[6]
Investments at Fair Value		45				35
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Preferred Series E-1
Investment Holding [Line Items]
Investment cost		56	[2]			35	[6]
Investments at Fair Value		$ 45				$ 35
Shares | shares		350,902		350,902		221,622		221,622
Investments Owned Acquisition Date		Dec. 30, 2022	[3]	Dec. 30, 2022	[3]	Dec. 30, 2022	[40]	Dec. 30, 2022	[40]
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment (0.04%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.04%		0.04%
Investment cost	[2]	$ 1,925
Investments at Fair Value		683
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment (0.07%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.07%		0.07%
Investment cost	[6]					$ 2,034
Investments at Fair Value						919
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Aspire Bariatrics, Inc., Warrant, Acquisition Date 1/28/2015, Common Stock
Investment Holding [Line Items]
Investment cost		455	[2]			455	[6]
Investments at Fair Value		$ 0				$ 0
Shares | shares		22,572		22,572		22,572		22,572
Investments Owned Acquisition Date		Jan. 28, 2015	[3]	Jan. 28, 2015	[3]	Jan. 28, 2015	[40]	Jan. 28, 2015	[40]
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated
Investment Holding [Line Items]
Investment cost		$ 714	[2]			$ 713	[6]
Investments at Fair Value		$ 0				$ 0
Shares | shares		836,752		836,752		836,752		836,752
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated, Warrant, Acquisition Date 11/3/2014, Preferred Series AA
Investment Holding [Line Items]
Investment cost		$ 362	[2]			$ 362	[6]
Investments at Fair Value		$ 0				$ 0
Shares | shares		110,946		110,946		110,946		110,946
Investments Owned Acquisition Date		Nov. 03, 2014	[3]	Nov. 03, 2014	[3]	Nov. 03, 2014	[40]	Nov. 03, 2014	[40]
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated, Warrant, Acquisition Date 9/21/2018, Preferred Series BB
Investment Holding [Line Items]
Investment cost		$ 352	[2]			$ 351	[6]
Investments at Fair Value		$ 0				$ 0
Shares | shares		725,806		725,806		725,806		725,806
Investments Owned Acquisition Date		Sep. 21, 2018	[3]	Sep. 21, 2018	[3]	Sep. 21, 2018	[40]	Sep. 21, 2018	[40]
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Intuity Medical, Inc., Warrant, Acquisition Date 12/29/2017, Preferred Series B-1
Investment Holding [Line Items]
Investment cost		$ 294	[2]			$ 294	[6]
Investments at Fair Value		$ 0				$ 54
Shares | shares		3,076,323		3,076,323		3,076,323		3,076,323
Investments Owned Acquisition Date		Dec. 29, 2017	[3]	Dec. 29, 2017	[3]	Dec. 29, 2017	[40]	Dec. 29, 2017	[40]
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Lucira Health, Inc., Warrant, Acquisition Date 2/4/2022, Common Stock
Investment Holding [Line Items]
Investment cost	[6],[40]					$ 110
Investments at Fair Value	[40]					$ 0
Shares | shares	[40]					59,642		59,642
Investments Owned Acquisition Date	[40]					Feb. 04, 2022		Feb. 04, 2022
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Outset Medical, Inc., Warrant, Acquisition Date 9/27/2013, Common Stock
Investment Holding [Line Items]
Investment cost		$ 401	[2],[39]			$ 401	[6],[40]
Investments at Fair Value		$ 683	[39]			$ 864	[40]
Shares | shares		62,794	[39]	62,794	[39]	62,794	[40]	62,794	[40]
Investments Owned Acquisition Date		Sep. 27, 2013	[3],[39]	Sep. 27, 2013	[3],[39]	Sep. 27, 2013	[40]	Sep. 27, 2013	[40]
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Common Stock
Investment Holding [Line Items]
Investment cost		$ 61	[2],[39]			$ 61	[6],[40]
Investments at Fair Value		$ 0	[39]			$ 1	[40]
Shares | shares		15,712	[39]	15,712	[39]	15,712	[40]	15,712	[40]
Investments Owned Acquisition Date		Mar. 31, 2017	[3],[39]	Mar. 31, 2017	[3],[39]	Mar. 31, 2017	[40]	Mar. 31, 2017	[40]
Investment, Identifier [Axis]: Warrant Investments and Semiconductors (0.04%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.04%		0.04%
Investment cost	[6]					$ 850
Investments at Fair Value						524
Investment, Identifier [Axis]: Warrant Investments and Semiconductors (0.05%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.05%		0.05%
Investment cost	[2]	$ 99
Investments at Fair Value		820
Investment, Identifier [Axis]: Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Preferred Series D-2
Investment Holding [Line Items]
Investment cost		99	[2]			99	[6]
Investments at Fair Value		$ 820				$ 524
Shares | shares		750,000		750,000		750,000		750,000
Investments Owned Acquisition Date		Jun. 26, 2015	[3]	Jun. 26, 2015	[3]	Jun. 26, 2015	[40]	Jun. 26, 2015	[40]
Investment, Identifier [Axis]: Warrant Investments and Semiconductors and Fungible, Inc., Warrant, Acquisition Date 12/16/2021, Common Stock
Investment Holding [Line Items]
Investment cost	[6],[31]					$ 751
Investments at Fair Value	[31]					$ 0
Shares | shares	[31]					800,000		800,000
Investments Owned Acquisition Date	[31],[40]					Dec. 16, 2021		Dec. 16, 2021
Investment, Identifier [Axis]: Warrant Investments and Software (0.59%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.59%		0.59%
Investment cost	[6]					$ 9,761
Investments at Fair Value						8,244
Investment, Identifier [Axis]: Warrant Investments and Software (0.75%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.75%		0.75%
Investment cost	[2]	$ 11,775
Investments at Fair Value		11,870
Investment, Identifier [Axis]: Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Preferred Series G
Investment Holding [Line Items]
Investment cost		74	[2]			74	[6]
Investments at Fair Value		$ 0				$ 0
Shares | shares		231,535		231,535		231,535		231,535
Investments Owned Acquisition Date		May 22, 2015	[3]	May 22, 2015	[3]	May 22, 2015	[40]	May 22, 2015	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 448	[2]			$ 448	[6]
Investments at Fair Value		$ 542				$ 365
Shares | shares		254,778		254,778		254,778		254,778
Investments Owned Acquisition Date		Sep. 23, 2022	[3]	Sep. 23, 2022	[3]	Sep. 23, 2022	[40]	Sep. 23, 2022	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Common Stock
Investment Holding [Line Items]
Investment cost		$ 284	[2]			$ 284	[6]
Investments at Fair Value		$ 514				$ 398
Shares | shares		29,691		29,691		29,691		29,691
Investments Owned Acquisition Date		Nov. 18, 2020	[3]	Nov. 18, 2020	[3]	Nov. 18, 2020	[40]	Nov. 18, 2020	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Common Stock
Investment Holding [Line Items]
Investment cost		$ 165	[1],[2]			$ 165	[6],[31]
Investments at Fair Value		$ 72	[1]			$ 61	[31]
Shares | shares		194,629	[1]	194,629	[1]	194,629	[31]	194,629	[31]
Investments Owned Acquisition Date		Oct. 04, 2021	[1],[3]	Oct. 04, 2021	[1],[3]	Oct. 04, 2021	[31],[40]	Oct. 04, 2021	[31],[40]
Investment, Identifier [Axis]: Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock
Investment Holding [Line Items]
Investment cost		$ 117	[2]			$ 117	[6]
Investments at Fair Value		$ 16				$ 1
Shares | shares		211,342		211,342		211,342		211,342
Investments Owned Acquisition Date		Sep. 30, 2020	[3]	Sep. 30, 2020	[3]	Sep. 30, 2020	[40]	Sep. 30, 2020	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Common Stock
Investment Holding [Line Items]
Investment cost		$ 71	[2]			$ 71	[6]
Investments at Fair Value		$ 46				$ 14
Shares | shares		477,454		477,454		477,454		477,454
Investments Owned Acquisition Date		Nov. 06, 2018	[3]	Nov. 06, 2018	[3]	Nov. 06, 2018	[40]	Nov. 06, 2018	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Preferred Series B
Investment Holding [Line Items]
Investment cost		$ 54	[2],[25],[26]			$ 54	[6],[27],[28]
Investments at Fair Value		$ 611	[25],[26]			$ 400	[27],[28]
Shares | shares		6,763	[25],[26]	6,763	[25],[26]	6,763	[27],[28]	6,763	[27],[28]
Investments Owned Acquisition Date		Apr. 10, 2018	[3],[25],[26]	Apr. 10, 2018	[3],[25],[26]	Apr. 10, 2018	[27],[28],[40]	Apr. 10, 2018	[27],[28],[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Convoy, Inc., Warrant, Acquisition Date 3/30/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 974	[2]			$ 974	[6],[24]
Investments at Fair Value		$ 330				$ 364	[24]
Shares | shares		165,456		165,456		165,456	[24]	165,456	[24]
Investments Owned Acquisition Date		Mar. 30, 2022	[3]	Mar. 30, 2022	[3]	Mar. 30, 2022	[24],[40]	Mar. 30, 2022	[24],[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Common Stock
Investment Holding [Line Items]
Investment cost		$ 462	[2],[39]			$ 462	[6],[40]
Investments at Fair Value		$ 695	[39]			$ 488	[40]
Shares | shares		105,350	[39]	105,350	[39]	105,350	[40]	105,350	[40]
Investments Owned Acquisition Date		Apr. 25, 2019	[3]	Apr. 25, 2019	[3]	Apr. 25, 2019	[40]	Apr. 25, 2019	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 26	[2],[20],[25],[26]			$ 26	[6],[23],[27],[28]
Investments at Fair Value		$ 28	[20],[25],[26]			$ 19	[23],[27],[28]
Shares | shares		102,898	[20],[25],[26]	102,898	[20],[25],[26]	102,898	[23],[27],[28]	102,898	[23],[27],[28]
Investments Owned Acquisition Date		Sep. 21, 2022	[3],[20],[25],[26]	Sep. 21, 2022	[3],[20],[25],[26]	Sep. 21, 2022	[23],[27],[28],[40]	Sep. 21, 2022	[23],[27],[28],[40]
Investment, Identifier [Axis]: Warrant Investments and Software and DNAnexus, Inc., Warrant, Acquisition Date 3/21/2014, Preferred Series C
Investment Holding [Line Items]
Investment cost		$ 97	[2]			$ 97	[6]
Investments at Fair Value		$ 181				$ 131
Shares | shares		909,091		909,091		909,091		909,091
Investments Owned Acquisition Date		Mar. 21, 2014	[3]	Mar. 21, 2014	[3]	Mar. 21, 2014	[40]	Mar. 21, 2014	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Common Stock
Investment Holding [Line Items]
Investment cost		$ 353	[2]			$ 353	[6]
Investments at Fair Value		$ 202				$ 168
Shares | shares		453,641		453,641		453,641		453,641
Investments Owned Acquisition Date		Mar. 11, 2019	[3]	Mar. 11, 2019	[3]	Mar. 11, 2019	[40]	Mar. 11, 2019	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Delphix Corp., Warrant, Acquisition Date 10/8/2019, Common Stock
Investment Holding [Line Items]
Investment cost		$ 1,594	[2]			$ 1,594	[6]
Investments at Fair Value		$ 2,485				$ 2,657
Shares | shares		718,898		718,898		718,898		718,898
Investments Owned Acquisition Date		Oct. 08, 2019	[3]	Oct. 08, 2019	[3]	Oct. 08, 2019	[40]	Oct. 08, 2019	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Common Stock
Investment Holding [Line Items]
Investment cost		$ 545	[2]			$ 545	[6]
Investments at Fair Value		$ 334				$ 180
Shares | shares		727,047		727,047		727,047		727,047
Investments Owned Acquisition Date		Aug. 02, 2021	[3]	Aug. 02, 2021	[3]	Aug. 02, 2021	[40]	Aug. 02, 2021	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Dragos, Inc., Warrant, Acquisition Date 6/28/2023, Common Stock
Investment Holding [Line Items]
Investment cost	[2]	$ 1,453
Investments at Fair Value		$ 1,452
Shares | shares		49,309		49,309
Investments Owned Acquisition Date	[3]	Jun. 28, 2023		Jun. 28, 2023
Investment, Identifier [Axis]: Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 278	[2]			$ 278	[6]
Investments at Fair Value		$ 374				$ 300
Shares | shares		95,911		95,911		95,911		95,911
Investments Owned Acquisition Date		Jun. 30, 2022	[3]	Jun. 30, 2022	[3]	Jun. 30, 2022	[40]	Jun. 30, 2022	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Eigen Technologies Ltd., Warrant, Acquisition Date 4/13/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 8	[2],[25],[26]			$ 8	[6],[27],[28]
Investments at Fair Value		$ 5	[25],[26]			$ 6	[27],[28]
Shares | shares		522	[25],[26]	522	[25],[26]	522	[27],[28]	522	[27],[28]
Investments Owned Acquisition Date		Apr. 13, 2022	[3],[25],[26]	Apr. 13, 2022	[3],[25],[26]	Apr. 13, 2022	[27],[28],[40]	Apr. 13, 2022	[27],[28],[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 583	[2]			$ 583	[6]
Investments at Fair Value		$ 307				$ 382
Shares | shares		362,837		362,837		362,837		362,837
Investments Owned Acquisition Date		Sep. 12, 2022	[3]	Sep. 12, 2022	[3]	Sep. 12, 2022	[40]	Sep. 12, 2022	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Esme Learning Solutions, Inc., Warrant, Acquisition Date 1/27/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 198	[2]			$ 198	[6]
Investments at Fair Value		$ 0				$ 0
Shares | shares		56,765		56,765		56,765		56,765
Investments Owned Acquisition Date		Jan. 27, 2022	[3]	Jan. 27, 2022	[3]	Jan. 27, 2022	[40]	Jan. 27, 2022	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Evernote Corporation, Warrant, Acquisition Date 9/30/2016, Common Stock
Investment Holding [Line Items]
Investment cost	[6]					$ 107
Investments at Fair Value						$ 6
Shares | shares						62,500		62,500
Investments Owned Acquisition Date	[40]					Sep. 30, 2016		Sep. 30, 2016
Investment, Identifier [Axis]: Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Preferred Series B
Investment Holding [Line Items]
Investment cost		$ 96	[2]			$ 96	[6]
Investments at Fair Value		$ 55				$ 39
Shares | shares		75,917		75,917		75,917		75,917
Investments Owned Acquisition Date		May 10, 2018	[3]	May 10, 2018	[3]	May 10, 2018	[40]	May 10, 2018	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 325	[2]			$ 325	[6]
Investments at Fair Value		$ 408				$ 314
Shares | shares		84,995		84,995		84,995		84,995
Investments Owned Acquisition Date		Jul. 29, 2022	[3]	Jul. 29, 2022	[3]	Jul. 29, 2022	[40]	Jul. 29, 2022	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Kore.ai, Inc., Warrant, Acquisition Date 3/31/2023, Preferred Series C
Investment Holding [Line Items]
Investment cost	[2]	$ 208
Investments at Fair Value		$ 273
Shares | shares		64,293		64,293
Investments Owned Acquisition Date	[3]	Mar. 31, 2023		Mar. 31, 2023
Investment, Identifier [Axis]: Warrant Investments and Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Common Stock
Investment Holding [Line Items]
Investment cost	[2],[20],[25],[26]	$ 16
Investments at Fair Value	[20],[25],[26]	$ 16
Shares | shares	[20],[25],[26]	39,948		39,948
Investments Owned Acquisition Date	[3],[20],[25],[26]	Jan. 23, 2023		Jan. 23, 2023
Investment, Identifier [Axis]: Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Preferred Series D
Investment Holding [Line Items]
Investment cost		$ 131	[2]			$ 131	[6]
Investments at Fair Value		$ 37				$ 1
Shares | shares		89,685		89,685		89,685		89,685
Investments Owned Acquisition Date		Feb. 14, 2018	[3]	Feb. 14, 2018	[3]	Feb. 14, 2018	[40]	Feb. 14, 2018	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock
Investment Holding [Line Items]
Investment cost		$ 252	[2]			$ 252	[6]
Investments at Fair Value		$ 299				$ 225
Shares | shares		82,362		82,362		82,362		82,362
Investments Owned Acquisition Date		Sep. 30, 2020	[3]	Sep. 30, 2020	[3]	Sep. 30, 2020	[40]	Sep. 30, 2020	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Nuvolo Technologies Corporation, Warrant, Acquisition Date 3/29/2019, Common Stock
Investment Holding [Line Items]
Investment cost		$ 172	[2],[20]			$ 172	[6],[23]
Investments at Fair Value		$ 156	[20]			$ 175	[23]
Shares | shares		70,000	[20]	70,000	[20]	70,000	[23]	70,000	[23]
Investments Owned Acquisition Date		Mar. 29, 2019	[3],[20]	Mar. 29, 2019	[3],[20]	Mar. 29, 2019	[23],[40]	Mar. 29, 2019	[23],[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Poplicus, Inc., Warrant, Acquisition Date 5/28/2014, Common Stock
Investment Holding [Line Items]
Investment cost		$ 0	[2]			$ 0	[6]
Investments at Fair Value		$ 0				$ 0
Shares | shares		132,168		132,168		132,168		132,168
Investments Owned Acquisition Date		May 28, 2014	[3]	May 28, 2014	[3]	May 28, 2014	[40]	May 28, 2014	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Common Stock
Investment Holding [Line Items]
Investment cost		$ 215	[2]			$ 215	[6]
Investments at Fair Value		$ 383				$ 298
Shares | shares		69,120		69,120		69,120		69,120
Investments Owned Acquisition Date		Jun. 30, 2020	[3]	Jun. 30, 2020	[3]	Jun. 30, 2020	[40]	Jun. 30, 2020	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and SignPost, Inc., Warrant, Acquisition Date 1/13/2016, Series Junior 1 Preferred
Investment Holding [Line Items]
Investment cost		$ 314	[2]			$ 314	[6]
Investments at Fair Value		$ 0				$ 0
Shares | shares		474,019		474,019		474,019		474,019
Investments Owned Acquisition Date		Jan. 13, 2016	[3]	Jan. 13, 2016	[3]	Jan. 13, 2016	[40]	Jan. 13, 2016	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Common Stock
Investment Holding [Line Items]
Investment cost	[2]	$ 96
Investments at Fair Value		$ 73
Shares | shares		77,934		77,934
Investments Owned Acquisition Date	[3]	Mar. 22, 2023		Mar. 22, 2023
Investment, Identifier [Axis]: Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Preferred Series D
Investment Holding [Line Items]
Investment cost		$ 103	[2]			$ 103	[6]
Investments at Fair Value		$ 513				$ 426
Shares | shares		312,596		312,596		312,596		312,596
Investments Owned Acquisition Date		Apr. 28, 2020	[3]	Apr. 28, 2020	[3]	Apr. 28, 2020	[40]	Apr. 28, 2020	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/28/2023, Ordinary Shares
Investment Holding [Line Items]
Investment cost	[25],[26]	$ 174
Investments at Fair Value	[25],[26]	$ 169
Shares | shares	[25],[26]	321,956		321,956
Investments Owned Acquisition Date	[3],[25],[26]	Jun. 08, 2023		Jun. 08, 2023
Investment, Identifier [Axis]: Warrant Investments and Software and Tact.ai Technologies, Inc., Warrant, Acquisition Date 2/13/2020, Common Stock
Investment Holding [Line Items]
Investment cost		$ 206	[2]			$ 206	[6]
Investments at Fair Value		$ 35				$ 69
Shares | shares		1,041,667		1,041,667		1,041,667		1,041,667
Investments Owned Acquisition Date		Feb. 13, 2020	[3]	Feb. 13, 2020	[3]	Feb. 13, 2020	[40]	Feb. 13, 2020	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and The Faction Group LLC, Warrant, Acquisition Date 11/3/2014, Preferred Series AA
Investment Holding [Line Items]
Investment cost		$ 234	[2]			$ 234	[6]
Investments at Fair Value		$ 730				$ 436
Shares | shares		8,076		8,076		8,076		8,076
Investments Owned Acquisition Date		Nov. 03, 2014	[3]	Nov. 03, 2014	[3]	Nov. 03, 2014	[40]	Nov. 03, 2014	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Ordinary Shares
Investment Holding [Line Items]
Investment cost	[2],[25],[26]	$ 174
Investments at Fair Value	[25],[26]	$ 204
Shares | shares	[25],[26]	254,877		254,877
Investments Owned Acquisition Date	[3],[25],[26]	Mar. 22, 2023		Mar. 22, 2023
Investment, Identifier [Axis]: Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Common Stock
Investment Holding [Line Items]
Investment cost		$ 1,275	[1],[2]			$ 1,275	[6],[31]
Investments at Fair Value		$ 325	[1]			$ 321	[31]
Shares | shares		152,048	[1]	152,048	[1]	152,048	[31]	152,048	[31]
Investments Owned Acquisition Date		Jan. 21, 2022	[1],[3]	Jan. 21, 2022	[1],[3]	Jan. 21, 2022	[31],[40]	Jan. 21, 2022	[31],[40]
Investment, Identifier [Axis]: Warrant Investments and Surgical Devices (0.04%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.04%		0.04%
Investment cost	[6]					$ 46
Investments at Fair Value						492
Investment, Identifier [Axis]: Warrant Investments and Surgical Devices (0.05%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.05%		0.05%
Investment cost	[2]	$ 39
Investments at Fair Value		731
Investment, Identifier [Axis]: Warrant Investments and Surgical Devices and Gynesonics, Inc., Warrant, Acquisition Date 1/16/2013, Preferred Series C
Investment Holding [Line Items]
Investment cost	[6]					7
Investments at Fair Value						$ 0
Shares | shares						16,835		16,835
Investments Owned Acquisition Date	[40]					Jan. 16, 2013		Jan. 16, 2013
Investment, Identifier [Axis]: Warrant Investments and Surgical Devices and TransMedics Group, Inc., Warrant, Acquisition Date 9/11/2015, Common Stock
Investment Holding [Line Items]
Investment cost		39	[2],[39]			$ 39	[6],[40]
Investments at Fair Value		$ 731	[39]			$ 492	[40]
Shares | shares		14,440	[39]	14,440	[39]	14,440	[40]	14,440	[40]
Investments Owned Acquisition Date		Sep. 11, 2015	[3],[39]	Sep. 11, 2015	[3],[39]	Sep. 11, 2015	[40]	Sep. 11, 2015	[40]
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology (0.01%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[4]	0.01%		0.01%
Investment cost	[2]	$ 539
Investments at Fair Value		120
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology (0.03%)
Investment Holding [Line Items]
Investment owned, percent of net assets	[5]					0.03%		0.03%
Investment cost	[6]					$ 723
Investments at Fair Value						488
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Common Stock
Investment Holding [Line Items]
Investment cost		52	[2]			52	[6]
Investments at Fair Value		$ 45				$ 44
Shares | shares		18,472		18,472		18,472		18,472
Investments Owned Acquisition Date		Apr. 15, 2022	[3]	Apr. 15, 2022	[3]	Apr. 15, 2022	[40]	Apr. 15, 2022	[40]
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Warrant, Acquisition Date 4/30/2013, Preferred Series C-1
Investment Holding [Line Items]
Investment cost	[6]					$ 64
Investments at Fair Value						$ 275
Shares | shares						93,632		93,632
Investments Owned Acquisition Date	[40]					Apr. 30, 2013		Apr. 30, 2013
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc.
Investment Holding [Line Items]
Investment cost		$ 218	[2]			$ 218	[6]
Investments at Fair Value		$ 75				$ 169
Shares | shares		456,883		456,883		456,883		456,883
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/22/2014, Preferred Series A
Investment Holding [Line Items]
Investment cost		$ 155	[2]			$ 155	[6]
Investments at Fair Value		$ 57				$ 126
Shares | shares		325,000		325,000		325,000		325,000
Investments Owned Acquisition Date		Apr. 22, 2014	[3]	Apr. 22, 2014	[3]	Apr. 22, 2014	[40]	Apr. 22, 2014	[40]
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/7/2015, Preferred Series B
Investment Holding [Line Items]
Investment cost		$ 63	[2]			$ 63	[6]
Investments at Fair Value		$ 18				$ 43
Shares | shares		131,883		131,883		131,883		131,883
Investments Owned Acquisition Date		Apr. 07, 2015	[3]	Apr. 07, 2015	[3]	Apr. 07, 2015	[40]	Apr. 07, 2015	[40]
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and IngredientWerks Holdings, Inc. (p.k.a Agrivida, Inc.), Warrant, Acquisition Date 6/20/2013, Preferred Series D
Investment Holding [Line Items]
Investment cost	[6]					$ 120
Investments at Fair Value						$ 0
Shares | shares						471,327		471,327
Investments Owned Acquisition Date	[40]					Jun. 20, 2013		Jun. 20, 2013
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Polyera Corporation, Warrant, Acquisition Date 3/24/2015, Preferred Series C
Investment Holding [Line Items]
Investment cost		$ 269	[2]			$ 269	[6]
Investments at Fair Value		$ 0				$ 0
Shares | shares		150,036		150,036		150,036		150,036
Investments Owned Acquisition Date		Mar. 24, 2015	[3]	Mar. 24, 2015	[3]	Mar. 24, 2015	[40]	Mar. 24, 2015	[40]
Investment, Identifier [Axis]: nvestment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022
Investment Holding [Line Items]
Investment cost	[6],[27],[28]					$ 381
Investments at Fair Value	[27],[28]					$ 375
Investments Owned Acquisition Date	[27],[28],[40]					Jul. 21, 2022		Jul. 21, 2022
[1] Denotes that all or a portion of the investment in this portfolio company is held by Hercules Capital IV, L.P., the Company’s wholly owned small business investment company. [2] Gross unrealized appreciation, gross unrealized depreciation, and net unrealized appreciation for federal income tax purposes totaled $92.5 million, $92.0 million and $0.5 million, respectively. The tax cost of investments is $3.1 billion. [3] Unless otherwise noted, all securities are restricted as of June 30, 2023 and were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s valuation committee (the “Valuation Committee”) and approved by the board of directors (the “Board”). [4] Value as a percent of net assets. All amounts are stated in U.S. Dollars unless otherwise noted. The Company uses the Standard Industrial Code for classifying the industry grouping of its portfolio companies. [5] Value as a percent of net assets. All amounts are stated in U.S. Dollars unless otherwise noted. The Company uses the Standard Industrial Code for classifying the industry grouping of its portfolio companies. [6] Gross unrealized appreciation, gross unrealized depreciation, and net unrealized depreciation for federal income tax purposes totaled $72.2 million, $112.0 million, and $39.8 million, respectively. The tax cost of investments is $3.0 billion. [7] Denotes that all or a portion of the debt investment principal includes accumulated PIK interest and is net of repayments. [8] Denotes that all or a portion of the debt investment secures the 2031 Asset-Backed Notes (as defined in “Note 5 — Debt”). [9] Denotes that there is an unfunded contractual commitment available at the request of this portfolio company as of June 30, 2023 (Refer to “Note 11 - Commitments and Contingencies”). [10] Denotes that there is an unfunded contractual commitment available at the request of this portfolio company as of December 31, 2022 (Refer to “Note 11 — Commitments and Contingencies”). [11] Interest rate PRIME represents 8.25% as of June 30, 2023. 1-month LIBOR, 3-month LIBOR and 6-month LIBOR represent 5.22%, 5.55%, and 5.76%, respectively, as of June 30, 2023. 1-month SOFR, 3-month SOFR and 6-month SOFR represent 5.07%, 5.00%, and 4.78%, respectively, as of June 30, 2023. [12] Interest rate PRIME represents 7.50% as of December 31, 2022. 1-month LIBOR, 3-month LIBOR, and 6-month LIBOR represent 4.40%, 4.77%, and 5.14%, respectively, as of December 31, 2022. [13] Denotes second lien senior secured debt. [14] Denotes second lien senior secured debt. [15] Denotes that all or a portion of the debt investment principal includes accumulated PIK interest and is net of repayments. [16] Denotes that all or a portion of the debt investment is pledged as collateral under the SMBC Facility (as defined in “Note 5 — Debt”). [17] Denotes unitranche debt with first lien “last-out” senior secured position and security interest in all assets of the portfolio company whereby the “last-out” portion will be subordinated to the “first-out” portion in a liquidation, sale or other disposition. [18] Denotes that all or a portion of the debt investment is pledged as collateral under the SMBC Facility (as defined in “Note 5 — Debt”). [19] Denotes unitranche debt with first lien “last-out” senior secured position and security interest in all assets of the portfolio company whereby the “last-out” portion will be subordinated to the “first-out” portion in a liquidation, sale or other disposition. [20] Denotes that all or a portion of the investment is pledged as collateral under the MUFG Bank Facility (as defined in “Note 5 — Debt”). [21] Denotes that the fair value of the Company’s total investments in this portfolio company represent greater than 5% of the Company’s total net assets as of June 30, 2023. [22] Denotes that all or a portion of the debt investment secures the 2031 Asset-Backed Notes (as defined in “Note 5 — Debt”). [23] Denotes that all or a portion of the investment is pledged as collateral under the MUFG Bank Facility (as defined in “Note 5 — Debt”). [24] Denotes that the fair value of the Company’s total investments in this portfolio company represent greater than 5% of the Company’s total net assets as of December 31, 2022. [25] Indicates assets that the Company deems not “qualifying assets” under section 55(a) of 1940 Act. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets. [26] Non-U.S. company or the company’s principal place of business is outside the United States. [27] Indicates assets that the Company deems not “qualifying assets” under section 55(a) of 1940 Act. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets. [28] Non-U.S. company or the company’s principal place of business is outside the United States. [29] Denotes that all or a portion of the debt investment is convertible debt. [30] Denotes that all or a portion of the debt investment is convertible debt. [31] Denotes that all or a portion of the investment in this portfolio company is held by Hercules Capital IV, L.P., the Company’s wholly owned small business investment company. [32] Control investment as defined under the 1940 Act in which Hercules owns at least 25% of the company’s voting securities or has greater than 50% representation on its board. [33] Debt is on non-accrual status as of June 30, 2023, and is therefore considered non-income producing. Note that as of June 30, 2023, only the PIK, or payment-in-kind, portion is on non-accrual for the Company’s debt investment in Tectura Corporation. [34] Control investment as defined under the 1940 Act in which Hercules owns at least 25% of the company’s voting securities or has greater than 50% representation on its board. [35] Debt is on non-accrual status as of December 31, 2022, and is therefore considered non-income producing. Note that as of December 31, 2022, only the PIK, or payment-in-kind, portion is on non-accrual for the Company’s debt investment in Tectura Corporation. [36] Gibraltar Acquisition LLC is a wholly-owned subsidiary, which is the holding company for their wholly-owned affiliated portfolio companies, Gibraltar Business Capital, LLC and Gibraltar Equipment Finance, LLC. [37] Denotes the security holds rights to royalty fee income associated with certain products of the portfolio company. The approximate cost and fair value of the royalty contract are $4.6 million and $3.1 million, respectively. [38] Denotes the security holds rights to royalty fee income associated with certain products of the portfolio company. The approximate cost and fair value of the royalty contract are $4.6 million and $3.4 million, respectively. [39] Denotes an investment in common stock or warrants of a publicly traded company. None of the publicly traded company securities are restricted securities as defined under the Securities Act of 1933 ("Securities Act") as of June 30, 2023. [40] Except for warrants in 27 publicly traded companies and common stock in 43 publicly traded companies, all investments are restricted as of December 31, 2022 and were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s valuation committee (the “Valuation Committee”) and approved by the board of directors (the “Board”). [41] Denotes investment in a non-voting security in the form of a promissory note. The terms of the notes provide the Company with a lien on the issuers' shares of Common Stock for Black Crow AI, Inc., subject to release upon repayment of the outstanding balance of the notes. As of June 30, 2023, the Black Crow AI, Inc. affiliates promissory notes had an outstanding balance of $2.4 million. [42] Denotes investment in a non-voting security in the form of a promissory note. The terms of the notes provide the Company with a lien on the issuers' shares of Common Stock for Black Crow AI, Inc., subject to release upon repayment of the outstanding balance of the notes. As of December 31, 2022, the Black Crow AI, Inc. affiliates promissory notes had an outstanding balance of $3.0 million. [43] Denotes all or a portion of the public equity or warrant investment was acquired in a transaction exempt from registration under the Securities Act of 1933 (“Securities Act”) and may be deemed to be “restricted securities” under the Securities Act.